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ABSTRACT
1
This final report of the results of research conducted with various
3
halocarbon compounds by the Institute of Human and Comparative Toxicology
(previously, the Institute of Experimental Pathology and Toxicology) of
•
Albany Medical College is in compliance with the requirements set forth in
the contract, NAS 9-9964, and/or agreed upon between the contractor and the
contract monitor. i
i
The research reported herein constitutes primarily the conclusions
reached by the contractor during this 4-year project. Detailed reports of
various aspects of the work are on file with the contracting agency.
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A. INTRODUCTION
Halogenated hydrocarbons are widely used in industry with the fluorinated
methanes and ethanes having found important use as dielectrics, refrigerants,
propellants, organic solvents, and fire extinguishers and suppressants. The
compounds (termed fluorocarbons since the properties are largely governed by
the fluorine moiety) are commanding an increasing market in consumer products
such as food toppings, hair sprays, deodorants, etc., from their use as
propellants. Although our interest in fluorocarbons was broadbased, attention
9
was largely addressed to determining the most feasible candidate fire extinguisher
-#
	
	 and/or suppressant. When used as fire suppressants in a confined space, such
as a spacecraft, aircraft, submarine, warehouse, etc., these compounds would
be inhaled by man on an almost continuous basis.
In order to evaluate the safety of the candidate fluorocarbons in relation
to man, we devised experiments, short-term exposures, in various animal species,
to look at specific parameters in; order to determine which of the candidate
compounds (Tahle A-I) were sufficiently non-toxic to warrant further investigation,
i.e., long-term exposures.
To provide the most comprehensive evaluation, of the toxic-potential of each
compound numerous physiologic criteria, were examined: tissue distribution,
fluoride ion concentration, effect on mitochondria, microsomes, liposomes and
liver cell nuclei, erythrocyte fragility, clinical chemistryvalues, hematology,
pathology, cardiac sensitization, behavioral effects, etc. It must be understood,
t
	
	
that data for all these parameters were not evaluated for all compounds since,
if,a specific compound was determined to be overtly toxic, thus elminating its
potential application for continuous exposure to man, further investigations
generally were not conducted.
a
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For these experiments, we used primarily rodent species for initial
investigations, with non-human primate exposure for Freon 116 which was
warranted by the negative results in rodents.
Species used included: rats (Sprague-Dawley), mice (Swiss albino),
rabbits (Dutch Belted and New Zealand), guinea pigs, dogs, cats, and monkeys
(Maraca mulatta). The choice of species was suggested by both the nature of
the compound and the parameter under investigation.
Animal exposures took place in various types of chambers. The chamber
selected for a particular experiment was dependent on three factors: length
of exposure, species used, and compound used.
Long-term exposures were conducted in the "closed dynamic" chambers which
allowed for a recirculating atmosphere and monitoring of CO 2 and 0 2 levels as
well as the particular halocarbon. Details. of the operation are described in
the Appendix (Studies in Rats Exposed Continuously.to
 Hexachloroethane).
For short-term exposures of rodents, we used either a 100 liter metabolic
exposure chamber, a 65 liter plexiglass inhalation chamber or, as in the case
of the LORRT experiments, a glove-bag chamber;(68 cm x 68 cm). These static
chambers were sufficient for exposures which were of 30 min duration or less.
For the monkey studies, either the long-term-exposure chamber or a
4. !
	
	 especially-designed behavioral chamber was used. This recirculating chamber
(So cu. ft.) was designed with a behavioral-task panel and monitored by
television to enable the investigator to observe the animal. The animal , was
t
F
	
	
unable to see out of the chamber, thus eliminating outside disturbances from
effecting performance.
2
Table A. I. COMPOUNDS OF INTEREST
A.	 Substituted methanes
Halon 1301 Bromotrifluorompthane CBrrj
Halon 1202 Dibronodifluoromethan- C?r2 F2
i
Freon 11 Trichlorofluoromethane CCl3 F
Freon 12 Dichlorodifluoromethane CC12 F2
B.	 Substituted ethanes
Freon 116 Hexafluoroethane CF3-CF3
9
Freon 115 Chloropentafluoroethane
s
CC1F2-CF2
	 {
Freon 114	 1, 2-Dichlorotetrafluoroethane -CC1F2-CC1F2
Halon 2402	 1, 2-Dibrorrotetrafluoroethane CBrF2-CErF2
Freon 113	 1, 1, 2-Trichlora-1, 2,
2-trifluoroethane Cci F-CC1r2
Halothane nromochlorotrifluoroethane C1iBrCi-Cf3
C.	 Other
i
Freon C-318 Octafluorocyclobutene C4 '3	 e
k
a
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S. METABOLISM
Tissue distribution and/or blood.levels of the fluorocarbon were deter-
mined following exposures of varying lengths of primarily rats and rabbits.
Five fluorocarbons were used in these exposures: Halons 2402, 1201 and 1301
and Freons 113, 116 and 12. Tissues. sampled included: liver, lung, heart,
brain, kidney, muscle and fat. Techniques developed for analyzing the content
of these fluorocarbons in the blood were developed in house. This and
other analytical procedures were described herein. Results of the exposures
and data accumulated are discussed by compound.
In order to determine the possibility of accumulations of F in bone,
data was obtained from some exposures. Urine F concentration data are also
included.
Analytical Procedures
Tissue Analys-is
Due to the high volatility of the halocarbons under investigation,
preliminary data of tissue concentrations revealed that recovery was only
about: 50%; therefore, methodologies were examined in order to determine which}
`	 procedure would provide the best recovery of these compounds from organicE	 ^
material. The procedure outlined below was _selected.
Tissue samples (1-5 g) were weighed and placed in a homogenizer.
One (1) ml of 1-butanol containing 0.216 Ug of Halon 2402 was added. An
E
additional 5 m1 of 1-butanol was also added and the tissues homogenized.
The homogenate was washed into a 50-m1 centrifuge tube using 10 ml of
-isooctane, and the homogenizes rinsed with 10  ml of isooctane.
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The centrifuge tube was stoppered, placed on a shaker for 30 min t
 and
then centrifuged. A 0.5 ml sample of supernatant was removed and diluted to
50 ml using isooctane. This final solution was injected into the gas
chromatograph.
A Hewlett/Packard 402 with electron capture detector was used. The
6' X 1/8' U-shaped glass column was packed with Poraoil "B". The carrier
gas was 95% Argon and 5% Methane. Injector port, column and detector were
;Maintained at 260°C, 150°C and 280°C, respectively. The detector was linear
between 10-12 and 10 log, and all readings were made in this range.
ff	 Blood Analysis
,	 1
Standards. Calibration curves were prepared using static methods for
making appropriate dilutions of Halon 1301 in air. Gas-tight equipment
	
-1
(syringes, volumetric glassware, etc.) was used throughout. The gas samples
were injected into the gas chromatography with syringes. Chromatographic
conditions were as follow:
Column: 6" X 3.5 mm glass. packed with 80/100 mesh Porapak Q. The
carrier gas was nitrogen flowing at 100 ml/min, and temperature was at
E
	
	 115°C. The injector and detector were maintained at 170°C and 250°C,
respectively.
Recovery studies. Since gaseous halocarbons are insoluble in aqueous
solutions, preparation of suitahle "spiked" samples for recoveries was
rendered practically impossible. To obtain some information on recoveries,,
experiments were carried out on samples to which known quantities of Halon
1301 were added to closed contaia;ars of blood and time allowed for diffusion
of the gas into the blood. Concentration of Halon 1301 in the air above the
blood was determined. The air above the blood was removed by flushing with
c,
dry nitrogen; the containers were allowed to stand for a suitable period of time,'
l
tand the concentration of Halon 1301 again determined. Using this procedure,
the recovery was between 87 and 110J which we felt acceptable considering
the amounts being detected and the small volumes being handled.
In all experiments using these techniques, the following precautions
were taken. Vials, with. rubber stopper, were weighed empty and again
completely filled with water to accurately determine their volume. Actual
blood volumes were computed from the weight of the sample and vial, and the
density of blood.
Blood and Tissue Analyses
Halon 2402
A 30-min exposure of female albino rats (130 - 140 g) to 3.7% Halon 2402
in the metabolism chamber was followed by sacrifices of two animals at each
of the indicated times. Sacrifices were at 0, 1.5, 3 and 24-hr post-exposure.
f
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Halocarbon levels in tissues were determined as previously outlined. Except
for liver and blood samples taken immediately post-exposure, all samples
were pooled prior to the determination. Replicate results of the liver and
k	 '
i
j	 blood samples at 0-h.our period were:
jLiver: 266 and 250 Ug 3g
{
Blood: 91 and 83 ug/g
The remaining values are shown in Table B-I. In all cases except brain and
i fat the highest levels of the Halon 2402 were noted just after exposure,i
at 0 hour. In the case of the brain and fat tissue, higher levels of the
C
agent were observed in the 1.5 hr samples indicating a shift to the lipid
containing tissues. With. the exception.of fat, the-.tissue containing the
i
highest concentration at the end of 1.5 and 3 hours is kidney which may
implicate this organ in the removal of the compound from.he body.
'I	6
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An additional 30-minute exposure with Fialon 2402 (47.) was conducted
using New Zealand rabbits (2 - 3 kg). The animals were sacrificed immediately
following the exposure. Data from the tissues are shown in Table B-II.
Highest levels of the fluorocarbon were found in the fat, which was also
true in the rat experiment. Brain levels between the two species were
significantly different.
Halon 1301
Four separate experiments were conducted using Halon 1301 in order to
determine tissue and/or blood levels reached during the exposures. The
E LL	 type and length of exposure and the animal species are disccused in this
fi
section.
A 30-min exposure of two rabbits to a 5% v/v of Halon 1301 culminated
in immediate sacrifice. Tissue levels for these animals are shown in
Table B-III.	 i
The remaining three studies were used to determine the blood levels
9
of Halon 1301 after exposure. In the first, female rats (approximately
s
200 g) were lightly anesthetized with sodium pentobarbital and exposed to
5% v/v of Halon 1301 for 30 min. Animals were removed from the chamber and
blood samples obtained by heart puncture at 0, 0.25, 0.5, 1, 2 and 4 hrs
post-exposure. Blood samples were immediately transferred to closed vials
and allowed to stand for 1 hour prior to analysis. Results showed a rapid
decline of the fluorocarbon level in the blood. A single 50-min exposure
of a rat at 5% v/v (Table B-IV) shows the decline.
The second such experiment was designed to 'determine blood levels of
Halon 1301 following continuous exposure of 2 or 4 weeks. Female and male
1
rats were exposed for 23 hour/day with an intermine sacrifice at ,2 weeks and
7
s
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final sacrifice at 4 weeks. Blood levels of the fluorocarbon.were measured
immediately following sacrifice. The results (Table B-IV) are consistent
with the other blood-levels studies, i.e., there was no accumulation of the
compound,'to any significant degree, and rapid elimination of the compound
resulted upon the termination of the exposure.
Therefore, in order to determine actual blood levels reached in an
exposed animal, it was decided to conduct a third experiment in order to
determine blood levels during actual exposure. Dutch-belted rabbits were
anesthetized by intravenous administration of 40 mg/kg of nembutal and the
carotid artery cannulated with. pol_vettiylene tuning. A tracheotomy was
performed to prevent obstruction of the airway. The animal was placed in
the 65-1 bubble-shaped static exposure chamber, and the chamber sealed with
the cannual leading to the outside. A baseline blood sample was
drawn prior to the introduction of the Halon into the chamber. A 5% v/v
of Halon 1301 was established in the chamber and fifteen samples drawn for
analysis during exposure (see Table B-VI.) as well as five post-exposure
samples.
Halon 1202
A 30-min exposure of 4% by volume Halon 1202 was followed by immediate
sacrifice of the rabbit, and tissues analyzed for the concentration of the
fluorocarbon (Table B'-VII).
Freon 113
k.	 •	 A similar exposure using 4% v/v Freon 113 was conducted. Distribution'
of the compound in rabbit tissues is shown in Table B-VIII.
}
I
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Freon 12
A single exposure of rabbit to 5% v/v Freon 12 resulted in maximum
blood levels of approximately 15 Vg/g. Data from this experiment are included
in the Appendix (Toxicological Responses to Halogenated Hydrocarbons).
Freon 116
A single exposure during which blood levels of Freon 116 were measured
is also presented in the Appendix (Toxicological Responses to Halogenated
Hydrocarbons). Compared to levels seen for Freon 12 and Halon 1301 the blood
levels of Freon 116 were negligible.
i Fluoride Ion Concentrations
In order to evaluate the metabolic liability of fluoride in selected
halocarbons, experiments were conducted to determine the F content of
urine collected from exposed and control rats, We modified the Rowley and
Farrah method (Am. Indust. Hyg. Assc. J. 23:314, 1962) to obtain greater
_	 accuracy and were still unable to obtain the precision desired; therefore,
additional experiments were conducted using the Singer, Armstrong and Vogel
method (J. Lab. Clin. Med. 74:354, 1969). This electrode potential measurement
method with EDTA added to the diluent provided the best accuracy we were
'c
able to obtain and was subsequently used to measure the F concentration in
urine of rats exposed to Freon. 116, Freon C-318, and Halon 1301.
Regardless to whether the animals were control or exposed, the F content
'	 of all urine samples was very low. Examples of data obtained are shown in
Tables B-IX AND B-X.
The method used for the determinations. is described below,
Solutions
Standard F s Dissolve 2.21 g of NaF in distilled water and dilute to
1 liter. Concentration of F _ 1000 ppm.
1
tWorking standard: Dilute 1 ml of the Above standard to 1000 ml with
the diluent.- Concentration of F m 1 ppm.
Diluent: Weigh out 8.5 g NaC1 and 5 g of disodium EDTA, add about
500 ml of distilled water, adjust the pH electrometrically to 6.5 with
dilute KOH, and dilute to 1 liter.
Calibration of Electrometer
ni,e electrodes used were a Coleman 3--803 (F ) and an Orion (reference)
no. 90-02-00. (The electrometer was. a Sargent-Welch model NX.) The working
standard (l ppm F) was arbitrarily set to give a reading of -0.133 mv;
when diluted 1:10 with the diluent the my reading was -0.077. Also, when
the diluent was diluted with. 1/4 volume of water the my reading was -0.025,
which was equivalent to 0.008 ppm of F and was, therefore, negligible. The
my readings for various F concs. between 1 and 0.1 ppm, when plotted on
semilog paper, gave a straight line. The unknowns were evaluated from this
	
.	 graph
G
Procedure
To l volume of the urine sample. added 4 volumes of the diluent and
t
determined the my reading'. The routine operations were as follows:
	
r	 Between samples the electrodes were washed with a stream of distilled
water and dried with a sheet of tissue paper (Kimwipes) After the electrodes
r
were immersed in the sample, an interval of 15 min (with frequent stirring)
was allowed for the attainment of equilibrium. The my reading, obtained in
this way, was then converted to ppm by reference to the calibration curve,
and the value so found was multiplied by 5 to give the urinary concentration
(preliminary value)
3
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1Table B. I
L'eve& o6 Ha eon 2402 in Rat Ti as ue Fottowi,ng Expawte by I nha ea ti,on
1 ^
r
Post - Inhalation Interval (hr.)
0 1.5	 3 24
Liver 258* 5,,	 2.. 0.28
Lung 44, 181.	 2 ', 0.18
Brain 0.70 2.1	 0.78 0.36
Kidney 82„ 27	 23 0.33
Heart 24, 2.1	 2	
_ 1.1
Muscle 71. 19	 2.8 1.0
Fat 365 469,	 410 11
Blood 87, 7.	 0.23 0.22
All values shown are in pg. Halon 2402 /gm tissue
n
^'`
11
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Table B.	 II
D"t iibuUon o6 HaZon 1301* in Rabbit U4.6ueA
Tissue	 Tissue concentration (Ug Halon 1301/g)
x
Animal #1	 Animal #2 Mean
Liver 37	 25 31
Lung 89	 102 96
Brain 19	 70 44
Kidney 21	 5 13
Heart 6	 21 13
Muscle 51	 31 _41
Fat
	
- 183	 118 150
..........	 :.
a
' * Animals were , exposed to a vapor concentration of 5% by volume for
30 minutes
t
,
r
M
1`
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Table B. III
x
Di6tcibuabn of Hazon 2402* in Rabbit Ti4,6ue6
Tissue Tissue concentration- (Vg Halon 2402Jg)
Animal #1	 Animal #2	 Mean
Liver 323	 128 226
Lung 312.	 133 223
Brain 313	 222 268
Kidney 101	 59 80
,.
II
	
Heart 161	 121 141
Muscle 126	 69 97
Fat 1048	 667 858
Animals were exposed to a vapor concentration of 4% by volume
for 30 minutes
13 ;	 ',

eTable Be V
-° Concen Aation oS Hato' n 1301 .cn nat blood SoMw.i,ng conti,nuoua expame.
2-week exposure
Females Males
Animal Time, Conc. b Animal Time, Cone.$
# min,) (uS/ ^1 mi!n: c lig/ It
19E 2.0 0.37 46E 4.5 ' . 0.04
25E 4.7 0.21 44E 24.0 0.01
22E 17,0 0.08 48E 31.0 0.01
23E 21.0 0.06
control - - 0.09 control - - 0
control - - 0.07 control - 0
,. 4-week exposure
r	 14E 1.5 0.12 47E 3.0 0.06
-	 11E 3.5 0.12 50E 5.0 0.13
34E 10.0 0.12
41E 17.0 0.08
control - - 0.00 control - - 0.04
a
elapsed time from removal of animal from exposure chamber until draining
of blood sample. j
b
expressed as ug Halon 1301/g whole blood.
i
i
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Table B, VI
`	 Stood •ZeveZs of HaZon 1301 in a Aabbit _exposed 
to an atmos phen i.c concentration o6 5 0, ' v/v.
.Time,.min. Conc.,in blood, VS/S
0 0.8
Start exposure
1.00 7.5 a
'	 2.17 4.6
3.75 2.8
5.00 9.7 1
6.05 8.3
7.17 7.3
i
8.50 13.8 9
10.33 13.1
11.67 14.4
;."	 13.28 15.7
_	
V	
15.17 14.9
18.00 13.9
21.00 13.1 r
Al
..	
--.	
25.75 9.0
`.
27.42 12.3
-	 29.67 15.3
Stop exposure
0.50 1.1
1.50 0.5
2.50 0.9
•
3.83 07
-	 5.58 1.4
16
Q
Tissue Tissue concentration (ug Halon 1202/g)
Animal #1 Animal #2
1
Mean
3
Liver •69 66 67
Lung 107 83 95
Brain 111 114- 112
Kidney 70 59 64
Heart 65 63 64
Muscle 147 112 130
Fat 298 380 339
`s
*Animals were exposed to a vapor concentration of 4% by volume for
30 minutes
3
j
^^
3
17 3
Di6t i.buti,on of Freon 113* in Rabbit Ti64ue6
Tissue	 "Tissue concentration (ug Freon 113/g
Animal t#1	 Animal #2	 Mean
Liver 27.6 27.2 27.4
Lung 21.0 10.7 15.9
Brain 26.6 20.6 23.6
Kidney 7.4 2.8 5.1
Heart 14.9 5.4 10.1
Muscle 12.3 9.8 11.0
a
Fat 21.0 27.2 24.1
* Animals were exposed to a vapor concentration of 4% by volume for
30 minutes
G	 t:
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Tab
• bxcAeti.on o6 6tuoAi,de in ari 	 concentAaUon o6 6tuoni.de
in bone o6 ha A expobed to Fkeon 116 6oh 37 weekb
Urine
Water F F_ F.. F'•
Rat no. intake Vol. ()Jgjml
( ml) (. ml )_ -, (pg/ml) : ()jg/24 hr) creatinine) ( X bone ash)
Controls - -
1 24.5 8.7 6.75 58.7 3.37 0.083
2 16.0 16.0 '3.15 500;4 2.63 0.065
4. 18.0 14.4 3.45 49.7. 2.65 0.076
8 25.0 17.5 3.70 64.7 3.36 0.076
9 8.0 6.5 3.45 22.4 1.57 0.060
12 21.0, 9.3 4.25 39.5 2.34 0.063
^ . Mean 18.7 .12.1 . 4^ 12 47.6 2.65
•	 .	 ,	 ,
0.071
I S.D. 6.3 4.5 1.34 1511 0.67 0.008
Exposed
r 13 26.5 11.2 3.90 43.7 2.78 0.073
14 28.0 919 3.30 32.7 2.54 0.070
16 11.0 14.6 3.23 47.2 1.86 0.073
17 17.0 17.4 2.20 38.7 1.83 0.083
18 10.0 11.0 2.71 29.8 1.93 0.050
` 19 12.0 ' 13.2 2.20 29.0 2.44 0.063
20 13.0 10.8 2.71 29.3 1.43 0.073
21 26.5 18.0 2.36 42.5 2.62 0.076
Mean 18.0 13.3 2.83 36.6 2.19 0.070
{ I S.D. 7:7 3.1
0.60 7.3 0,45 0.009	 +
' 19
Table B. X
F
Concentu ion of 4-tee F in av:ne o6 nota conti.nuoua.ty exposed to
F
_-Ha,ton 1301.	 Vatue6 a6	 ug /m.t.
1 week exposure 3 weeks exposure
exposed control exposed control
1.,9 1.3 0.8 1.0
0.7 , 1.6 0.6 0.7
1.8 1.1 0.7 0.9
07 1.8 0.9 1.1
M 1.1 3.0 __ 2.2
1.2 -- -- 2.3
1.1 -- -- 1.0
1.8 -- --
*.^ 1.3 ± 0.5 1.8 ± 0.7 0,8 t 0.1 1.3 ± 0.6
i
k
20^,
a
C. CLINICAL CHEMISTRY AND HEMATOLOGY
Halon 1301
Forty rats (20 each male and female) were exposed in a recirculating
chamber containing approximately 5% of Halon 1301 for up to 30 days (23 hr/
day). Equal numbers by sex of control rats were housed outside of the chamber.
Control and exposed animals received water and n commercial laboratory diet
ad libitum. The Halon 1301, oxygen and CO 2 concentrations in the chamber were
monitored. The average Halon 1301 concentration was 5.3%.
To determine the validity of some effects noted at the end ofthe 30-day
exposure between control and exposed animals, a second.30-day control experiment
was run. Equal numbers of controls (20 each male and female) were housed in
the chamber and outside the chamber under identical circumstances except for
the composition of the chamber environment. No halocarbon was used. Data
from this experiment indicated that the chamber environment did, in itself,
have an effect on the animals.
Comparative data was obtained from blood samples analyzed for Na+ and
K+ content as an indicator of cell integrity and lactic dehydrogenase (LDH)
(Tables C-I to C-VIII), and hemoglobin concentration, red and white cell counts,
and measurement of hematocrit (Tables C-IX to C-XVI) at l wk, 3 wk and 4 wk.
In addition, the osmotic fragility of erythrocytes was measured at 1 wk and
4 wks (Tables C-XVII to CXIX). 9
No effects were noted between the chamber-exposed and the chamber-control
animals; although there were minor differences noted initially between the,.
! chamber-exposed and outside-control animals. 	 Primarily, LDH values were slightly
F elevated in chamber-exposed animals (noted also for chamber-control animals).
Secondly, mild hemoconcentration evidenced in the exposedanimals was also 4
noted in the chamber controls, but not in the outside controls.	 No specific '.
sex differences were noted. y,
I^
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Freon 116 (Rodents)
Following preliminary exposures of rats and rabbits to Freon 116 in
concentrations of up to 20% (v/v), which revealed no effect of exposure to
the test species, a long-term (37 week) exposure to a 20% v/v concentration
of Freon 116 was conducted in a closed dynamic chamber. Freon, oxygen and
CO2 concentrations were monitored throughout the exposure (Table C-XX). The
23-hr/day exposure allowed for cleaning and animal care.
Twelve male Sprague-Dawley rats were housed in the chamber for the exposure
and an identical number housed outside the chamber as controls The animals
were weighed weekly (Table C-XX). The number of animals was reduced from the
Jlj	 number used in the Halon 1301 exposure because of effects seen in the chamber
controls which were probably due to overcrowding in the chamber. Hematology
data was recorded at 18, 34 and 37 weeks of the exposure period and revealed
no significant differences (Tables C-XXI to C-XXIII). Likewise, clinical
chemistry data obtained at 37 weeks (which included: alkaline phosphatase,
j	 acid phosphatase, serum glutamic oxaloacetic transaminase, serum glutamic
pyruvic transaminase, sodium and potassium ion concentration, glucose, blood
urea nitrogen and creatinine phosphokinase) are presented in Table C-XXIV and
4	
show no effect of the exposure to Freon 116.kk
F`
Freon 116 (Rhesus Monkey)
Following the negative results of the 37-wk exposure in rats, a rhesus
monkey was exposed to Freon 116 (20%) for 19 weeks. Chamber conditions during
the exposure period are shown in Table C XXV. Routine hematology data (Table
C-XXVI) including hematocrit, hemoglobin, RBC and WBC showed no signs of change
due to the exposure to the fluorocarbon. Likewise, clinical chemistry values
presented in Table C-XXVII indicate no effect from the exposure,
22
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TABLE C I
Serum 6ioehemt6LA^ o6 jemate nags exnobed .to'Haton 1301 4on 1 week.
Rat Na+ K+ LD14
Outside
Controls	 .lE 157 5.9 2000
2E 153 6.9 2000
3E 150 5.9 1880
4E 147 5.4 1380
i
5E 148 6.4 1930
Mean 151 6.1 1840
S.D! ± 4 t0.6 ±260
Exposed 	 16E 147 6.3 1310
17E 149 5.8 1420
18E 147 6.3 1410
19E 152 6.5 2000
:. 20E 150 5.8 2000
21E 153 6.0 2000
22E 146 5.9 1910
r
_
23E 146 5.4 2000
24E 150- 5.8 1410
25E 150 6.6 1930
Mean 149 6.0 1740
S.D.
±2
±0.4 ±300
E i	 Berger-Boida units
z	 Standard deviation
a.	 1
t TABLE C II
Serum biochemivsLAy o^ mate xat.6 expozed to Haeon 1301 4ox 1 week.
Rat Na+ K+ LDH
No (meq/1) (meq/1) (UnitsI )"
Outside
Controls
	 26E -150 4.3 2000
27E 149 6.0 1760
28E 151 6.7 1490
29E 149 6.2 1880
30E 150 6.5 1860
Mean 150 5.9 1800
S.D! ±1 ±0.4 ±190	 .
Exposed	 31E 147 Y4.5 1270t
32E 151 5.9 2000
33E 146 5.8 ' 1970
34B 147 5.8 1220
35E 151 5.6 1450
a
36E 148 5.1 1920
37E 155 5.8 1880
_	 38E 146 5.9 1420
39E 147 5.5 1420
40E 147 5.8 2000
Mean 149 5.6 1655
S.D. ±3 ±0.4 ±320
a_
3	 Berger—Boida units
s	 Standard deviation
24
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TABLE C III
t
Serum biochemizt,%y *o6 Semate nab con^ined • to exposuAe chambea
(no hatocahbon) ion l week.
Rat Na+ K+- LDH LDHS/LDH1
No. (mWl)	 '(meq/1.) -Nnitsi)
Outside
Controls
	
1C 156 7.5 1880 2.0
.	 2C 155 7.1 1100 1.2
3C 144 6.8 2820 1.6	 i
4C - - - - 1940 1.9
SC - '- = - . 1620 1.2
Mean 152 7.1 1870 1.6	 1
S.D! t7 ±0.3 •±620 ±0.4
Chamber
Confined-	 .31C - - - - 3400 2.0
Controls
f	 32C - - - 2880 1.4
33C' 155 7.4' 2900 1.5
34C 160 7.4 2380 1.8
35C 159 7.4 3180 1.5
36C - - - - 1380 1.4	 a
37C 158 7.5 2960 1.6
38C .
- -
- - 2480 10
7
3
39C 146 _7.1 1580 1.4
40C 157 7.4 1580 1.7
Mean 156 7.4 2470 1.5
S.D. ±5 f0.1 ±720., ±0.3
p^
	
1	
Berger-Boida units
I	 2Y	
.Standard deviation
25
i
tTable C IV
'	 Serum
F
biochem,iztAy of mate nab confined to expo.6me chamber
(no hatoca cbon) for 1 week.
.Rat Na+ K+ LDH LDHS/LDH1
No. (meq/1)	 (meq/1)
	 (
-
Units l )
Outside -
G	 Controls 41C 151 6.5 1380 1.1
42C 154 7.3 1340 1.4
43C - - - '520 1.0
44C 155 8.0 ..1400 1.3
45C - 1280 1.1
Mean 153 7.3 1180 1.2
S.D! ''-*2 ±0.8 ±370 t0.2
_.	
Chamber
`.	 Confined 61C - - - - 3300 1.3
Controls
62C
'
157 7.8 2040 1.7
63C 157 7.3 2720 1.3
64C 153 6.8 2200 1.3
65C 151 6:7 2200 1.4
-
66C 160 7.4 3480 1.4
67C - - - - 3160 1.7 E
-
68C 158 6.9 3400 1.4
69C - - - - 3660 1.6
70C 160 6.7 3680 1.3
Means 157 7.1 2980 1.4
S.D. ±3 +0.4 ±640 ±0.2
Berger Boida units
.z	 Standard deviation
1
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dTABLE C V
Serum biochem-i to ag jemaCe ut6 . exposed to Hagan 1301 ion 3 weeU.
Rat	 NA+	 Kf	 LDH
	 LDHS /LDHI
No.	 " (m 	 (meq/1) 	(11nii:s_1)	 iOutside
Controls
	
1E	 148	 6.8	 1340	 1.8
2E	 146	 6.7	 1920	 1.7
3E	 147	 66	 1140	 2.0
4E'	 146	 5.6	 660	 2.3
5E	 147,	 6.2	 1680	 1.9
Mean	 147	 6.4	 1350	 1.9
S.D?	 ±1	 t0.5	 ±450	 ±0.2
a
Exposed	 9E	 147	 _	 5.4	 1960	 2.0	 r
10E	 148	 5.7	 2940	 1.4
11E	 148	 5.8	 2640	 15
12E 	 150	 5.7	 2440	 1.6
13E	 147	 5.6	 3540	 2.0
14E	 152	 5.8	 1580	 1.9
15E	 146	 6.2	 3200	 1.7
16E	 148	
_	
5.6	 2440	 1.7
w	 21E
	 148	 6.0	 2940	 1.2
24E	 148	 5.9	 1280	 1.9
I
Mean	 148	 5.8	 2500	 1.7
S.D.	 ±2	 ±0.2	 +720	 ±0,3
i
Berger-•Boida units
c	 z	 Standard deviation
27
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ITABLE C VI
Senwn biochemistAy oA mate %at6 exposed to Haeon 1301 {on 3 weep.
Rat Na+ K+ LDH LDH5/LDHl
No. (me	 i a	 tmaq/1)
- 
(Unit s l )
&u InUrdoI a 26E 143 5.9 2640 1.4
Ci •	 27E 146 5.9 1800- 1.7
28B 145 6.2 1500 1.5
29E 145 6.0 2580 1.5i
30E 1_45_ 5.9 1840 1.6
Mean 145 6.0 2070 1.5
S.D?. ±1 #0.1 1510 ±0.1
Exposed ' 31E 149 4.9 2080 2.0
32E 152 6.5 3260 1.9
33E 153 6.2 2440 1.6
34E, 148 5.7 3080 1.5
35E 151 5.8 2880 1.6
36E' 150 5.1 3540 - 0.8
37E 147. 5.9 .3080 2.0
38E 150 5.1 3460 1.4	
j
39E 149 5.3 3680 1.8
40E 147 5.7 3580 3.3
Mean 150 56 3110 1.8
S.D. +2 ±0.5 ±520 ±0.6
Berger-Boida units
3
z	 Standard deviation
28
TABLE C VII f
SeAm bioch.ent at y o6 6emae rata con6ined to exposure chamber
`	 (no hatoearrbon)	 ion I month..
Rat Na+ K+ LDH LDHS/LDH1
No. (meq/1) (meq/1) ^Unitsl)
Controls
	
11C 160 5.3	 ' 600 2.0
12C 157 6.8 600 1.8
14C 142 •6.4 1100 0.5
15C - 860 3.2
Mean 153 6.2 790 1.9
S .D? t10 t0.8 +240 ±1.1(
Coanmtined	 31C 154 6.2 2740 1.3
Controls	 34C 157 6.2 1920 3.3
35C 160 6.9, 2040 2.7
36C - - - - 2640 4.4
37C 160 6.7 •2580 2.2
38C 152 6.0 2520 2.0
39C 160 6.6 2000 3.8
_	 40C 150 5.8 2580 2.1
Mean 156 6.3 2380 2.7
S.D. t4 ±0.4 ±330 t1.0
1	 Berger-Roida units
3	 Standard deviation -
29
t_	 (no hatocatl
Outside.
TABLE C VIII
biochemi t y of mate nat.6 con4ined to exnozme chamber
P& 1 month.,
Rat	 Na+
	 K+	 LDH I
	
LDHs/LDHi
No.	
+(meq/1)
	 (meq/1)
	 Units
48C - - - - 1000 2.5
49C - - - - 810 2.8
50C 156 7.4 380 2,2
•	
Mean 155 7.3 810 2.4
^-	 S .D. t2 10.2 ±250 t0.4
Chamber -
^'	 Confined	 71C - - - - 1540 2.0
Controls
72C 158 6.4 1880 4.0
736 154 7.9 760 18
_	 74C 154 80 2040 5.0
75C 152 6,7 2100 1.7
76C - - - .- 1700 3.4
77C 157 5.8 1760 2.1
78C 158 5.9 .2100 1.8
79C 158 6.9 2260 1.7
80C 155 6.9 2840 1.7
Mean '-156 6.8 1920 2.5
S.P. ±2 ±0 .8 ±520 ±1.9
i	 Berger-Boida unite
Z	 Standard deviation
f 30
' r
J
TABLE C IX
Hema toZo9 y o4 Semate nat6 exposed to Haeon 1301 Son 1 week.
Rat RBC Hb I3ct WBC
No. ( X10 ( g%) (%	 ) (X143 )
Controls
	
lE 6.69 17.6 46.5 5.9
2E 5.99 15.8 43.0 8.2
3E 5.66	 - 15.2 •43.0 11.8
4E" 5.65 15.2 42.5 9.7
SE 5.07 14.9 42.0 8.5
Mean 5.81 15.7 43.4 8.9
=	
S.D. ±0.59 ±1.1 t1.8 t2.2
Exposed	 16E 5.88 16.0 42.5 15.1
17E 4.96 14.7' 35.0 4.5
18E 5.07 13.6 39:0 7.8
_	 19E 6.21 15.8 46.5 10.4
20E 6.40 15.7 44.0 13.1
21E 6.39 15.7 44.0 7.0
22E 6.00 14.9 44.0 6.1
23E 6.07	 ! 15.5 41.5 15.1
24E 5.43 13.6 39.0, 7.8
25E
'
6.02 15.0 42.5 7.5
1
Mean 5.84 15.0 41.8 9.4
S.D. •_*0.52 ±0.9 ±3.3 ±3.9
---	 '
 31
TABLE C X
Hema totog y o g mate nab expos ed to Haton 1301. gon 1 week.
Rat RBC Hb Hct WBC
No. (X106) W.) M (X103)
Controls	 26E 6.59 15.4 44.0 6.9
27E 6.47 15.3 46.0 7.5
a _ 30E 6.33 15.3 42.5 5.7
Mean 6.46 15.3 44.2 6.7
' Exposed	 33E 5.95 15.4 44.0 8.7
36E 6.51 16.2 47.0 4.8
37E 6.06 15.2 43.0 4.2
39E 6.12 16.5 45.0 5.9
Mean 6.16 15.8 47.7 5.9
S.D. ±0.24 ±0.6 ±1.7 ±2.0
f
1
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TABLE C XI
HK."l ogy os D WI, a rata COP& ned to exppbu/m chamber ono nacocanoonj
gon 1 week.
u...4
Rat RBC Hb _ Hct WBC
No. (X106) ( Q%) (y	 ) (X103)
Control 1C 5.10 16.2 44.0 16.9
3C 5.56 15.7 44.0 23.6
4C 6.71 17.0 49.0 13.4
Mean 5.80 16.1 45.7 17.9
..'	 Confined 32C 7.67 18.3 49.0 9.0
34C 6.42 17.0 48.0 8.1
,. 35C 5.20 16.4:. 43.0 14.7	 j
36C 5.91 16.7 46.5 7.4
37C 6.60 17.1 47.0 8.7
38C 8.27 19.7 49.5 11.8
39C 6.57 16.9 46.0 8.9
40C 7.35 17.5 50.0 11.2
' Mean 6.75 17.5 47.4 10.0
S.D. ±0.99 +1.1 ±2.3 ±2.4
33
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t TABLE C XII
Nema to fogy o4 Jemaee nags exposed to Haton 1301 4on 3 week6 .
Rat RBC Hb Hct WBC
. _ No. OC10 6 ) C g%) (%) (X103)
1
Controls	 2E 7.05 18.0 46.0 9.4
3E 6.60 18.4 46.0 8.8
4E 6.35 17.5 43.0 8.2
.5E 7.12 18.4 45.5 6.5
Mean 6.78 18 . 1 45.1 8.2
S.D. ±0.36 ±0.4 ±1.4 t1.3
Exposed	 9E 7.05 17.4 46.5 12.8
10E 7.76 17.5 49.0 14.7
11B 5.70 16.9 44.0 10.9
-	 12E 7.92' 18.0 48.0 11.0
13E 8.34 18.8 50.0 14.9
14E 7.46 17.0 47.0 11.2
15E 6.85 17.2 46.5 5.8
21E 7.60 17.8 47.0 12.1.
24E 8.25 17.4 47.5 10.6
Mean 7.44 17.6 47.3 11.6
S.D. ±0.82 ±0.6 t1.7 •_*2.7
f
c
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TABLE C XIII
Hemaxotog^ o6 mate hats exposed to Haton 1301 4on 3 weeU
Rat RBC Hb Hct WBC
No. (X106) (g%) (%) ( X10 9)
Controls	 26E 6.33 15.2 44.0 11.0
k	 27E 7.46 17.7 47.0 17.0
28E 7.48 16.6 45.0 12.5
29E 7 .05 15.4 45.0 4.2
30E 7.67 17.9. 46.0 16.1:	 i
Mean 7.20 16 .6 45.4 13.2
'S.D. f0.54 ±1.3 tl.I ±3.3
• Exposed	 31E 7.33 17.4 48.0 16.4
_	
32E,' 6.63 17.7 46.5 16.2
.-	 33E 6.47 16.4 46.0 10.3
34E 7.43 16.2_ 47.0- 13.9
-^	 35E 8.63 17.3 49.0 18.5
36E 7.15 16.8 46.5 12.1
38E 7.77 17.4 48.0 16.9
39E 7.02 16.6 Y	 46.0 13.1
40E 8.46 18.7 49.0 10.5
Mean 7.43 17.2 47.3 14.3
S.D.
r
+0.74 t0.8 ±1.2 ±1.1
35
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TABLE C XIV
Hematotogy o6 mate nat6 eonj ned to expo4uhe ehamben (no hatocanbon)
goh 1 week.
Rat RBC Hb Hct WBC
No. X106) W) (%) X103)	 i
Control
	 41C 6.88 16.1 48.5 11.2
'42C 5.14 15.3 42.5 21.8
Mean 6.01 15.7 45.5 16.5
Confined	 62C 5.29 15.5 44.0 9.4
630 7.79 16.1 46.5 12.8
64C 7.35 -	 16.1 47.0 16.0
65C 6.79 18.1 50.0 8.5
66C 7.26 16.3 46.0 10.7
67C 6.83 17.5 51.0 12.3
68C 7.62 16.9 -	 47.0 6.9
70C 8.55 17.3 48.0 15.3
Mean 7.18 16.7 47.4 11.5
S.D. ±0.95 ±0.9 #2.2 ±3.2
36
TABLE C XV
Hematotogy o6 Semae.e nab con6 i.ned to expobwce ehamben (no
hatocaAbon)	 :Son 1 month.
Rat RBC Hb Hct WBC
No. (X106) (g%) (%	 ) (X103)
Control	 12C 5.96 16.6 47.5 8.6
14C 6.74 18.3 48.5 15.2
15C 8.28 18.7 49.0 7.6
Mean 6.99 17.9 48.3 10.5
Confined	 31C 7.05 18.3 51.0 5.2
33C 7.38 19.5 49.0 9.0
34C 6.22 17.6 43.0 6.8
`	 36C 677 17.6 48.0 8.1
37C 7.00 17.6 47.0 5.3
38C 6.33 .17.4 45.0 6.5
-	
_	
39C 6.88 17.8 49.0 10.4
40C 7.30 17.4 49.0 11.0
Mean 6.87 17.9 47.6 7.8
i	 S.D. ±0.42 t0.7 ±2.6 t2.2
37
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1TABLE C XVI
Hema totog y o s mate ra tb• con6ined to expo swce chamber. (no
haeocahbon) gon 1 month.
Rat RBC Hb Het WBC
:
.'
No. (X106) (% 1 1X103^
E
Control 46C 8.78 19.9 48.0 13.7
47C 8.19 17.6 •	 47.5 14.7
48C 8.66 18.3 48.0 13.4
49C 7.96 19.1 49.0 8.7
50C 8.70 18.4 49.0 13.9
Mean 8 .46 18.7 48.3 12.9
S.D. ±0.36 ±0.9 .t0.6 2.4
`	 Confined 71C 7.39 18.0 •51.0 11.4
_	 72C 7.32 17.8 48.0 9.2
Y
75C 7.10 16.9 46.5 5.5
77C 7.87 18.5 52.0 7.0
79C 6.50 16.2 44.5 6.4
80C 6.81 16.2 48.,0 6.9
Mean 7.17	
_
17.3 48.3 7._7
S.D. ±0.48 t1.0 ±2.8 ±2.2
38
Table C. XVI1
0.6mo.tZa J,%agitA'4 os eWth),ocytea IAOm Aatb exposed to Ha,Zon
1301 ion 1 week.
Rat 2 hemolysis in indicated salt concentration
No. 0.55 0.50 0.45 6.40 0.35 0.30 0.20
Controls lE 0 1.0 . 46.0 97.0 99.5 100 100
2E 0 0 7.2 74.9 97.6 100 100
i
3E 0 1.0 17.8 '	 83.9 98.0 99.5 100
4E 0 3.8 38.8 96.2 99.4 100 100
5E 0 0 32.0 92.2 98.8 99.8 100
26E 0 0.5 24.1 89.4 100 100 ' 100
277E 0 0 19.9 85...8 99.7 100 100
••
28E 0 3.0 9.0 63.8 97.0 99.8 100
2_9E. 0 1.0 ^7.0_ 80.2 97.8 99.99 99.9
Mean 0 1.1 22.4 84.8 98.6 99.9 100
Exposed 19E 0 0 3.8 66.0 95.9 99.0 100 11
22E 0 0 10.8 83.2 97.8 98.0 100
23E 0 0 6.0 75.0. 95.8 98.0. 100
5E 0 2.0 1'1).0 81.0 97.8 99.5 100
42E 0 0 4.0 80.2 99.0 100 100
44E 0 0 12.2 91.0 99.5 100 100
46E 0 0 8.4 78.1 97.8 99.5 100
48E 0 0.8 22.1 89.1 98.8 99.9 100
mean 0 0.4 9.7 80.5 97.8 99.2 100
J 39
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j Oamotic 4,%agUi4 oS enythweyted Snom cats expo.aed to Haeon 130
'- F ion 1 month.
. Rat % hemolysis in,indicated salt concentration
No. 0.55 0.50 0.45 0.40 0.35 0.30 0.20
Coptrola lE 0 3.0 23.5 91.0 100 100 100
2E 0! 0 18.0 84.0 99.8 100 100
3E 0 0 23.8 95•.0 100 100 100
5E 0 0 16.8 83.0 86.8 100 100
- 26E 0 0 1.5 63.6 95.2 99.1 99.5
27E 0 0 1.0 46.0 64.2 100 100
28E 0 0 6.0 78.0 98.0 99.6 100
29E 0 0 0 45.9 94.1 99.5 100
30E 0 0:2 0.6 48.0 91.2 99.0 100
Mean 0 0.4 10.1 70.5 92.1 99.7 99.9
C^
Exposed 11E 0 0 16.8 83.0 86.8 100 100
14E 0 0 18.2. 81.'8 99.7 100 100
r	 1
15E • 0 0 .7.2 70.8 96.8 99.7 100
a
•	 - 17E 0 0 16.8 86.5 - - 100 100
24E !	 0.	 . .0.2 33.1 93.4 99.1 99.8 100
34E 0.', 4.8 54.2 95.2 99.2 100 100
41E 0 0 39.0 94-.0 99.8 100 100
45E 0 8.8 63.9. 96.1 100 100 100
1t	 •
47E 0 0 0 57.9 95.0 99.1 100
50E 0 0 0 72.5 96.8 99.1 100
:,.. Mean '0 1.4 24.9 83.1 97.0 99.8 100
1
s
.
t
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04motia 649Uy o6 mythnocy-tea 6,com rata_ con6.ined to eXPO4U ce
^-°• chambeic (no ha.tocanbon) ion 1 month. .
Rat x hemolysis in indicated salt concentration
No. 0.55 0 .50 0.45 0.40' 0.35 0.30 0.20
Controls
	
1C 0 0 9.5 99.5 100 100 100
2C 0 0 72.8 93.8 190 100 100
.	 3C .0 6.4 58.2 90.0 100 100 100
4C' 6 0 -. 46.0 .  • 85.5 99.0 100 100
•
•	 5C 0 13.7 66.2,., 90.8 99.3 100 100
46C 0 0 18.2 86.8' 99.0 100 100
47C 0 0 16.0 74.6 96.2 98.2 100
49C 0 2.8 36.6 88.8 98.2 100 100
50C 0 0_ 10.1 76.8 99.5 100 100
Mean 0 2.5 37.1. 87.4 99.0 99.8 100
Confined	 23C 0 0 22.7 94.4 98.5 100 100
25C 0' 0 6.8 96.3 99.2 100 100
^
26C 0 0 6.0 89.4. 98.6 100 100
"	 30C 0 0 4.0 16.8 91.0 98.5 100	 a
32C
•
0 0 33.5 85.5 97.7 100 100
61C	 ... 0' 0 11.0 87.0 98.0 199.0 100
62C 0 0 8.6 83.6. 98.0 99.5 - 100
65C 0 0 25.0 88.2 96.-8 100 100
66C 0 2.2 13.5 80.6 87.1 98.8 100
76C- 0 0 5.0 65.8 94.8 100 100
j Mean 0 .2 13.6 78.8 96.0 99.6 100
t1	 ^
TABLE C XX
Weeh„Cy ChambvL COULi,UOnz and Body Weights o6 Rates
f	 Bxpozed to Fneon 116
Chamber conditions Body weight, g
Week Freon, %	 0 2 , CO2, % T, °F Exposed Control
1 20.8 19.8 0.09 77 194 192
2 18.3 18.1 0.23 77 197 237
3 20.7 19.2 0.51 77 257 290
4 24.8 19.4 0.43 77 271 310
5 18.7 19.4 0.38 77 287 327
6 24.4 19.6 0.34 77 324 366
7 18,4 19.9 0.42 76 326 372
8 22.4 20.0 0.27 77 350 380
9 20.7 19.6 0.39 78 380 408
10 18.3 19.3 0.48 78 396 422
11 24.1 20.7 0.66 77 395 419
12 19.1 20.5 0.58 76 406 422
13 15.6 19.6 0.80 79 409 431
14 16.2 19.9 0.21 79 422 438
15 20.0 19.9 0.43 81 428 426
16 24.0 20.4 0.38 81 434 431
17 20.1 19.9 0.26 81 433 436
18 22.2 19.9 0.29 75 433 447
'	 19 20.2 18.8 0.37 73 436 450
20 21.7 19.5 0.36 77 425 454
>K	
21 22.4 20.7 '0.39 80 416 456
22 24.3 20.8 0.35 79 426 461
23 21.9 20.5 0.35 77 428 466
24 20.9 20.1 0.42 77 432 470
25 17.8 19.3 0.43 77 435 475
26
C	 ••
18.5 20.3 0032 77 429 464
27 22.8 20.6 0.41 77 442 470
P	 28 19.6 24.4 0.31 75 439 465
29 20,6 20.7 0.34 76 442 466
30 23.1 20.9 0.33 76 449 462
31 21.3 20.4 0.43 76 455 477
32 21.6 20.1 0.31 76 457 488
33 21.0 19.2 0,.35 77 460 499
34 20.2 21.2 0.52 77 466 508
35 20.3 20.5 0.36 77 479 508
36 20.1 21.6 0.42 77 484 509
37 19.7 20.7 0.36 76 489 516
TABLE C XXI
Hema toZog y Pno 6iZe^s o6 Rata Expob ed
to Fuon 116 gon 18 WeeU
Rat Hct Hb RBC WBC
No. % g% X106 x10,
Control
1 45.0 15.2 7.47 18.1
2 46.0 15.0 7.87 14.1
4 45.0 15.8 8.51 11.5
8 49.0 17.4 8.46 11.7
9 47.0 17.0 8.53 13.3
12 47. 0 17.8 8.21 16.4
Mean 46.5 16.4 8.17 14.2
S.D. 1.5 '_.2 0.x2 2.6
Exposed
13 50.0 17.8 '9.34 23.6
14 57.0 18.0` 9.37 19.3
17 51.0 17.4 7.99 8.0
18 48.5 18.4 '10.14 8.3
19 43.0 15.5 8.45 13.0
Mean 49.9 17.4 9.06 14.4
S.D. 5.0 1.1 0.84 6.8
43
I_
3	 iit	 ^	
in
TABLE C XXII
Hein toZog y Paco 6ites o6 Rats Fxpoz ed
to Pneon 116 bon 34 Weeks.
Rat
	 Hct	 Hb	 RBC	 WBC
No.
	 %	 g%	 X106	 X.103
Control
1 50.5 19.1 8.95 7.2
2 45.0 16.8 6.77 8.0
4 48.5 18.0 8.32 7.9
8 _51.0 19.3 8.16 6.0
9 48.0 18.3 8.74 6.1
12 48.5 19.3 8.51 14.2
Mean 48.6 18 . 5 8.24 8.2,
t S.D. 2.1 1.0 0.77 3.0
Exposed
13 47.0 18.3 7.76 8.3
14 46.0 19.1 7.19 6.1
16 50.5 20.5 8.51 7.1
17 48.0 18.3 8.03 .9.7
18 50.0 18.1 8.19 9.8
19 •47.5 17.6 8.05 8.3
20 51.5 19.2 9.77 10.4
21 48.5 17.6 8.63 8.3
M+-an 48.6 18.6 8.27 8.5
S.D. 1.9 1.0 .I:i 1.4
44
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TABLE C XXIII
Hema totog y Pu S.i a o6 Rats Expoz ed to Pam 116
Son 37 weeh,6
Rat No.	 Hct	 Hb	 RBC	 14BC	 Differential
g%	 x10c	 x103	 Neut	 Lymph	 Mono	 Eosin
Control
1	 47.0	 16.4	 6.87	 10.4	 16-	 82	 - 2	 -
2 43.5 17.6 6.13 8.6 21 79 - -
4 45.0 18.3 7.14 5.4 17 82 1 -
8 47.5 17.5 6.76 6.0 24 74 2 -
9 45.0 16.2 7.81 5.7 36. 60 3 1
12 47.5 15.0 7.27 9.1 23 74 1 2
Ex^sa::.^
13 46.5 16.0 7.22 10.6 15 82 3 -
14 43.5 15.6 6.65 6.9 23 73 3 1
16 46.5 16.6 7.39 9.9 19 75 2 4
17 44.5 14.7 6.34 7.1 12 86 - 2
18 -46.0° 15.8 6.58 6.2 18 75 5 2
3
19 44.5 14.4 6.88 7.7 34 64 - 2
20 43.0 15.7 6.92 9.2 .34 62 3 1
21
f
43.0 15.0 6.59 6.9 28 70 2 -
,
t
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TABLE C XXIV
f
Chemt6tAy Prco4.ctu of Rats E'xpoaed to Freon 116
bon 37 week.6
Rat No. CPKA1k.P. Acid.P. SGOT SGPT Nat K'L Glu BUN
Control
1 13.9 9.4 84 32 144 5.2 112 18 51
2 16.9 13;.5_`. 74 20 142 5.6 120 20 76
4 6.8 12.6 62 27 166 4.9 136 14 41
II4	
8 15.8 12.0 55 17 145 5.0 140 17 25
9 9.4 9.0 55 20' 145 5.1 124 18 30
12 23.6 9.2 58 50 146 5.1 156 18 6
i
i
13 18.6 11.4 74 20 145 5.6 120 16 20
14 35.3 11.3 70 25 145 5.2 150 14 50
16 17.8 1114 62 11 144 5.3 128 17 25
17 26.3 11.8 90 25 144 5.6 126 14 33
18 12.8 12.0 84 30 144 5.9 126 19 53	 j
19 26.8 9.6 58 27 145 4.8 148 13 30
20 29.6 1506 74 27 142 5.4 168 18 38
21 24.4 5.8 21 17 143 4.7 158 20 9
P
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WeeiiCy Chainben Conditi,ort.b and Body Weight o4
Monkey Exposed to Freon 116
Chamber conditions Body weight
Week Freon, % 0 2 , 9 CO 21 % T, O F kg
0 - 21 0.12 78 3.76
1 19.5 21 0.28 79 3.81
2 22.3 20 0.20 79 3.96
3 21.5 21 0.32 80 4.04
4 22.8 21 0.15 78 3.67
5 23.6 21 0.23 78 3.83
6 17.8 22 0.14 79 3.82
7 22.3 21 0.17 77 3.90
8 20.8' 21 0.32 77 4.04
9 23.4. 20 0.32 78 4.10	 3
10 26.2 21 0.40 78 4.02
11 26.0 20 0.42 78 3.96	 I
12 19.9 20 0.39 78 4.06
13 20.9 21 0.40 79 4.10
14 23.5 21 0.42 78 4.09
15 21.7 21 0.11 77 4.05
16 20.3 20 0.18 77 4.00
17 19.8 21 0.20 76 4.02
18 20.3 21 0.23 7-7 3.99
19 21.2 21 0.28 77 3.99
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TABLE C XXVI
Heniatotogy P,%oSite ob Rheauh Monkey
.Expo.aed to Reon 116
Date	 Het Hb RBC 14BC
6 Jun 72 1 	 44.0 14.8 6.45 18.4
9 Sep 72 1	45.0 14.2 6.44 22.2
13 Sep 72 1	39.0 13.2 5.47 24.8'
20 Sep 72	 36.0 10.2 5.78 16.9
j
27 Sep 72	 36.0 11.8 5.69 11.8
12 Oct 72	 42.0 14 2 6.33' 14.0
1 Dec 72	 43.5 14.6 6.61 14.9
•	 22 Dec 72	 40.5 13.6 5.84 18.4
3 Jan 73	 42.5 14.4 6.50 14.0
31 Jan 73	 42.5 15.1 6.10 16.4
28 Feb 73 2
	41..5 14.6 '5.40 11.5
1Baseline
I_
One month post-exposure
E
k
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TABLE C XXVII
Chmi6tky Pno Site o6 Rhe4u.6 Monkey Expos ed to Freon 116
Date T.P.	 ALB CA.	 I.P.	 CHOL. GLU U.A. CREAT. T.BIL ALIC.P. LDH SGOT
6''Sep 72 1 7.6	 4.0 11.2	 7.9 175 129 0.40 1.0 0.15 315 280 46
13 Sep 722 7.3	 3.4 10.4	 6.8 148 80 0.25 0.8 0.20 312 483 49
11 Oct 72 3 8.2	 3.8 9.6	 8.1 175 110 0.40 1.4 0.30 206 1880 88
22 Nov 72 7.6	 3.4 10.5	 5.0 162 87 0.40 0.9 0.10 203 139 29
20 Dec 72 7.5	 3.9 12.0	 7.9 191 68 0.20 0.9 0.10 239 285 43
3 Jan 73 7.0	 3.7 9.7	 3.4 146 80 0.20 0.8 0.10 197 130 30
31 Jan 73 -7.0	 3.7 10.1	 6.2 167 90 0.30 0.9 0.20 253 289 37	 {
28 Feb 7 3" 6. 9 	 3.6 9.6	 4.8 135 70 0.40 0.9 0.20 294 414 43
1 Baseline
{
2 Monkey in chamber 6 Sep 72 - 13 Sep 72 w/o Freon
3 Sample badly hemolysed 3
4 One month post-exposure
3
1
3
i
9
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D. M N3RANE SYSTEMS
In a continuing effort to assess subtle manifestations of toxic
various studies were conducted to evaluate the in vivo or in vitro e
of halocarbon exposure on membrane sys:tema. The specific chemicals
for the exposures were determined by previous experimental results.
were selected for studies designed to evaluate their effect on mitoc
microsomes, liposomes, and erythrocyte fragility. Each portion of t
section discusses the development and results of these studies.
Mitachondria and Microsomes
Preliminary studies to evaluate. the effect of halocarbon expose
mitochondrial and microsomal function revealed some differences prof
to be caused by the exposure; however, the methodology selected for
initial tests was thought questionable, therefore, new methods were aeveiopea
(see Table D-I for a comparison of the "old" and "new" methods) and the
experiments repeated.
The new method was applied to intermittent in vivo exposures involving
Freon C-318 and Freon 116, short-term exposures to Halon 1301, Freon 116,
Freon C-318, Freon 12 and Halon 2402, and long-term exposure to Freon 116.
In vitro studies involved Freon 12 and Halon 1301.
In Vitro Studies
An experiment was designed to exposeisolated mitochondria in vitro.
The isolated mitochondria were placed in a respixometer with 20% v/v of
halocarbon. Oxygen consumption was measured with,the instrument during the
actual exposure.
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Studies involved exposure to Halon 1301 and Freon 12 on liver and
heart mitochondria (Table D-II). No changes in mitochondrial activity were
noted from these exposures.
In Vivo Studies
Short-term exposures. Female weanling rats were exposed to either Halon
1301, Freon 116, Freon C-318 or Freon 12 for 30 min or to Halon 2402 (10 min)
in a static chamber. Concentrations of the halocarbons ranged from 5 - 8% v/v
(see Table D-III). Control rats were placed in the chamber for an identical
period but without altering normal atmosphere. Rats (control and exposed)
were sacrificed immediately after removal from the chamber and mitochondria
from liver, lung, brain, heart and kidney prepared and analyzed by the new
procedure. Data from the analyses are presented in Table D-III. No effect
	
3
i
on respiration or phosphorylation was indicated; however,.there was a suggestion
that Halon 1301 and Freon 116 and C-318 might increase the phosphorylation of
brain mitochondria, or may have protected it from uncoupling during isolation.
Further coverage of these data is in the Appendix (Toxicological Responses to
Halogenated Hydrocarbons).
Another 30-min exposure of female rats (200 g) to Freon 12 was conducted
which elicited no effect from mitochondria from heart, lung, brain or liver
(Table D-IV), ` gut indicated a possibility of a partial uncoupling of kidney
mitochondria.
Long-term exposures. Following the 37-wk exposure of rats to Freon 116,
various biochemical parameters of the microsomal mixed function oxidase in
livers were examined. No significant effect on any of these measurements
(Table D-V) was noted.
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a
IRats exposed to Halon 1301 (5.3%) for 30 days (23 hr/day) were evaluated
for effects on mitochondrial enzyme systems from heart, lung, brain, kidney
and liver.	 Also, mitochondrial membrane activity was evaluated by measuring
the respiration of NADH in the absence of any other substrate. 	 Since NADH
cannot penetrate an intact mitochondrial membrane, it was felt that this assay
would be a useful indicator of the quality of the mitochondrial preparations.
The results of studies of mitochondria are shown in Tables D-VI - D-XI.
1
No effect from exposure was indicated by any of these data. 	 Plus, from Table
D-XII, it can be seen that studies were carried out with intact, functioning
mitochondria.
l
Microsomal enzyme systems were assessed by measuring demethylase and
3
biphenyl hydroxylase activity.	 Studies were made on rat liver 12,000 x g
supernatant fraction from the mitochondrial preparations. 	 The effect of
exposure to Halon 1301 on the enzyme activities are presented in Table D-XIII.
Table D-XIV shows the data from identical parameters measured in confined control
animals and the outside control animals.	 Both the exposure and/or the confinement
to the chamber resulted in increases in enzyme activity; however, only in the
case of 2-hydroxybiphenyl hydroxylase was the increase significant when compared
f	 to the chamber-confined controls.
Intermittent Exposures.	 Female rats were exposed to either Freon C-318
(5% v/v) or Freon 116 ('5% v/v) for 1 hr/day, 5 days /wk for 6 wk in order to
assess the effect on mitochondrial and microsomal function.	 Exposed and control 1
animals were sacrificed at 2, 4 and 6 wk except for the Freon 116 exposed animals
which were sacrificed at 1, 2, 4 and 6 wk,
3
In neither exposure was there any noted significant effect due to the
exposure as can be seen from the samples of data from the Freon C-318 exposure
(Tables D-XV through D-XIX).	 However, for this exposure, there was a suggestion
52
fof an inhibition of oxidative phosphorylation in heart mitochondria at 4
and 6 wk.
	 Also, for both exposures, a small consistent inhibition of liver
microsomal biphenyl hydroxylase activity was noted.
Erythrocyte Fragility
To establisli the effect of halocarbons on red cell erythrocyte fragility,
preliminary in vitro studies were conducted, the results of which were equivocal;
therefore, a second experir;5^at using the Da(.ie method of measuring osmotic
fragility of erythrocytes was conducted.
	 The results of this study (Table D,-^^n
show a stabilizing effect on the membrane at 1 and 2 mM concentration of U.b.011
2402 thus confirming the earlier data.
However, these studies required a mixture of ethoxyethanol/ethanol to
dissolve the halocarbon in the suspension of erythrocytes making it difficult
to ascribe the observed effect to the halocarbon.
	 Therefore, an in vivo study
was conducted.	 Rats were exposed to 4.3% v/v Halon 2402 (10 min).
	 The results
(Table D-XXI) indicate a slight but definite increase in erythrocyte fragility. -1
Information was obtained during the 30-day exposure of rats to Halon 1301
on the integrity of the red cell membrane.
	 Measurements of osmotic fragility
f
of erythrocytes were determined at 1-wlc exposure, l-mon exposure and 1-mon
confinement, i.e., chamber controls (see Table D-XXII, D-XXIII, and D-XXIV).
No effect was noted from either the exposure of the animals or their confinement.
These tables were also presented in Section C, as Table numbers C-XVII,
C-XVIII and C-XIX. Iy
r
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LORRT and IT
To indirectly measure the effect- of Freon 116 on microsomal function, a
study was devised to measure the loss of righting reflex time (LORRT) following
hexobarbital administration and induction time (IT), i.e., the time between
injection and LORRT. Hexobarbi.tal was administered to mice prior to the
exposure. The effect of either a 1-hr exposure or 10-day exposure to Freon
116 was evaluated in male and .female mice for the short exposure and male
mice for the 10-day study.
For the 1-hr study, mice were placed in a glove bag chamber which was
filled with air and Freon 116 (approximately 23%). A control group was exposed
w
to an air/nitrogen mixture to assess the effect of decreased oxygen tension.
Concentrations of oxygen, nitrogen and Freon 116 are shown in Table D-XXV.
During the 10-day exposure make-up, oxygen was replaced in the closed
dynamic mode chamber and CO 2 absorbed by a UGH scrubber. The 23-hr/day
exposure allowed 1 hr for cleaning, feeding, etc. Average body weights of
the animals are shown in Table D-XXVII. Table D-XXVI contains measurements
of concentrations applicable to this exposure.
Following the 10-day exposure, the animals were transferred to the glove
bag for LORRT and IT Measurements. Atmospheric concentrations in the glove bag
were measured (Table XXV).
Although-there was a'variation in response to hexobarbital, the data was
sufficient to demonstrate that Freon 116 had no effect on hexobarbital LORRT
or IT at the exposure levels and under these conditions (Tables D-XXVIII and
D-XXIX) .
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tLiver Cell Nuclei
In order to study the effect of halocarbons on membranes, various
preliminary investigations were conducted on biological membrane systems
to determine the feasibility or value of extending these investigations to
one or more of the halocarbons under study.
One such investigation involved the in vivo exposure of mice and rats
to halothane gas followed by the homogenization of the livers upon sacrifice
and subsequent isolation of a nuclear pellet for analysis for halothane
(Tables D-XXX and D-XXXI). A second series of experiments using rats and
mice was conducted to measure the in vivo incorporation of 14C-labeled
thymidine into liver DNA. Data from both these experiments are presented in
Tables D-XXXII and D-XXXIII. Details of the studies were included in the
i
First Annual Report.
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A cornpani4on o6 the Wd' and 'new
methoda' Son ".baying m-i toch:ondtia.
procedure 'old method'. 'new method' comment
homogenization 0.25M sucrose-0.01M 0.25M sucrose + EGTA removes calcium which
buffer Tris CL 0.001M EGTA damages mitochondria
homogenization virtis (heart, lung) Dounce (kidney,brain less shear force and less mi-'
or Potter-Elvehjein heart) and Potter- tochondrial damage with
(liver,kidney,brain) Elvehjein (liver,lung) Dounce homogenizer.
homogenizers homogenizers
resuspension of
' filets	 stirring rod or	 cold finger	 cold finger gives homogeneous
	
homogenization	 suspension with almost no
shear force. Stirring rod
gives poor suspension-hamo-
genization damages mitochon-
dria by shear force.
isolation of connective tissue connective tissue nagarse treatment 'frees mito,
heart mitochondria broken by virtis digested with an chondria without high shear
homogenizer enzyme, nagarse forces which damages mito-
chondria
}	 assay buffer chance media chance media with fluoride inhibits ATPase whi
without fluoride fluoride hydrolyses ATP as it is form
ed in the mitochondria.
r Fluoride gives higher measur'
ed phosphorylation.
3	
additions to 1.0% bovine no BSA BSA binds fatty acids and
assay buffer serum albumin other lipophyllic compounds
9 (BSA) and prevents them from act-#
ipg on the mitochondria.
BSA may bind the compound
whos effect on mitochondria
is being measured.	 Hence,
omission of BSA makes the
mitochondria more sensitive
to the compound being teste<
0.5% glucose 1.0% glucose 0.5% glucose can only trap:
26% of the phosphate in the
assay as glucose-6-phosphat
This value is exceeded quit
often in the assay. Hence,
we switched to 1.-0X glucose
which extends the trapping
capacity to 52% of the Pi.
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Table D, I Cont.
f r
(eont'd) A compav:zon oS the 'o.ed' and
E
new methods' Son ab.day.i.n.g m•i toehondki-a
r
4
,
t
procedure 'old method' 'new method' comment i
r
additions to no glucose-6- 5mM glucose-6-
-
the experimental flasks
assay buffer phosphate phosphate trap P	 as glucose-6-
phosphIte while very little
is formed in the blank flasks;
However glucose-6-phosphate
ase activity is present in
the mitochondria and is not
corrected for in the blank
flasks. F
add',	 Ions to 0.3 ml 0.25 M 0.3 ml 0.2 M KCL• KCL is better since it
sidearm sucrose-0.01 M to sidearm of matches the K+ added in
Tris CL to sidearm blank flasks. the experimental flasks
of blank flasks (they get 0.3 ml 0.1 M K2
succinate). Chloride matches
the negative charge of the
succinate.
'cu erections no time correct- time corrected time corrected phosphory- '
ion for when phos- lation gives lower but real i
p1mrylation occurs values of phosphorylation.
but respiration i
is not measured
P	 analysis
i
Fisk subbarow in Fisk subbarow autoanalyzer reduces human
the test tube on autoanalyzer error, standardizes reagents
-and generally gives more t
reproducible results. )
R
r^
b
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Table D. II
- The e66ect o6 in vitro expozuAe o4 heaht and
tiven m.i tochonTZ, 	 .to Haton 1301 and Freon 12,
Oxidative
phosphorylationb. Respirationc P/Od
con Ao Z
Liver 1.09 0.92 1.19
Heart 2.29 1.84 1.24
Haton 1301 Trial #la
Liver 1.21 0.84 1.44
Heart 2.82 1.74 1.62
i
9
I
Conoco C
Liver 0.99 0 . 92 1.07
Heart 1.72 2.62 0.66
Haton 1301 Trial #2
Liven 1.10 0.86 1.28
{	 Heart 2.42 2.31 1.05
Contco ,
Liver 1 . 39 1.35 1.02
Heart 1.34 1.70 0.79
a{	 Meon 12a
{	 Liver 1.52 1 . 40 1.08	 y
Heart 1 .26 1.71 0.74
4
a.	 The respirometer was gassed with air or 20%-Freon prior to assay.
°	 b	 Expressed as PMoles Pi esterified/mg protein/20 minutes.
el	 Expressed as pAO/mg protein /20 minutes.
d	 Expressed as the ratio of oxidative phosphorylation,to respiration.
^-
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Table D. III
E66ect o6 an acute expostme to ha,Zoca,%bons on mi tochondv, at
ne,4p.iA t o)i and phosphon.y.Zation as niemmed by the .i.mpnwved methode
Group Exposure Mitochondrial Activities (Succinate)
of Conc. Duration Liver Lung Brain Heart Kidney
Rats % min. 0.4apl->ATPb P/Oe Ozy Pi->ATP	 P/0 02+ Pi-ATP P/0 02+ pi+ATP P/0 021Pi-}ATP P/0
control 0 30 4.9 7.2 1.4 9.0	 14	 1.5 3.2 4.2. 1.3 8.6 8.8 1.0 15 17 1.1
2402
E
6.2 10 6.6 8.4 1.3 12	 17	 1.4 2.9 3.9 1.3 10 12 1.2 15 17 1.1
control 0 30 5.8 9.5 1.7 11	 18	 1.8 3.0 3.7 1.2 7.7 '7.5 1.0 18 21 1.2
1301 6.8 30 5.6 9.5 1.7 11	 23	 2.1 2.5 4.6 1.8 8.1 8.7 1.1 14 16 1.1
rn
LO
control 0 30 6.3 9.5 1.5 11	 16	 1.4 3.0 3.3 1.1 8.4 8.0 1.0 18 21 1.2
116 7.3 30 6.6 9.8 1.5 9.4	 15	 1.6 3.1 4.4 1.4 9.5 8.6 0.9 16 22 1.3
l
control 0 30 5.0 9.4 1.8 9.5	 15	 1.6 2.3 3.4 1.5 6.3. 7.8 1.2 14 24 1.7	 j
C-318 5.0 30 7.1 12 1.7 9.4	 16	 1.6 2.8 4.7 1.7 8.4 10 1.2 15 22 1.5
control 0 30 5.8 11 1.9 9.8	 17	 1.8	 - 2.8 4.0 1.4 7.7 10 1.3 14 17 1.2.
12 7.6 30 4.9 8.2 1.7 11	 18	 1.6 2.6 4.1 1.6 7.4 8.5 1.1 14 16 1.1
a expressed as mVAO taken up/mg protein/minute x 10 i
o i
expressed as m1.i Moles Pi
 esterified/mg protein/minute x 10-
_
P /0- phosphorylation
respiration_
I
i1 • 	 f
Table D. IV
' The e64ect o6 a 30-minute expo4une
to 56 WO Faeon 12 on mitochondkiat
d
+NADHOxidativea
phosphorylation :Respiration 0 	P/OC -NADH
Confii otz
Heart 2.00	 1.23
	 1.65 79/0
Lung 1.41	 0.96	 1.47 0/0
Brain 0.83	 0.60	 1.41 7/0
Fxpo4 ed
Heart 1.59	 1.37
	 1.16 206/0
.^ Lung 1.10	 0.95
	
1.71 3/0
Brain 0.70	 0.37	 1.90 12/5
Succinate	 a-kg	 6-oxy• +NADH
...^ ADP/O	 .3/4e	 ,ADP/.0..3/4:. ADP/O	 3/4 -NADH
ContWtA .
Liver	 1.73 3.45	 3.71	 3.62	 4.05	 .3.24 12/10
Kidney
	
1.75 2.44	 -	 -	 -	 - 10/0
- -
Fxpo4 ed
t Liver
	
1.12 3.36	 3.92	 3.04	 3.24	 3.04 11/11
Kidney	 1.48 1.65	 -	 -	 -	 - 30/0
a	 Expressed as pXoles Pi esterified/mg protein/20 minutes.
b	 Expressed as pAO/mg protein/20 minutes.
C	 Expressed as the ratio of oxidative phosphorylation to
respiration.
d Expressed as PAO/mg protein/min X 105.
e	 State 3 respiration ove.- state 4 respiration.
a-kg (a-ketoglutarate) and $-oxy (0-hydroxybutyrate)
JJ
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Table D. V
Siochemi,caZ pahameteu o4 ttie micAozomaC mixed 6unc;tion
o xidaa e in t i.veu o6 kat6 expob ed 37 weefvs to Freon. 116
Biochemical	 Control	 Freon
parameter rats	 rats(N=6)	 (N=8)
(0.D. 450nm X 10 3 /mg protein/ml) 76 ± 25 69 t 18
cytochrome b5
i
(O.D.428nm X 10 3 /mg protein/ml) 34 + 14 35 ± 15
biphenyl hydroxylase
(nMoles 4-011-biphenyl)
43 4 36 ± 21(	 mg/Protein/hr	 )
N-demethylase
(nMoles p-chloroaniline) 166 t 30 146 ± 32(	 mg/Protein/hr
	 )
lipid peroxidation
kun,les maiona denvde)
48 t 12 41 + 11
^)(	 mg/Protein/hr -
glucose-6-phosphatase
(	 nMoles Pi
(mg/Protein/20 min) 3.4 _* 0.9 3.8 + 1.0
y
a
F
i
f
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Table D. VI
F The es-6ect at continuous--expo.aune to Haton 1301 on heaft t
-	 mitochondn i..a o ^ tat6 .
Oxidative	 Respiration, P/0
phosphorylationa
- Females	 Males	 Females Males Females Males
2 weeks exposed 1.64
	
1 . 28	 0.70 • 1.09 2.. 33 1.17
controls - -	 2.16
	 1.69 1.91 - - 1.13
2 weeks confined 1.68	 1.65
	 .0.62 0.93 2.72 1.77
controls 1.67
	
1.53
	
0.90 0.93 1.86 1.66
4 weeks exposed 3.50	 1.80	 1.15 1.05 3.05 1.71
controls 4.26
	 2.53
	
1.55 1.17 2.74 2.18
_	 4 weeks confined 2.27	 1.55	 1.12 0.85 2.04 1.82
controls 2.04	 2.17	 1.04 0.87 1.95 2.49
expressed as PMoles	 Pi esterified /mg protein /20 minutes.
- b
expressed as pAO/mg protein /20 minutes.
a
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Table D. VII
The e6ject o6 conti.nuou6 exnoaune to Haton 130 .1 on Lung
mi tochondA.Za o Aatz .
Oxidative	 Respirationb P/0
phosphorvlationa
Females Males	 Females	 Males Females Males
2 weeks confined	 1.57 2.47	 0.89	 0 .92 1.77 2.69
controls 3.47 2.69	 1.34	 1.13 2.61 2.38
4 weeks exposed 3.12 3.36	 1	 1.07	 1.26 2.93 2.66
controls 2.08 2 .67	 0.97	 1.38 2.15 1.94
4 weeks confined 	 3.10 1.81	 1.24	 0.81 2.51 2.25
controls 2.12 1.96	 0.73	 0.99 3.02 1.98
a
expressed as P Moles Pi esterified /mg protein /20 minutes
b expressed as u AO/mg protein/20 minutes 1A
{
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Table D. VIII
The ejSect o6 continuou6 expobune to Haeon 1301 on bna,i.n
mitochondti.a o A %atA .
Oxidative Respirationb P/0
' phosphorylationa
Females Males Females Males Females Males
2 weeks exposed 1.30 1.28 0.93 0.81 1.38 1.61
(i controls 1.56 0.63 0.97 0.63 1.61 1.01
i
2 weeks confined 0.49 0.67 0.37 0.36 1.33 1.80
controls 0.59 0.63 0.25 0.30 2.32 2.08
4 weeks exposed - - - 1.24 - - - 0.53 - - - 2.36
controls - - - 1.22 - - - 0.39 - - - 3.23
4 weeks confined 1.07 1.49 0.52 0.61 2.04 2.44
controls 1.36 1.95 0.43 0.61 3.15 3.71
t	 --
a
expressed as V Moles Pi esterified/mg protein/20• minutes
expressed as u AO/mg protein/20 minutes
64,
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Table D. IX
The eject o6 eontti.nuous exposure to HaZon 1. 301 on kidney
mitoehondAia oS %at6.
F Oxidative Respirationb P/0
phosphorylationa
Females Males Females Males Females Males
2 weeks exposed 1.35 0.57 1.80 0.91 0.85 0.63
controls 0.96 0.57 1.70 0.92 0.57 0.62
2 weeks confined 3.90 3.26 1.72 1.87 2.27 1.74
controls 3.68 2.35 1.92 1.41 1.90 1.67
4 weeks exposed 4.01 2.22 2.45 1.80 1.64 1.23
controls 3.99 2.66 2.37 2.08 1.68 1.28
4 weeks confined 1.50 1.62 1.59 1.59 0.94 1.02
controls 2.03 1.42 1.77 1.58 1.15 0.90
-
a.
expressed as U Moles P i -esterified/mg protein/20 minutes
3
_
b
expressed as Vi AP/mg protein/20 minutes
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Table D. XI
E The e6ject oS conti,nuoub expobune to HaCon 1301 on ti.veh m,itochondAi.a o6
E	
A&u. Ab4ebbmentd with thAee b u6.6 tu ta.
succinate	 a a-ketoglutarate 0-hydroxybutyrate
"
ADP /O 3/4 ADP/0 3/4 ADP/0 3/4
2 week exposed females 1.56 -	 4.14 2.80 3.70 2.17 3.48
` control females 1.55 4.06 2.29 3.31 2.31 4.20
2 week exposed males 1.79 3.91 2.26• 4.05 2.20 3.48
control males 1.67 2:93 2.28 3.66 2.24 3.32
2 week confined females 2.14 3.80 3.16• 3.04 2.26 3.42
control females 1.85 3.76 3.12 3.93 2.94 3.39
-2 week confined males 1.70 3.15 2.32 2.43 2.12 2.10
control males 1.84 4.62 .2.77 2.62 2.65 4.31
4 week exposed females 1.75 4.49 2.85 3.52 2.46 3.26
:. control females 1.65 4.39 2.70 3.37 2.59 4.17
4 week exposed males 1.98 4.28 3.38 5.05 2.98 4.81
control males 1.84 4.16 3.24 4.56 3.02 4.85
4 week confined females 1.70 3.76 2.85 ''	 2.91 2.55 2.92
control females 1.75 3.91 -•2.86 2.70 2.62 2.80"
11
4 week confined males 2.08 4.16 .3.34 3.09 3.28 3.74
control males 2'.08 4.04 3.19 2.94* 3.46 3.80
a
state 3 respiration/state 4 respiration.
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Table D. XII
The e66ect o6 Haton 1301 on mitochondkiat ,i.ntegnity ab meamed
by the penetAakitUy and .a ub^s erg uent oxidation o S NAUH .
respiration + NADHa•
respiration - NADH
Heart Lung Brair. Kidney Liven
4 week exposed
females 23/3-7.67 2/2-1 - - - 23/2-11.5 12/6-2
males 159/0 - - - 5%5-1 24/1-24 10/10-1'
controls
females 29/3-9.67 5 /5-1 - - - 20/3-6.67 15/15-1
males 87/5-17.4 - - - 6/6-1 14/0— 12/10-1.2
4 week confined
females 69/3=23 2/2=1 7/7-1 43/5=8.6 - - -
-	 males 79/6=13.2 5/5-1 10/10-1 7/0= 1- 12/12-1
controls a
females 74/5-14.8 3/3-1 7/7-1• 36/5=7.2 - - -
males 56/6-9.33 5/5-1 7/7-1 23/7=3.28 12112-1
a	 expressed
i	 - as W
/rain/mg protein X 105
e
a
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j Table D. XIII
WcAobomaZ enzyme ae ti.vitiea in ei.veA 6)tom Aata expo.aed eonti.nuoua.Zy
to HaZon 1301.
exposed controls
Demethylasea
2 week females 12.25 t 3.45 9.82 t 2.87
males 12.07 ± 3.09 11.72 ± 2.41
4 week females 10.77 t 1.49 7.03 ± 2.02
i
•	 males 12.41 t 1.32 10.20 t 1.32
I _	 6 •4-0H Biphenylhydroxylase
2 week females 0.402 ± ,.057 0.273 ± .023
{
males 0.084 ±;.027 0.094 ± .011
4 week females 0.788 ±f,,.096 0.482 + .073
males 0.847 t",184 0.630 t'.078
2-0H Biphenylhydroxylase
2 week females 0.253 ±}.066 0.113 ± .020
males 0.153 ±'.',.023 0.158 ± .028
4 week females 0.387 t ;.036 0.174 + .049
males 0.379 ± .066 0.169 + .033
a pg Ca/20 min/100 mg liverb u Moles/hi/g liver
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Mi,chodomat enzyme acti.vc ti.ea in ti.ven 6nom nat6 con6i.n
expo,6uAe chamber.-
' confines: -controls
Demethylasea
2 week females 9.81 a- 1.04 6.90
males 12.41 ± 2.47 11.22
5 week females 6.64 t 1.40 5.03
i
males 10.51 ± 1.98 11.39
4-OR Biphenylhydroxylaseb
2 week females '0.993 ± .129 0.654
males 0.539 ± .057 0.368	 -
5 week females 0.245 + .036 0.226
males 0.229 ± .047 0.260
1
- 2-01i Biphenylhydroxylase
a
I
_2 week females 0.218 t .031 0.231
males 0.196 t .052
A
0.187
5 week females 0.474 ± .084 0.392
males 0.258 t .060 0.236
a Vg Ca/20 min/100 mg liver
U Moles/hi/g liver
t .
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Table D. XV
Fj6ect o[ Fp eon C-318 on heart mi6chondAiat
neapi4ation and oxi,dat.ve ,ahosphanytation. i
Controls Exposed
Weeks of Oxidative Oxidative
_	 exposure phosphorylation	 Respiration	 'P/0; , phosphorylation	 Respiration P/0
2 2.04 1.54 1.330	 1.06	 1.75 0.667
1.38 1.52 0.909	 2.05	 1.88 1.090
4 2.22 2.46 0.899	 1.20	 1.90 0.631
2.44 2.68 0.907	 1.45	 1.90 0.764
6 2.51 1.87 1.340	 1.76	 1.90 0.929
2.09 1.88 1.120	 1.58	 1.91 0.828
1 The data are expressed as follows:	 oxidative phosphorylation,
't
UMoles Pi esterified/mg protein; respiration, pAO consumed/mg protein.
j
G
Qj
Table D. XVI
1
E66ect o6 Fneon C-318 on kidney wtochondtiat
,%upc4a ion and oxidative pho4phony anon. l
Controls Exposed
Weeks of Oxidative Oxidative
exposure phosphorylation	 Respiration	 P/O phosphorylation	 Respiration P/O
2 0.282 1.640 0.172• 2.610	 2.31 1.130
0.677 1.750 0.387 2.310	 2.35 0.983
4 0.598 1.000 0.595 0.706	 1.23 0.574
0.660 0.997• 0.661 0.599	 1.16 0.517
6 0.784 1.340 0.588 1:070	 1.30
•
0.823
	
ia
0.892 1.330 0.670 0.945	 1.25 0.755
The data are expressed as follows: oxidative phosphorylation,
VMoles Pi esterified/mg protein; respiration, JIAO consumed/mg protein.
I,
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Table D. XVII
ES 6ec t o6 FAeon C-318 on bna i.n. mitochondtiat
&e6piAati,on and oxidative phoaphonytat<on. i
Controls Exposed
Weeks of Oxidative Oxidative
exposure phosphorylation	 Respiration •• R/O--- phosphorylation
	 Respiration P/0
2 0.687 0.570 1140 0.530	 0.482 1.10
0.731 0.581 1.26 0.859	 0.523 1.64
4 0.435 0.309 1.41 1.190	 0.701 1.69
- 0.395 0.307 1.29 1.190	 0.714 1.66
6 0.702 0.474 1.48 0.835
	
0.445 1.88
0.702 0.566 1.24 0.663
	
0.445 1.49
j The data are expressed as follows: oxidative phosphorylation,
- VMoles Pi esterified/mg protein; respiration, PAO consumed/mg protein.
JTable D. XVII^ -
E66ect o6 Fneon C-^318 on ADP-dependent nuPiAat on
and rcea pi4a to t y cont.ot in t i veAL mitochondn.Za..'
Controls	 Exposed
Weeks of Succinate	 a-kg	 $-oxy	 Succinate	 a-kg S-oxy
exposure ADP/0	 3/4	 ADP/0	 3/4 ,	ADP/0	 3/4	 : , ADP/O	 3/4	 ADP/0	 3/4 ADP/0 3/4
2 •1.43	 3.21	 2.07	 2.75
	
1.97	 2.74	 1.56,	 3.35	 2.41	 3.40 2.10 3.40
4 1.44	 3.25	 2.19	 3.01	 2.03	 3.26	 1.50	 2.88	 2.26	 3.27 2.16 2.70
I 6
1
•1.32	 2.43.
	
2.16	 2.98	 2.10	 3.02	 1.45	 2.57	 2.48	 3.60 2.20 3.40
1 The data are expressed as follows:	 ADP/0, uMoles ADP/,pAO;
3/4, state 3 (elec.tron transport limited) /state 4 (ADP limited);
the substrates are succinate (not abbreviated), a-kg (a-ketoglutarate)
-` and S-oxy (0-hydroxybutyrate).
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Table D. XIX
F'64ec t o6 Fneon C-318 on t i,veA
micaoeoma- biphenyl hydno xy A4 e, 1
Weeks of
exposure Controls	 Exposed
2 0.888	 0.763
0.865	 0.740
4 1.170	 0.880	 I
1.150	 0.880
6 1.180	 0.988
• 1.180	 6.988
i The data are expressed as vMoles of 4-OH
^--^`	 biphenyl produced per hour per gram of
fresh liver.
j
i
I
f
i
f	
.-•	
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Table D, XX
Dacie Osmotic Frajility Method
Hemolysis measured as OD at 545 mu of Supematent
Salt Control Vehicle Freon 2402 in 12% 2-ethoxyethanol/ethanol
conc. 12% % Hemoly	 as_sis- reasured OD at 545 mu (SUE.)
'2-ethoxyethanol/
ethanol 2 mH	 MM 0.2 Irm 0.1 irm 0.02 mM
0 1 85 0 0 0	 0 0 0 0
0 075 0.29 2.2 0.12	 -0.31 0,23 011 -0.56
0,65 -0.48 0.67 0,23	 -0.20 0,57 0,3 -0145
0 1 60 0 -0.56 0.70	 0.41 0.57 0*1 -0.23
CD	 0.55 0.48 0,44 0,23	 0.20 1.85 011 -0.45
0.50 1.44 1.8, 0,94	 0.62 1.94 1.3 0,45
0,45 34 29 7.7	 14 29 28 1125
0,40 al so 72.	 70 76 76 73
0.35 as 83 73	 74 79 78 76
0.30 87 96 96	 90 96 95 92
0,20 100 97 102	 97 94 100 97
01,10 100 100 100	 100 100 100 100
Table D. XXI
1
The a&ct o6 Haton 2402 inhateati,on (4.3% bon 10 minutea ) on
, ted blood ceU 6nag.i.0 ty*
Hemoglobin released
NaCl	 Control	 Exposed
	
conc n	 (X)	 rats	 rats
	
0.85	 0	 0
	
0.75	 0	 0
	
0.65	 0	 0	 1
	
0.60	 0	 0
	
0.55	 0.8	 1.1
	
0.50	 2.7	 2.7•
	
0.4,9	 5	 7.2	 11.7
	
0.40	 53	 65
	
0.35	 77	 89
,
	
0.30	 89	 93
0.20	 96	 98
* Determined, by the method of Dacie (Miale, 1967)
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iTable D. XXII
0.6motie &%ag.i,Uty o5 enyxhnoeyte^s 6nom hate expoaed to Haton
1301 bon 1 week.
Rat % hemolysis in indicated salt concentration
No. 0.55 0.50. 0.45 0.40 0.35 0.20
Controls	 lE 0 1 . 0 .46.0 97.0 99.5 100 100
2E 0 0 7.2 74.9 97.6 100 100
3E 0 1.0 17.8 83.9 98.0 99.5 100
4E 0 3.8 38.8, 96.2 99.4 100 100
`	 5E 0 0 32.0 92.2 98.8 99.8 100
26E 0 0.5 24.1 89.4 100 100 100
27E 0 0 19.9• 85.8 99.7 100 100
28E 0 3.0 9.0 63.8 97.0 99.8 100
29E 0 1.0 7.0 80.2 97.8 99.9 9919
Mean 0 1.1 22.4 84.8 98.6 99.9 100
9
d
Exposed	 19E "0 0 3.8 66.0 95.9 99.0 100
22E 0 0 10.8 83.2 97.8 98.0 100
23E_ 0 0 6.0 75.0. 95.8 98.0 100
25E 0 2.0 10.0 81.0 97.8 99.5 100
42E 0 0 4.0 80.2 99.0 100 100
44E 0 0 12.2 91.0 99.5 100 100
46E 0 0 8.4 78.1 97.8 99.5 100
48E 0 0.8 22.1 89.1 98.8 99.9 100
Mean 0 0.4 9.7 80.5 97.8 99.2 100
78
Table D. XXIII
04mofiic jh.agitity of enyxhAocyxeb 6nom UU expo4 ed
'	 doh 1 month.
' Rat % hemolysis in indicated salt concentration
No. 0.55 0.50 0.45 0.40 0.35 0.30 0.20
Controls 1E 0 3.0 23.5 91.0 100 100 100
2E 0 0
•
18.0 84.0 99.8 100 100
3E 0 0 23.8 95.0 100 100 100
5E 0 0 16.8 83.0 86.8 100 100
- 26E 0 0 1.5 63.6 95.2 99.1 99.5
27E 0 0 1.0 46.0 64.2 100 100
28E 0 0 6.0 78.0 98.0 99.6 100
29E 0 0 0 45.9 94.1 99.5 100
30E 0 0.2 0.6 48.0 91.2 99.0 100
A4
Mean 0 0.4 10.1 70.5 92.1 99.7 99.9
Exposed 11E 0 0 16.8 83.0 86.8 100 100
14E 0 0 18.2 81.8 99.7 100 100
15E 0 0 7.2 70.8 96.8 99.7 100
17E 0 0 16.8 86.5 - - 100 100	 j
24E 0 0.2 33.1 93.4 99.1 99.8 100	 l
34E 0 4.8 54.2 95.2 99.2 100 100
41E 0 0 39.0 94.0 99.8' 100 100
45E 0 8.8 63.9 96.1 100 100 100
47E 0 0 0 57.9 95.0 99.1 100
50E 0 0 0 72.5 96.8 99.1 100
a
Mean 0 1.4 24.9 83.1 97.0 99.8 100
r
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Table D. XXIV
0amoti.c 64giQ,ity o4 enythwcytu Snom na A conSined to exposwce
chamben (no hatoca&bon) 4on 1 month.
Rat % hemolysis in indicated salt concentration
No. 0.55 0.50 0.45 0.40' 0.35 0.30 0.20
Controls
	 1C 0 0 9.5 99.5 100 100 100
2C 0 0 72.8 93.8 100 100 100
3C 0 6.4 58.2 90.0 100 lU0 104
`	 4C 0 0	 •- .. 46.0• .85.5 99.0 100 100
5C 0 13.7 66.2 90.8 99.3 100 100
46C 0 • 0 18.2 86.8' 99.0 100 100
47C 0 0 16.0 74.6 96.2 98.2 100
49C 0 2.8 36.6 88.8 98.2 100 100
50C 0 0 10.1 76.8 99.5 100 100
{ ^	 Mean 0 2.5 37.1. 87.4 99.0 99.8 100	 a
Confined	 23C- 0 0 22.7 94.4 98.5 100 100
25C 0 0 68 96.3 99.2 100 100
26C 0 0 6.0 89.4. 98.6 100 100
30C 0 0 4.0 16.8 91.0 98.5 100
32C 0 0 33.5_ 8505 97.7 100 100
61C 0 0 11.0 87.0 98.0 99.0 100
62C 0 0 8.6 83.6 98.0 99.5 100
65C 0 0 25.0 88.2 96.8 100 100
66C 0 2.2 13.5 80.6 87.1 98.8 100
76C- 0 0- 5.0 65.8 94.8 100 100
Mean 0 .2 13.6 78.8 96.0 99.6 100
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iOxygen cued Ftceon 116 Concentnati.on3 in the GZove Bag
Containing Ai t, Ai&-Nitwgen on AiA -Freon AL tuA"
Gas	 1 hour	 10 day
Measured	 study	 study
Concentrations
Group	 in %	 Males	 Females	 Males
Air Only	 02	 19.5 t 0.6	 19.4 ± 0.9	 19.2 ± 1.0
Air-N2	02	 16.0 ± 1.4	 16.1 ± 0.9	 --------
Air-Freon	 02	 16.8 ± 0.3	 17.2 ± 0.4	 17.9 ± 1.2
(116)	 '
Air-Freon	 Freonb 23.2 ± 2.6	 22.1 ± 2.5	 25.1 t 3.6
(116)
a ::crr, t S.L of 4 determinations (includes both tria1c)
b Mean ± S.D of 6 determinations (includes both trials).'
Table'D. XXV
Table D, XXVI
Oxygen andReon 116 ConcentAatiaws in the Expame
Chambeu Containing Aih, on Aix Reon M.i.xtuta
Gas
Measured	 Experiment 1	 Experiment 2
Concentration
Group	 in
Air Only	 02
	
21.1 ± 2.3	 21.8 ± 0.5
Air-Freon	 02	 21.4 ± 0.5	 21.4 ± 0.5
Air-Freon	 Freon	 26.3 + 3.6	 22.0 ± 1.2
r'
I
i
s
Table D. XXVII
Body Weights o6 Chaste Riven Wee Exposed 10 dayA to Fneoh-116
Experiment 1	 Experiment 2
Body Weight (g)
Groupa
	Initial	 Final	 Initial	 Final
Air Only	 25.7 ± 2.0	 - 26.3 ± 1.7	 25.0	 1.1	 26.6 ± 1.3
Air-Freon 116	 23.8 ± 2.7	 25.4 ± 1.8	 23.6 ± 2.2	 27.2 ± 1.7
a Ten mice per group
i Table D. XXVIII
Induction Time in Cha,ctes Riven Mice aster
80 mglkg HexobaAbitae .i;.p.
i One Hour Study in day study
{
Mean induction time ± S.D. (min)
Group Male Female Male
t Air Only
t Exp. 1 (10)a 1.9 ±'0.7 (9) 2.4 1
-
0.9 (10) 3.4 ± 0.9
Exp. 2 (8) 4.4 ± 2.2 (10) 2.4 ± 0.5 (10) 3.2 ± 1.2
Total (18) 3.0 ± 2.0 (19) 2.4 t 0.7 (20) 3.3 ± 1.0
Air-N26
Exp.	 L (10) 2.4 ± 0.9 (10) 2.3 ± 1.1 - - -
Exp. 2 (10): 2.3 ± 0.4 ('19)
	 2.9 ± 1.6 - - -
Total (20) 2.3 ± 0.7 (19) 2.6 ± 1.4 - -
c
Air-Freon
{ Exp. 1 (8) 2.3±0.4 (9)2.8±1.4 (10) 2.8 ±0.7
Exp. 2 (10) 2.4 ± 0.9 (10) 2.6 ± 1.0 (10) 2.5 ± 0.4
i
Total
, (18) 2.3 ± 0.7 (19)_2.7 ± 1.2 (20) 2.7 ± 0.6
a Value in parenthesis indicates number of mice per group.
f b See Table 1 for parameters.
C See Table 1 and 2'for parameters.
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Table D. XXIX
LORRT in Cha tte, P. veA Mice a6ten 80 mglkg Hexoba^cb.c ta,2 i. p.
One Hour Study 10 day stud.
Mean LORRT i S.D.	 (min)
Group Male Female Male
Air Only
Exp. 1 (10)x' 31.2 ± 12.1 (9)	 26.5 ± 9.1 (10) 29.0 + 8.7
Exp. 2 (8) 21.6 ± 8.7 (X0)120.8 ± 8.9 (10) 32.9 ±12.3
Total (18) 26.9 ± 11.5 (19)	 23.5 ± 9.2 (20) 30.9 ±10.6
Air-N 
26
Exp. 1 (10) 31.5 ± 7 .0 (10) 29.1 ± 8.9' - -
Exp. 2 (10) 22.1 ± 8.4 (9)	 21.9 ± 8.0 - - -
Total (20) 26.8 ± 8.9 (19)	 25.7 ± 9.1 - - -
3
Air-Fre n i
Exp. 1 (8) 21.7 ± 4. 4 (9)	 18.6 + 9.6 (10) 20.2 ±	 6.5
Exp. 2 (10) 22.4 ± 10.3 (10)	 29.4 ± 9.8 (10) 35.2 ±	 4.2
,Total` (18) 22.1 ±	 8.0 (19)	 24.3 ± 11.0 (20) 27.7 ±	 9.4
a Value in parenthesis indicates number of mice per group.
b See Table 1 for parameters.
C See Table 1 and 2 for parameters.
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Table D. XXX
Natothane ConcentAationd in Notated Moube Liven Nucee.i
as a Function oS Repeated Su6pena.ion and Cent iSugafii.on
Number of times	 Halothane concentration in nuclear pellets
separated	 (% of conch. in first pellet)
1	 100
2	 17.5
3	 8.75	 I
i	 4*	 10±0.5
* Mean of three samples
1
Hatothane Coneenthattt on in Li ve c Nuc eei o Mice	 j
Fxpod ed to It Hatoth.ane bon One Houn
Halothane extracted from nuclear pellet*
Time after end	 (g x 10'11)
of exposure (hr)
Freshly-exposed**	 Pre-exposed**
0	 5.73
	
12.52	 1
1	 1.64	 1.05
* Nuclear pellet resuspended in sucrose (2.4 M) and separated by centri-
fugation.
Mean valuer for nuclei isolated from the livers of two mice.
** Freshly-exposed mice were untreated prior to the experiment. Pre-exposed
4	 had been exposed to 1% halothane gas 1 hr/day, 5 days /week for 16 days.
k
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Table D.. XXXII
- The e j sects o6 expob uhe o f mice to hatothane vapon' on tet ti.:ve t iven weight and the
.inconpon ti.on o f tabe22ed #h.ymtdine into Liven nucteoA DNA
i Expt. Halothane Body	 Limier Relative Specific
no, concne wt.	 wt. liver wt,. activity
±(% by vol. in air) (g)	 (g) (g./100g) (DPM/pg DNA	 S.E.)
l 0 27.0	 1.54 5.70±0.14 4.14±0.55
1.0 28.0	 1.96 7.00+0.40** 3.74±0.16
2 0 27.7	 1.69 6.09±0.17 lost
	 E
CO
q 1.0 24.6	 1.88 ±0.357.64** lost
3 0 28.2	 1.53 5.424.17 5.47±1.45
1.0 23.0	 1.83 7.97+0.09** 5.96±2.07
*	 Halothane exposures:
	
1 hr per day, 5 days a week, for 2 weeks.
Four mice per group, pretreated with labelled thymidine 2 hr before sacrifice.a
**	 Significantly different from controls (P<0.05 by Student's t test)
rTable D. XXXIII
The ei4ects o4 expoeun.e o4 Aat6 to hatoxhane vapoh* on ne.2ati.ve
 t i.veA weight and inemponation
os tabetted th ymEdine into Zi.veh. nucteah. DNA.
Halothane No.	 Pretreatment Body Liver Relative
i
Specific a^tivity
C.- Expz, concn, of	 period** wt. wt, liver wt. (DPM/pg DNA - S.E.)
M. no. (X by vol. in	 rats	
__	 (hr) (8) (g) (g./100 g.)
air)
1 0 4	 2 151 8.29 5.49 1.02±0.24
s 0 4	 24 158 7.93 5.02 0.72±0.26
0.5 4	 2 166 6.34 3.82 1.2610.54
	
J
0.5 4	 24 133 7.32 5.50 0.6z+0.16
2 0 4	 2 127 5.78 4.55 1.74±0.64
r
0.5 4	 2 121 5.93 4.90 3.28±0.76
9
3 0 2	 2 250 13.0 .5.20 4.52
0 1 (1 lost)	 24 255 13.8 5.41 8.53
0.5 2	 2 187 16.0 8.581 1.52
0.5 2	 24 188 17.9 9.52 1.10
0 4	 2 130 4.03 3.10 2.11±0.44
N 1.0
4	 2..
130 4.00 3.08 1.77±0.21
Halothane eXposures:	 1 hr per day, 5 days a week, for 2 weeks.
** Duration of incorporation of thymidine prior to sacrifice.
t Significantly differe-rst from controls (P	 0.05 by Student's t test).
__
FE. OTHER BIOCHD, 1ICAL STUDIES
ynthesis'and Secretion of Protein in Lung Tissue
Experiments were designed to study.behavior of lung tissue at the
cellular level and to ascertain its sensitivity to epinephrine following
exposure to halocarbon chemicals. The study involved pulse-labeling of
excised lung tissue with radioactive amino acid after the animal's
exposure to a halocarbon. Secretion of protein was estimated by
counting radioactive protein produced by the lung tissue. The method of
Massaro, Weiss; and Simon (Amer. Rev. Resp. Dis. 101:198, 1970) was used.
Lung slices studies by Massaro et al., were composed primarily of cells lining
alveolar sacs, and epinephrine acted in vitro to stimulate protein synthesis
by these cells. Since these cells are the first to come into contact with
vapors from halocarhon exposure, it was felt that the permeability of these
cells and their organization might be, affected by foreign materials which
dissolve extensively in their membranes. To study the effect of rialocarbon
inhalation on the synthesis and secretion of protein in lung slices, therefore,
30-min exposures were conducted and the tissues of exposed and unexposed animals,
with and without added epinephrine, were compared.
Male New Zealand rabbits (2 3 kg) were used for the exposure. Four
animals were exposed to each of the halocarbons (11alons 2402, 1202, 1301,
and Freons 113 and 116). For each exposure, one control rabbit was used.
Following the 30-min exposure, the rabbits were removed and sacrificed
by stunning. Lungs were immediately removed and immersed in iced saline
solution. Duplicate weighed 2 - 3 mm slices from each animal were incubated
for 30_ min at 37°C in 3.0 ml of oxygenated Earle t s balanced salt solution
f containing l uc of uniformly 14C-labeled leucine (sp. act. 251 me/m mole).
I	 Following pulse-labeling, the slices were removed, washed with cold Waymouth
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medium and placed in a vial containing 3.0 ml of oxygenated Waymouth medium.
Epinephrine was added to the appropriate vials (7.0 x 10 -5M final concentration)
and the vials were incubated for 15 min at 37°C. The contents of each vial
was filtered and protein content of the filtrate determined by the method of
Lowry, et al. (J. Biol. Chem. 193:265, 1951).
The results of protein estimation, 14C counting and specific activity
calculations are shown in Tables E-I through .E-VI. Statistical treatment of
this data in Tables E-VII - E-IX compares exposed animals with non-exposed,
and epinephrine treated with un-treated.
Protein measured by the Lowry procedure showed an increase in amount secreted,
but only in one case (Halon 1202) was the P>0.05. For those slices not treated
with epinephrine (E) only Halon 2402 produced a decrease in the rate of protein
secretion. For epinephrine-treated slices, Freon 113 showed a significant
increase in secretion. Protein secretion measured radiometrically indicated
decrease.. .n treated and non-treated slices following Halon 2402 exposure.
Lowered specific activities reflected changes in either the rate of
uptake or the rate of protein synthesis by the lung slices. The results of
these experiments are shown in Tables E-X and E-XI. The effect of variation
of pulse-labeling time are shown in Table E-X. The change with time of the
number of counts/min/g of lung was due to 14C leucine uptake and protein
synthesis since secretion times were constant. The decrease observed in the
chemically-measured protein could reflect either a deterioration in the protein
synthesizing mechanism with time or loss of protein into the medium during
labeling.
In Table E-XI, protein secretion is compared after a constant pulse
labeling period but with a varying secretion incubation time. In this case
both the chemically-measured and radiometrically-measured amounts of protein
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increased with time. This is also reflected in a fairly constant specific
activity.
Tissue Levels of 5 Hydroxytryptamine
It was felt that measurement of tissue levels of 5-hydroxytryptamine
(serotonin) might disclose a response of tissues to exposure to halocarbons.
Some of the physiological responses of animals during halocarbon i.ntoxicatiolA
were strongly suggestive of central nervous system effect and serotonin is
ros tulated to function as a neurohumoral agent. Therefore, serotonin levels
were estimated in blood, brain and lung tissues of rats following exposures
]
	
	
to various halocarbons. The procedure of Bogdanski (J. Pharmacoll. Exp. Ther.
117:82, 1956) was used to make the measurements in blood, brain and lung of
female Sprague-Dawley rats (100 - 150 g) after 30-min exposures to either
Halon 2402, Halon 1202, Halon 1301, Freon 113, or Freon 116.
Serotonin was estimated spectrofluorometrically using a Farrand Mark I
with.a Farrand 7-54 primary filter and a 3-73 secondary-filter. Fluorescent
intensities were compared with those of appropriate standards prepared from
serotonin creatinine sulfate.
Concentrations of serotonin in. tissues from control animals (Table E-XII)
i,
and in tissues from exposed animals (Table E-X111)` were compared. No significant
changes were observed in blood levels of serotonin. For brain levels, Halon
2402 caused an increase and Freon 113 caused a decrease. Both were significant
at the 0.05 level of probability. However, the absolute value of these levels
is extremely low, and it is doubtful that there was any real difference.
Serotonin levels in the lung were higher and permitt-d more accurate
estimation. Halon 1202 caused a significant decrease in serotonin concentration
while Freon 116 elicited an increase.
I
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Table E. I
Note in eyntha L and dead im in Lung to suez 4.kom contnot 46W6
Animal Protein (Pg,/g lurid Activity'in' lung (CPM/g) Specific activity (CPIyu^protein)
# No E*	 +E* No.E +E No E +E
1 2349	 1411 3624 1714 1.54 1.21
2155	 4719 1810 3360 0.84 0.71
2 1932	 2989 3092 3505 1.60 1.17
2539
	
3028 3740 4005 1.47 1.32
3 1974	 2744 2089 2287 1.06 0.83
ca 2521	 4669 1943 3444 0.77 0.74
41 792	 3117 3311 4702 4.18 1.51
r
4656	 5082 4858 6463 1.04 1.27
5 2183	 3277 5457 3541 2.49 1.08
2747	 3659 5137 4654 1.87 1.27
Mean 2385	 3469 3506 3767 1.69 1.11
S.D. ±962	 +1105 ±1329 #1324 1.02 ±0.27p
No E: without added epinephrine +E: with added epinephrine
r
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4 Table E. II -^
Photein 6ynthe,6is and seaetion in Lung U6.6ue 6hom nab6.itz expoad to Haton 2402, 4% by
volume Son 30 m Ku<tee
-Animal Protein (u8/8 lung)' 'Activity in'lung (CPM/g) Specific activity (CPM/ug protein
No E* _ 	 +E* No E +E No E +E
1 1084	 3924 680 1,831 0.65 0.47
' 857
	
1599 889 487 1.04 0.30	
j
k 2 1061	 2310 719 484 0.68 0.21
1695	 2963 817 1324 0.48 0.45
3 1788	 3527 1853 1243 1.04 0.35
1192	 3185 1264 1139 1.06 0.36	 i
4 738	 4051 1097 1937 1.49 0.48
346	 3325 952
:..
1564
..
2.73 0.47
Mean 1091	 3111 1034 1250 1.15 0.31
S.D. ±478	 +821 ±383 ±545 ±0.72 ±0,10
` * No E: without added epinephrine; +E: with added epinephrine.
F<
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Table E. III
Photei.n aynxheais and aechetion in Lung .tazua 6&om hu66.i t6 expozed to Haeon 1301,	 5%by votume Ooh 30 minutea
activity(CPM/ug
 proteinAnimal Protein (ug/g lung) -Activity in lung (CPM/g) Specific
E No E*	 +E* No E +E No E +E
1 2974	 4429 471] 5255 1.58 1.19
2384	 3744 3290 5435 1.38 1.45
2 2853	 3744 6756 10534 2.37 2.79
1567	 3209 5772 5404 3.69 1.68	 j
u 3 .2268
	 5080 2698 3570 1.19 0.70
4953	 5080 3867 3783 0.78 0.74
4 2869
	 5066 2111 3372 0.74 0.66
2299	 4883 1743 2607 0.76 0.53
Mean 2271_	 4404 3868 4982 1.56 1.22
3S.D. ±992	 ±745 ±1772 ±2445 ±1.02 ± 0.76
* No E: without added epinephrine; +E: with added epinephrine
fl ,
"Animal '_ Protein (ug/g'lung) "Activity in lung (CPM/g) "Specific activity (CPM/ug protein)
No E +E* No E
....
+E
.....
No E +E
1 3049 3226 2569 2488 0.84 0.77
3230 4190 5167 2144 1.66 0.50
2 4878 4110 4615 3020 0.95 0.73
rn
2542 4086 4167 2227 1.64 0.67
3 2263 4522 3125 3487 1.38 0.77
3181 4880 3300 3446 1.04 0.71
4 1471 3801 2763 4347 1.88 1.14
3689 2764 3175 2169 0.86 0.78
Mean 3036 3948 3610 2975 1.27 0.76
S.D. ±1013 }681 +931 +761 ±0.40 ±0.18 
Table E.
Pute,i.n synthe^stz and .becketfon in .dung tasue jum na.bbdt's exposed to Reon 116,	 5$
by volume Son 30 minute
Animal Specific activity (CPM/ U g proteinProtein (u^lung) 'Activity in lung' (CPM/g)
No E* +E* No E +E No E +E
'	 1 2349 1411 3624 1714 1.54 1.21
2155 4719 1810 3360 0.84 0.71	 —
2 1932 2989 3092 3505 1.60 1.17
2539 3028 3740 4005 1.47 1.32
3 1974 2744 2089 2287 1.06 0.83
2521 4669 1943 3444 0.77 6.74
4 792 3117 3311 4702 4.18 1.51
4656 5082 4858 6463 1.04 1.27
5 2183 3277 5457 3541 2.49 1.08
2747 3659 5137 4654 1.87 1.27
h	 Mean
l
•2385 3469 3506 3767 1.69 1111
S.'D. 4-962 t 1105 ± 1329 ± 1324 + 1.02 ± 0.27
Table E. VI
PAoxein synthesis and becAe ion in Lung U6.6ue jnom Acabbits exposed to FAeon 113,	 4%
by votume Jon 30 win:ute^s
Animal 'Protein (vg/9 lung) Activity in lung (CPM/g) 'Specific activity (CPM/u 	 protein
r
No E*	 +E* No E
I
+E. No E
7
+E
1 1887	 4483 5419. 3207 2.87 0.72
1290	 4149 5226 3394 4.05 0.82
2 2395	 4545 3669 3151 1.53 0.69
2915	 4851 2901 4944 0.99 1.02
3 985	 6766 2500 4977 2.54 0.744	 m
1643	 6595 2690 6365 1.64 0.97
r 4 3308	 4323 2646 2199 0.80 0.51
4073	 5412 3399 2776 0.83 0.51
-^
p Mean 2312'	 5141 3556 3876 11.91 0.75
S'.D. ±1062	 ±1025 ±1160 ±1402 t 1.15 ± 0.19
No E: without added epinephrine; +E: with added epinephrine.
6
Table E. VII
E44ect os exposure o6 %abbiu to haeocanbon.d on pnote,i,n
6ecv,:t on bu tong U6.6ue (ab detenmZned by the Lowey
procedure) .
Inhalation 'Amount of protein secreted'(ug/g lung tissue) P
exposure* No E** +E value
Control 2385±962 3469±1105 <.05
	 ?;
4% Halon
2402 1091±478 3111+821 <.01
P<.01 P<.5
5% Halon
1301 27711992 4404±745 <.01
P <.5 P <.4
42 Halon
1202 303611013 3948±681 <.1
F
P <.1 P <.1
5% Freon .
116 3010±575 4072±1109 <.05	 a
P <.2 P <.4
4% Freon
113 2312±1062 5141±1025 <.01	 a
P <.9 P <.O1
*	 All exposures' iwere for 30 minutes
**	 No E: 	 without added epinephrine; +E:	 with added epinephrine.
3
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Ejject of expoaune o6 tabb.it,6 to hatocahbona on pute,in
4ecAetion by tang tibbue as determined bN the ',tadiome 4i.c
i
pkocedune.
Activity in lung'(CPM /g) P
Inhalation No E** +E value
exposure*
a
Control 3506±1329 3767±1324 <.07
i
4% Halon 1034±383 1250±545 <.4
2402 P <.Ol P <.O1
57 Halon 3868±1772 4982±2445 <.4
i
1301 P <.7 P <.2
4% Halon 3610±931 2975±761 <92
1202 P <.9 P <.2
,^. 5% Freon 4396±1470 4634±1204 <.8	 d
116 P <.2 p <.2
4X Freon 3556±1160 3876±1402 <.7
113 P <.9 P <.9
1
*	 All exposures were for 30 minutes
**	 No E:	 without added epinephrine;	 +E: with added epinephrine.
a
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Table E. IX
F 6 beet o6 expob une o6 nabb.i to to ha,toeaxbon on the 4 peci4i,e
activity o6 prate-,n .a a cu ted by Lung U6,6 ue
Specific activity of secreted protein
Inhalation	 '(CPM/ug'protein) P
exposure* No E**	 +E value
Control <.11.69±1.02	 1.11±0.27
4% Halon 1.15±0.72	 0.31±0.10 <.O1
^} 2402 P <.2	 P. <.O1
5% Halon 1.56±1.02	 1.22±0.76 < . 4
1301 P <.8.	 P a .4
4% Halon 1.27±0.40	 0.76±0.18 <.Ol
1202 P <.3	 P	 <.O1
5% Freon 1.51±0.54
	
1.17±0.28 ^.1
` 116 P -<. 6 	 P	 <.2
4% Freon 1.91±1.15	 0.75±0.19 <.02
113 P	 .6	 P	 <.Ol
,^	 *	 All exposures were for 30 minutes
**	 No E: without added epinephrine; +Es	 with added epinephrine.
r.,
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rTable E. X
E S Seca o S put 4e-ZabeZ ng time on the amount o ^ pn zero
eecAeted in lung -6Zieea Snom nabbitz tAeated with Haeon
2402.
Treatment Pulse
labeling Amount of secreted protein Sp. act.
time ug protein/g P-M/g (CPM/ug protein)
• (min.) lung * lung
Control 15 2222 1644 0.74
30 1355 3577 2.64
60 546 8974 16.44
120 889 9707 10.92
Control + 15 3250 2740 0.84
added 30 2929 5071 1.73
epinephrine 60 2972 9401 3.16
120 3374 18630 5.52
4% Halon 15 1774 1139 0.64
2402 30 1852 2403 1.30
(30 min), -60 .499 6344 12.71
120 122, 7220 59.18
4% Halon 15 2675 1160 0.43
2402 + 30 1884 2030 1.08
added 60 •3846 4757 1.24
epinephrine 120 4524 12800 2.83
* Lowry procedure
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Table E. XI
1
'	 Amount o S pnote,i n b eaeted as instuenced by peni.od o6
	
{
active putea-n -Aeutetion in tung 6t iced itom nabbit6 treated
with Halon 2402,
Treatment Time 'Amount of secreted protein Sp. act.
(min.)' u$ protein/g CPM/U$ (CPM/}gig
lung* "lung 'protein)
Control 15 2513 1918 0.76
30 3630 2260 0.62
60 3941 3313 0.84
120 8396 8066 0.96
Control + 15 2581 2145 0.83
added 30 4218 1790 0.42
epinephrine 60 5836 3568 0.61
120 -------Sample Lost-------
4% Halon 15 2075 830 0.40
"	
. 2402 30 1756 719 0.41
(30 min.) 60 3090 1957 0.63
120 6645 2558 0.38
4% Halon 15; 4158 917 0.22
2402 +-_ 30 3374 1125 0.33
added 60 4298 1474 034
epinephrine 120 6538 2735 0.42
Lowry procedure
F
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Seucotoni ►1 (5-hydnoxytAyptontne) teveta in
`	 emtAot nat t ibbued
•Serotonin levels (ug/g)
Blood	 Brain
i
Lung
1.5	 0.8 (10.2)	 l
0.7	 0.8 3.9
1.7	 0.8 2.4
0.9	 0.5 2.9
1.1	 0.6 4.9
1.1	 0.5 1.5
0.4	 0.5 4.4
1.0	 0.7 3.4
1.4	 0.4 3.9
0.6 4.1
0.5 4.4
0.5 4.3'
0.6 4.6
0.5 1.4
0.5 4.2
_ 4.3
3.1 i
1.1±0.4*	 0.6±0.1 4.0±1.2
`
*	 Meant standard deviationf
4
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Table E. XIII
Seuton.in (5-hydnoxyt-cypxamine) ZevetA in
nat6 expoaed to va&i.oua hatoeanbou jon 30
mtnuta
Concn.
Halocarbon	 in air
(by vol.)
	
Serotonin levels (U g/g)
Blood Brain Lung
1.1 0.8 2.1
0.6 0.7 (10,2)
Halon	 4.0%
	
0.8 0.7 2.9
2402	 1.1 0.7 4.7
1.0 0.7 4.7
Meant S.D.	 0.9±0.2 0.7±0.1 3.8±3.1
1.1 0.5 1.0
1.1 0.5 3.7
Halon 2.02 0.5 0.6 1.1
1202 1.1 0.5 3.3
1.0 0.5 1.1
Meant S.D. 1.0±6.3 0.5±0.1 2.0±1.3
0.6 0.6 3.3
1.1 0.5 5.3
Halon 5.02 1.2 0.5 4.9
1301 0.7 0.5 4.2
0.6 _0.6 2.7
Mean f S.D. 0.8±0.2 0.5±0.1 4.1±1.2
0.8 0.5 4.3
0..6 0.4 1.5
Freon 4.02 1.3 0.5 7.8
113 0.5 0.4 3.9
-- 0.4 2.6
:. Mean"+ S.D. .0.8±0.4 0.4±0.1 5.7±2.4
0.4 0.5 8.6
0.8 0.5	 - 5.8
Freon 5.02 0.5 0.4 9.3
,.	 116 0.9 0.6 6.6
1.0 0.5 6.8
yF. BEHAVIORAL EFFECTS
During the first year of study, behavioral changes were noted during
30-min exposures of rats and/or rabbits to Halon 2402, Halon 1202 and Freon
113 at levels of 3-to-4% by volume. However, 30-min exposures of rabbits to
Halon 1301 and Freon 116 elicited no such response.
Since results of clinical observations, as well as man y physiologic
parameters were predominantly negative for Freon 116 and Halon 1301, they were
selected for use in a behavioral task using a mature male rhesus mor&ey.
This study, incorporating an instrumental task, was employed in an effort to
detect subtle behavioral changes as a function of the fluorocarbon
1	 concentration. A chamber was designed to hold a single animal during the
exposure with monitoring both by computer, which programmed the task and
recorded each response, and by television to detect gross behavioral changes.
No gross differences were noted; however, response data obtained suggested
that for these two compounds, a differential effect upon certain behavioral
components at reasonably high levels of concentration (35-to-50%) did occur.
A general discussion of this study was included in an earlier report. Although
the results were interesting, we are aware that more extensive testing would
be necessary to corroborate these findings.
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yG. HISTOPATHOLOGIC FINDINGS
Single, Acute Exposures
Four groups of six female rats were sacrificed immediately after 30-min
exposures to either Freon 116 (5% v/v), Freon C-318 (5% v /v), Halon 1301
(5% v/v) or Halon 2402 0% v/v). The animals were killed by servical
dislocation. All three body cavities were opened and the contents examined
in situ. Heart, brain, lungs, liver, kidney and spleen were removed and fixed
in buffered formaldehyde solution. Tissue samples were embedded in paraffin
and stained with hematoxylin-eosin. Some frozen sections of liver were stained
with an oil red 0 method. The results are summarized as follows:
Respiratory system. There were no gross or microscopic changes in the
trachea, bronchial tree and pulmonary parenchyma that could be attributed to
inhalation exposure.
Central Nervous System. A slight, foamy vacuolisation_ was found in the
ground substance of the frontal area of the brain, indicating a slight degree
of edema. The incidence was 4/6 for all compounds except Halon 1301. Samples
were not taken at autopsy from the Halon 1301 animals
Heart.- In one rat (Freon 116) some vacuolisation of the`mycardial fibers
was seen. The cardiac muscle from all other animals were normal,.
Liver. No gross abnormalities were seen. Microscopically some degree of
fatty infiltration was seen.
Spleen and kidney. No gross or microscopic changes were noted in any
animal.
Freon 116 Multiple Exposures
Twenty female rats were exposed to a concentration of 5% Freon 116 1 hr
daily for 9 days All animals were killed by cervical dislocation 48 hrs after
trachea $ lung, esopahgus, stomach, small and large intestines, liver, pancreas,
kidney, urinary bladder, ovary, uterus, pituitary, thyroid, adrenal, spleen,
thymus, bone marrow, cerebrum, cerebellum, eye and skeletal. muscle were fixed
in neutral buffered formaldehyde. Paraffin sections 6p thick, were stained
with hematoxylin-eosin, and examined microscopically.
All organs examined except brain, liver and lung were grossly and micro-
scopically normal. For the lung, 10 of the 20 animals examined had slight
edema surrounding middle-sized branches of the pulmonary veins. For the
cerebrum, 12 rats showed a slight edema of the frontal lobe. For the liver,
18 rats showed a slight vacuolation of the .liver cells in the portal area.
Freon 116 Long-term Exposure.
Following the 37-wk exposure of rats to Freon 116 (20% v/v), eight exposed
males and six control males were sacrificed and five organs (heart, lung, kidney,
liver and brain) processed and examined microscopically.
All rats were sacrificed (ether inhalation) and immediately after death
all body cavities were opened and the contents examined in situ. Representative
samples were fixed as previously described, and stained with H&E.
All livers, hearts and central nervous system sections were grossly and
microscopically normal. Various minimal to slight degrees of chronic murine
pneumonia were found in almost all exposed and control animals. One case of
11
a
focal vascular calcification was found in an exposed animal. For the kidneys,I
one case of moderate interstitial nephritis (control animal) was noted. Two	 i
-i
exposed rats had a few optically empty cysts in the cortex and-cortico-medullary
border. An additional exposed rat had bilateral hydronephroses with thinning
3
of the cortex and medulla.
All morphological changes in.the lungs and kidneys are known as spontaneous
c
diseases in rats and 'could not be attributed to the exposure to Freon 116.
at
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H. CARDIAC SENSITIZATION
Various studies were conducted in order to determine the effect of
halocarbon inhalation on the cardiovascular system. Guinea pigs, cats
and dogs were used throughout the experiments to determine the ability of the
compounds to sensitize the heart to infused or injected epinephrine.
The six halocarbons selected for study were two Halons (1301 and 2402)
and four Freons (11, 12, 116, and C-318). Results of the in vivo work are shown
in the Appendix (Sensitization of the Heart to Catecholamine-Induced
Arrhythmia and Studies of Sensitization of Cardiac Muscle to Epinephrine by
Selected Halocarbon Compound).
In addition to the in vivo exposures, an in vitro study using Freon 11
was conducted and the results presented in the Appendix (The Effects of
Freon 11 and Certain Drugs on Isolated Auricles).
..........
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Halogenated hydrocarbons are widely used in industry with the
	
-^	 fluorinated urethanes and ethanes having found important uses as dielectrics,
refrigerants, propellants, organic solvents and fire extinguishers and
suppressants. These compounds (termed fluorocarbons 'since the properties
are. largely governed by the fluorine moiety) are commanding an increasing
market in consumer products such as food toppings, hairsprays, deodorants,
etc., from their use as propellants. Although our interest in fluorocarbons is
broadbased, our attention has largely been addressed to the study of
candidate fire extinguishers and fire suppressants. The list of compounds
we have investigated incorporates 11 different halogenated hydrocarbons,
including the anesthetic halothane (see Table 1), but most of our attention
has been directed to studies of bromotrifluoromethane (Halon 1301) and
hexafiuoroethane (Freon 116). Some detailed attention has also been given
to 1,2-dibromotetrafluoroethane (Halon 2402),_ dichlorodifluoroethane (Freon
12) and octafluorocyclobutane (Freon C-318).
Exposure of animals by the route of-inhalation is important since
the compounds are either gasses or highly volatile liquids at ambient
temperatures and pressure. This route of administration was chosen
for the majority of our studies. Our investigations have involved
the use of three different types of inhalation exposure in laboratory
animals. In the first, animals have been exposed for a single short period
of time (a few minutes up to one hour) and the immediate effects of exposure 	 `.
assessed. Exposures of this type have been widely used in studies of effects 	 f
on biochemical systems, pharmacologic effects and studies of metabolism and
'tissue distribution of the compounds. The `results we have obtained in the
single short-term exposures will be emphasized in this presentation. Other
f	 ,
I
investigations have employed the.use of multiple intermittent expos
we are currently conducting studies in which animals were exposed c
for periods up to 23 hours per day or longer in environmentally-con
exposure chambers
we GVLL.l1LLCLCU LLVW Lnumans would De exposea as a result or tne lntencea use
•
of the halocarbon. Bromine-containing 'fluorocarbons, such as Halon
.1301, are good fire extinguishers and have been studied from the standpoint
that they will be used in situations resulting in brief exposures of humans.
4
	
	 They have not 'received extensive study in continuous exposure situations.
However, if such a,compound were used in an enclosed atmosphere such as
that of a spacecraft, it could remain as part of the atmosphere for an extended
period and occupants of the vehicle would be in a continuous exposure situation.
ss
	
	 On the other hand, compounds such as Freon 116, which have been proposed
for use as fire suppressants, might deliberately be incorporated into the
spacecraft atmosphere resulting in continuous exposure of human beings.
With regard to immediate toxic effects as judged by behavioral
A..
	
	
responses of laboratory animals during exposure, our studies have shown
that animals appeared to tolerate well single as well as multiple exposures
to Halon 1301, Freon 116 and Freon C-318. Halon 1301 and Freon 116 are
both well-tolerated by rats and guinea pigs at atmospheric concentration
as high as 20%. We have not studied higher concentrations of these compounds
in intact, unanesthetised animals. By contrast, laboratory animals are
less able to tolerate exposures to 5% concentrations of Halon 1202, Halon
2402, or Freon 113. All three of these compounds caused convulsive movement
in rabbits, and Halon 1202 caused violent convulsions and death in rats.
l	 ,
_
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These observations are in accordance with the generally-accepted principle
relating the chemical constitution with the toxicity of many of the fluoroalkanes,
namely a lower toxicity is associated with an increasing number of fluorine
atoms in the molecule (Clayton, 1966). The low order of toxicity in highly
fluorinated alkanes is a reflection of low-chemical reactivity and low-
biological activity. Since one of the goals of our research is to select
at least one compound suitable for controlled, continuous exposure in human
volunteers, our more detailed investigations have centered largely around
less toxic compounds.
One biological action of halocarbons which is well recognized is
the phenomenon of sensitization of the myocardium to epinephrine. Studies of
these effects are extremely important and are covered in greater detail else-
where in this symposium. Suffice it to say that we are including studies
of cardiac sensitization in our general investigations on fluorocarbon toxicity
and that our results are consistent with the findings of others in this area.
`
	
	
Compounds containing chlorine such as the Freons 11 and 12, are among the
most potent sensitizers investigated while the perfluorinated compounds, for
example Freon. 116, are among the least active cardiac sensitizers.
k	
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Because of the non-polar character and subsequent high degree of
lipid solubility of the compounds under investigation, it is conceivable that
they may exert effects on biological lipid membrane systems. In an investigation
of'this possibility, we directed some of our studies to the effects on
mitochondrial function in tissues obtained from animals exposed to fluoro-
carbons. Some of our early investigations suggested that exposure of rats
to halogenated hydrocarbons may have some effect on-respiration and oxidative
phosphorylation in isolated mitochondria. However, more thorough investigations
r'
•	
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failed to substantiate any such effects. The results of studies of effects on
oxygen consumption are shown in Figure 1. In these studies, mitochondrial
functions were measured in animals which were sacrificed immediately following
a single exposure to the halocarbon under the conditions shown in the Figure.
It can be seen that, in general, the levels of oxygen consumption in mito-
chondria from the exposed animals were within the range of control values
obtained for each of the five tissues studied. 'A similar pattern of response
was seen for oxidative phosphorylation shown in Figure 2. There is, however,
a suggestion of enhanced mitochondrial function, e.g., phosphorylation in
mitochondria 'from brain of animals exposed to Halon 1301, Freon 116 or Freon
a
•	 C-318.. The effect, if real, more likely means that the compounds may have
	 e
protected the mitochondria from uncoupling during isolation. Further investigation
would be required to substantiate this observation.
r-
	
	 Preparation of mitochondria for assay of enzyme activities requires
•homogenization and centrifugation techniques. These treatments certainly
reduce, if not entirely eliminate, the content of gaseous halocarbons in
these preparations. In an attempt to overcome these difficulties, an
experiment was designed to expose isolated mitochondria in vit1W to the
halocarbons. In order to accomplish this., the isolated mitochondria were
placed in the respirometer, but the air in the respirometer was replaced
with air containing 20% byc-volume of either Freon 12 or Halon 1301. Oxygen
consumption was then measured with the instrument as usual, but during the
actual exposure to the halocarbons. Studies carried out with liver
and heart mitochondria did not demonstrate any changes in oxidation or
phosphorylation.
We have also examined mitochondrial function in animals exposed
continuously to fluorocarbons. In an experiment involving exposure of rats
Q
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continuously to an average of 5.3% Halon 1301 for one month (vide in6nu)
we also failed to demonstrate any decrement in mitochondrial function in
heart, lung, brain, kidney or liver.
Although our efforts to date have not revealed strong interactions
between halocarbons and oxidative enzyme 'systems of mitochondria, work by
others has demonstrated the formation of a cytochrome P-450 substrate
complex with perfluoro-n-hexane (Ullrich and Diehl, 1971). The system
used was a rat liver microsomal preparation. It was shown that perfluoro-n-
hexane in contrast to n-hexane was not hydroxylated by the microsomal mono-
oxygenase system but that the fluorocarbon formed an enzyme-substrate
complex and stimulated N"PH oxidation. Hydrogen peroxide was not formed
and it was concluded that the fluorocarbon acted as a typical dead-end
inhibitor of the microsomal monooxygenase system and lead to the uncoupling
of electron transport from monooxygenation.
Any biological response to a fluorocarbon, whether it be sensiti-
zation of the myocardium-or any other manifestation of effect, requires
transport of the agent to the primary site of action. Assessment of this
can be made through measurement of tissue levels. In our first such
_ experiments, attempts were made to measure concentrations of the halocarbons
in the tissues of animals immediately following exposure to the compounds.
The results of such a study in which rats were exposed to -Halon 2402 are
shown in Table 2. In this experiment, the rats were exposed to 3.7% vapor
concentration of Halon 2402 for 30 minutes. Immediately following the
exposure, and at intervals thereafter, pairs; of rats were sacrificed and
tissue levels of Halon 2402 measured. Detectable concentrations of the
compound were present in the animal even 24 hours after exposure. The
increase of concentration of Halon 2402 in brain tissue and fat tissue
X	 6.
demonstrates that the 30-minute exposure to the compound was not long
enough to establish an equilibrium in the animals.
	 The half-life of the
compound in blood was less than one hour.
One interesting aspect of this study concerned the relationship,
or ,lack thereof, between levels of Halon 2402 in the brain and the CNS
effects as evidenced by behavior.
	 Although,behavior patterns returned to
normal within 15 minutes after cessation of exposure, brain levels were
apparently higher 1.5 hours after exposure and were significantly elevated
even 3 hours after exposure.,
Since blood is a readily accessible tissue, and may be obtained
€- without sacrificing the animal', additional studies were made in blood to
compare the absolute amount of halocarbon following exposure and the half-life
a
in blood.	 The results of such a study with Halon 1301 are shown in Table 3.
In this investigation, anesthetized rats were placed in the chamber and
exposed to a vapor concentration of 5% Halon 1301 for 30 minutes. 	 Levels
of Halon 1301 were then determined in blood which had been obtained by
heart puncture.
	 These data show that the half-life of Halon 1301 is much
less than the 30-minutes observed for Halon 2402.	 Accurate assessment of
half-life from these data is not possible since the 0-time was actually a
period 0.5 minutes to 1.5 minutes following removal of the animals from
exposure since this amount of time was required to obtain the blood samples.
It should be noted at this time that in order to obtain any 
a
meaningful results at all with a
	 aseous halocarbon	 it was necessary tog	 g
utilize methods representing a significant departure from our usual'
procedure.	 Whereas with the liquids, such as Halon 2402, solvent extraction
i techniques provided quantitative results, severe losses were observed when
the techniques were applied to the gaseous halocarbons.
	 In order to obtain
1	 .
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quantitative data with the gaseous compounds, it . was necessary to employ
• techniques involving head-space analysis. In these procedures, blood was
withdrawn from the animals by techniques which did not allow the blood
samples to come in contact with air. The sample was then transferred
quantitatively to a small vial which was sealed with a septum. After a
suitable period to allow equilibrium conditions to be obtained within the
vial, the gaseous halocarbon was quantitatively determined in the air
space within the vial itself.
Previously we had withdrawn animals from exposure chamber, sacrificed
them, and removed blood for analysis.	 In our studies with Halon 1301, using
k	 l` the improved head-space analysis technique, it soon became evident that
more suitable approaches would be required in making meaningful estimations 	 l
of blood levels of low boiling materials during the exposure of the animals. 	 1
i
The data indicated that very rapid decreases irr blood concentrations occurred
during the first few minutes after cessation of exposure.	 The time required
to obtain the blood sample after the animal was removed from the chamber
' was long enough, in relation to the half-life of the gasses in blood, to
preclude accurate estimation of blood levels during exposure. 	 In, order
J;
I.
to overcome these difficulties, a different type of procedure was followed.
+	 For these studies, Dutch-belted rabbits were chosen as the
experimental animal since they were large enough to allow a sufficient
number of blood samples to be obtained yet small enough for the static
exposure chamber employed. 	 The animals were anesthetized by means of
intravenous administration of nembutal and the carotid artery was cannulated
with polyethylene tubing.	 A tracheotomy was performed to prevent any
possible obstruction of air way. 	 The animal was placed in the exposure
E
chamber and the chamber sealed with the arterial cannula leading to the
E
s.
exterior. A blood sample was then withdrawn to establish the baseline
condition. Halocarbon vapor was then admitted to the chamber in the desired
concentration and blood samples were collected periodically during the exposure.
Finally, the chamber was opened, effectively lowering the fluorocarbon concen-
tration to zero, and blood samples were taken for several minutes thereafter.
Halocarbon concentrations' were then determined in the blood, samples by the
head-space analysis technique previously. described. The results of two experiments,
one with Halon 1301 and the other with Freon 116, are shown in Figure 3.
The study with Halon 1301 showed that blood levels as high as about 15 ug/g
. 	 were encountered during exposure to 5% atmospheric concentrations of the
halocarbon. Our previous work had indicated blood levels of•only about
5 ug/g immediately after exposure. The reason for this difference is apparent
when one considers the rapidity with which blood levels followed changes in
exposure conditions.- Within 30 seconds of the time the animals were removed
from the chamber, the blood level dropped from 15 ug/g to insignificant
levels. This demonstrates the importance ,of obtaining a blood sample during
the actual exposure to the halocarbon-and not a few moments afterwards.
a,
	 Events during the start of the exposure were not so straightforward. Stabilized
'	 blood levels were not reached until about ten minutes after the start of
the exposure. While it-is conceivable that this period was -requirzd to
establish an equilibrium condition within the animal, a more likely explanation
is that the time was required to establish an equilibrium within the exposure
chamber. Indeed, analysis of the air within the chamber at various points
indicated that stable conditions were not achieved until after about 15
minutes. Contrastingly, at the end of the experiment, the animal was removed
.	 from the chamber, and admitted instantaneously to a stable (0 halocarbon
concentration) atmosphere.
4
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Data obtained during a similar exposure to Freon 116 at 5% showed
less fluctuation during the initial stages of the exposure but more importantly
demonstrated that the highest levels of this halocarbon reached in the blood
of the animals during exposure was less than l ug/g. In fact, during
exposure, the concentration ranged from 0.2 to 0.6 pg/g. As in the case
of Halon 1301, blood levels of Freon 116 decreased to unmeasurable levels
within one or two minutes after the animals were removed from the exposure
chamber. We have also demonstrated a rapid equilibration and short half-life
in rabbit blood with the gaseous fluorocarbon Freon 12. Tice results of a
study with this compound are shown in Figure 4. In this study a circulating
fan was incorporated into the chamber to establish as rapidly as possible a
stable exposure condition. A short half-life in blood also has been demon-
strated for Freon 11 (Patterson, Sudlow and Walker, 1971). A half-life of
0.5 to 1.5 minutes was measured in humans using pressurized aerosols of
adrenergic bronchodilator drugs.
Our laboratory is now undertaking studies of continuous exposure
of laboratory animals to selected fluorocarbons. A 30-day exposure of rats
to 5% Halon 1301 has recently been completed. 'In the study, the animals
were exposed continuously for 23 hours each day in an- environmentally-
controlled exposure chamber. The remaining time each -day was used for
maintenance and animal- care within the chamber. Extensive studies failed
to reveal effects on serum electrolytes or hemotologic parameters including
erythrocyte fragility in the exposed animals. As indicated previously,
mitochondria) function was not altered.
Studies of blood did not reveal any accumulation of Halon 1301,
as the material was apparently cleared from the continuously-exposed animals
as rapidly as it was cleared from animals 'exposed only for a few minutes.
3
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There was no elevation in the rate of excretion of-fluoride ion in the urine.
There was some indication of elevated levels of liver enzymes although the
results were not conclusive. Grossly, there was no pathology at autopsy
and a thorough histological examination is.underway. We are currently conducting
a, study in which rats are being exposed in a similar manner to 20% Freon 116.
To summarize, we have investigated a number of conceivable biological
effects of selected halogenated hydrocarbons in laboratory animals exposed
briefly to the compounds. 
I 
Similar 'studies are underway in continuously-
exposed animals. With the exception of cardiac sensitization and within the
limits of our exposure conditions, only minimal'effects have been observed
with the highly fluorinated compounds (Freon 116 and Halon 1301). While
these observations support the general concept of biological inactivity of
.highly fluorinated compounds, we still hesitate to apply the term "biologically
inert". We plan studies employing procedures which, hopefully, will provide
more sensitive probes into the biological action of fluorocarbons.
i
ii
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Table I.	 COMPOUNDS OF INTEREST
A.	 Substituted methanes
Halon 1301 Bromotrifluoromethane CBrF3'
Halon 1202 Dibromodifluoromethane CBr2F2
.Freon 11 Trichlorofluoromethane CC13F
Freon 12 Dichlorodifluoromethane CC12F2
B.	 Substituted ethanes
Freon 116 Hexafluoroethane CF3-CF3
Freon 115 Chloropentafluoroethane CC1F2-CF2
Freon 114 1,2-Dichlorotetrafluoroethane CCIF2-CClF2-
Halon 2402 1,2-Dibromotetrafluoroethane CBrF2-CBrF2
Freon 113 1,1,2-Trichloro-1,2,2-trifluoro-
ethane CC12F-CC1F2
Halothane Bromochlorotrifluoroethane CHBrCl-Cf3
a
-	 C.	 Other
Freon C-318 Octafluorocyclobutane CaFe
i
F
r	 ,
Table 2. LEVELS OF HALON 2402 IN RAT TISSUE FOLLOWING
EXPOSURE BY INHALATION.
Post-inhalation interval (hrs
Tissue
	
0	 1-1/2	 3	 24
Liver	 258a	 5	 2	 0.28•
Lung	 44.-	 18	 2	 0.18
Brain	 0.70	 2.1	 0 . 78	 0.36
Kidney	 82	 27	 23	 0.33
Heart	 24	 2.1	 2	 1.1
Muscle	 73	 19	 2.8	 1.0
?Fat	 365	 469	 410	 11
Blood
	 87-	 7	 0.23	 0.22	 i
-	 a All values shown are in ug Halon^2402/g tissue.
E
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Table 3. HALON 1301 IN RAT BLOOD
OXYGEN CONSU'APTION IN MITOCHONDRIA
FROM RATS EXPOSED TO HALOCARBONS
® RANGE OF CONTROLS	 LIVER	 LUNG
ioEXPOSURE CONDITIONS 	 10 w 	 ^".r
• .	 COMPOUND %IN AIR TIME, MIN
HALON 2402 6.2	 10	 5	 5
HALON 1301 6.8	 30
FREON 116	 7.3	 30
FREON C-318 5.0	 30	 0. <?:	 :.	 p	
v
FREON 12	 7.6	 30	 2402 1301 116 C-318 12	 2402 1301 116 C-318 12
BRAIN	 HEART	 KIDNEY
10	 20
4- ^^...	 .
,tom,	 .h = `	
. 4\^ +q^^`, h^
5	 lo-
2
2402 1301 116 C-318 12 	 p 2402 1301 116 C-318 12 	 0 2402 1301 116 C-318 12
Figake L. Oxygen Consumption in Mitochondria from Rats Exposed to Halocarbons.
Mitochondria were isolated from tissues after the rats were exposed
under the indicated conditions. Mitochondria from controls were
assayed simultaneously'with the ex erimentalY
	 P	 groups and the range	
a
of activities includes data from all five groups of controls. The 3
.-	 rate of oxygen consumption is expressed as mp AO consumed/mg
±	 protein/min X 10-1.
OXIDATIVE PHOSPHORYLATION IN MITOCHONDRIA
FROM RATS EXPOSED TO HALOCARBONS.
® RANGE OF CONTROLS
	
LIVER	 LUNG
EXPOSURE CONDITIONS 	 10
COMPOUND %IN AIR TIME,MIN
HALON 2402 6.2	 10	 5
HALON 1301 6.8	 30
^ k
7
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O
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HALOCARBONS IN BLOOD OF RABBITS
DURING 5% ATMOSPHERIC EXPOSURES
0	 10	 20	 }0 5
TIME; MINUTES END of
.EXPOSURE
a
Figurz 3. Halocarbons in Blood of Rabbits During 5% Atmospheric Exposures.
Blood samples were withdrawn from the animals before, during and
after exposures to either Halon 1301 (open circles) or Freon llb
(solid circles. Concentrations of the halocarbons in blood were I
determined by gas-liquid chromatography.
Li
^r
• FREON 12 IN BLOOD -OF RABBIT.
DURING 5% ATMOSPHERIC EXPOSURE
15
•
0100
z
5
v
w	
00	
10	 20	 30 t5 f 0
TIME , -MINUTES	 END OF
 EXPOSURE
F.igu,ke 4. Freon 12 in Blood of Rabbit During 5% Atmospheric Exposure.
Blood samples were., withdrawn from the animals before; during
and after exposure to Freon 12 and the halocarbon concentra-
tions determined by gas liquid chromatography.
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rFrom the standpoint of toxicology, , the greatest immediate threat
to victims exposed to fire is represented by the smoke and combustion products
formed during burning of a variety of materials. In some circumstances,
however, there can exist a threat from inhalation of substances other
than combustion products, e.g., inhalation of substances used to combat
the fire. A number of halogen-containing compounds are being developed
as components of fire extinguishers and fire suppressing apparatus and
release of these substances contributes to the total toxicologic hazard
faced by either victims or persons involved in combatting the fire
	 j
i
itself. In fact, as more efficient fire-fighting systems evolve, it
is possible that exposure to fire extinguishers and suppressants and their
combustion products will constitute more of a hazard than that posed by
exposure to combustion products indigenous to the fire itself. In a study
of eight fluorinated hydrocarbon compounds that were possible fire ex-
tinguishers, Chambers'et'al. (1950) reported that the pyrolysis products
of six compounds were more lethal to rats exposed for 15 min. to atmospheres
containing them than the original compounds_, in'one case by nearly 79 times.
Depending on the nature of the facility to be protected and the
type of fire-combatting material employed, there are at least two situations
representing rather different toxicologic problems. An acute danger 'could
ensue from the deployment, particularly in a closed space, of`a halogenated
substance emitted by a-fire extinguisher. This could occur in aircraft
.cockpits or cabins, compartments of ships, warehouses, etc. On the other
hand, chronic exposure could follow the use of a halogenated fire suppressant,;	 t
incorporated into the atmosphere of a vessel, such as a spacecraft, to prevent
even the initiation of fire. In this situation, exposure could be continuous
for several weeks or even several months.
Both of these problems in toxicology are under investigation in
our laboratories and some of the halocarbons we have investigated are shown
in Table I. With the exception of Freon C-318 (C 4 Fe), all are fluorinated
methanes or ethanes. Despite the obvious structural similarities, they
produce a variety of pharmacologic effects in laboratory animals ranging
from violent convulsions and death following exposure to Halon 1202 CCBr2F2)
to anesthesia induced by Halothane (CHBrCl-CF3) which :is, in fact, a widely
used anesthetic mentioned here for comparison purposes only. Others induce
myocardial sensitization to catecholamines, e.g. Freon 12 (CC12F2), while
others such as Freon 116 02FO , affect biological systems only subtly if
at all. In general, the observations we have made have been in accordance
with the generally accepted principle relating the chemical constitutior.
with the toxicity of many of the fluoroalkanes, namely a lower toxicity is
associated with an increasing number of fluorine atoms in the molecule
(Clayton, 1966). The low order of toxicity in highly fluorinated alkanea
is a reflection of low-chemical reactivity and low-biological activity.
Experiments with laboratory animals have shown also that physical 	 i
chemical characteristics of halocarbons can influence biological activity.
For example, blood levels of gaseous compounds such as Halon 1301 (CBrF3)
and Freon 116 (C2 F6) decrease rapidly during the first few minutea after
exposure is terminated (Figure 1). Exposure to a less volatile material, 	
s
such as Halon 2402 (CBr2F4), which is liquid at room temperature, leaves
substantial residues in the blood (and other tissues) even several hours
after the exposure is terminated (Table 2).
One of our objectives has been to determine the extent to which
toxicologic studies in laboratory animals can aid in the selection of
6
8
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halocarbons suitable for long-term continuous exposure in humans inhabiting
closed atmospheres containing substantial quantitite of a halocarbon. To
aid in the selection, a variety of halocarbons were first studied in short-
term exposures to disclose which were the least acutely toxic. The results
of such studies have been reported elsewhere (Griffin et al., 1972). One
compound, Freon 116, showed a remarkable lack of biological activity in
.these acute investigations and long-term, continuous exposures were in-
itiated. Freon 116 has also been shown to be potentially useful as a fire
`I	 auppressant (Huggett, 1973). In our acute studies, Freon 116 was well
tolerated by rats and rabbits. No immediate toxic effects were observed
even when the concentration of Freon 116 was raised to 20% (v/v) for periods
up to one hour. With this background , and with the goal of obtaining de-
.finitive data during more prolonged exposure, an experiment was devised
in which rats would be exposed to the fluoralkane almost continuously for
an extended period. We planned an atmospheric concentration of 20% (v/v),
an 'effective concentration of Freon 116 for use as an inerting gas. A
concentrated multidisciplinary approach was taken because only a limited
number of animals would be available.
Hematological and biochemical serum examinations wereselected
with a two-fold purpose in mind. In the first place, we wanted data on
the general health and clinical status of the animals and this was ob-
tained through a battery of tests performed at the termination of the
exposure. Secondly, some selected tests were incorporated with the hope
' ..oi showing-specific sensitivity to exposure to the halocarbon. Osmotic
^1
I
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fragility studies were employed to demonstrate whether the fluorocarbon
had any effect on the integrity of the erythrocyte membrane. It was hoped
that studies of enzyme activities within serum-would disclose liver or
other tissue damage.
Preliminary studies employing acute exposures had not revealed
lability of the carbon-fluorine bond as determined by measurements of con-
centrations of fluoride in samples of urine obtained after the exposures.
This approach to studying the metabolism of Freon 116 was employed in the
-^	 present experiment also. We felt also that, since excess fluoride accumu-
lates in bone, a study of that tissue was necessary and would provide a
more sensitive indicator of metabolism." Fluoride levels in bone were studied
at the termination of the experiment.
Previous biochemical studies had shown that acute exposure to
Freor. 116 had no effect on mitochondria (Griffin et al., 1972). Since
then, the biochemical emphasis has been to determine whether perfluorinated
hydrocarbons have any effect on the endoplasmic reticulum of the liver.
Mixed function oxidase and cytochrome P-450 were measured to determine
whether the Freon 116 would induce production of processing enzymes in
the microsomes.
For exposure of the animals, a portable animal exposure chamber
as described by Hinners'et*al. (1968) was modified to operate in a "closed
dynamic" mode for control of the gaseous content. This manner of'operation
was utilized because of long-term exposure studies involving concentrations
of Freon 116 of the order of 20% would necessitate the use of large,quanti-
ties of the fluorocarbon if the open dynamic , system of exposure were used.
	
r	 ;
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Such a system would not be economically feasible because of the high cost
of the fluorocarbon; therefore, a recirculating system, based on that
described by Clayton et al. (1960), permitting the recovery and reuse
—	 l
i
	
	 of Freon 116 was devised... In our variation of the closed byname system
chamber gases were circulated through a bed of lithium hydroxide to remove
f
I
	
	 carbon dioxide. For each mole of carbon dioxide removed, it was necessary
to add back an equivalent amount of oxygen. This was accomplished by
metering oxygen to the changer at a rate required to maintain the concen-
tration at about 20%. Freon 116 was also metered to the chamber at the
rate required to maintain a 20% by volume concentration.
i
k	 ,
The chamber was operated'for 2' hours a day, 7 days a week. The
da-A.1y one hour down time was used for animal care and for cleaning. In
order to prevent the build-up of ammonia and other odorous materials, strict
at4:.dards of cleanliness were observed. Animal cages and the trays for
zQllecting urine and feces were changed daily and the inside of the chamber.
k	 was washed each day. Urine and any spillage from water bottles was absorbed
on Pel-E-Cel (Paxton Products). In addition, boric acid crystals were i
sprinkled on the trays holding the absorbent to help prevent the formation,
of ammonia. Finally, the chamber was purged at a slow rate throughout the
exposure period to help prevent the build-up of foreign materials in the
atmosphere.
With the chamber operating in this manner, we determined that its
3
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size limited the exposure capability to about 12 rats; therefore, the ex-
periment was started with that number of male Sprague-Dawley rats in the
IS
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chamber. Twelve male animals housed outside the exposure chamber served
as controls for the study. The exposure lasted for 37 weeks, or nearly 9
months.
..
	
	 The concentrations of Freon 116, oxygen, and carbon dioxide
measured during the study are shown in Figure 2. The grand average of the
weekly Freon 116 concentrations was 20.7% and the averages of those of
oxygen and carbon dioxide were 20.1% and 0.39% respectively. The sydtem
of exposure proved to be a suitable one for maintaining the gaseous con-
centrations at the desired levels, although there were some variations.
i
Carbon dioxide concentrations were maintained well below the upper limit
j	 of 1% which would have been tolerated. Lesser variations in the concen
.ration of CO2 after the 15th week of exposure followed an improvement
f
in the design of the lithium hydroxide scrubber. The temperature within
3
i the chamber reflected the temperature outside the chamber except that con-
ditions were 2-3 0F higher inside.
I
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The general response of the animals to the exposure conditions is
indicated by the body weights shown in Figure 3. Although the weights were
i	 equivalent at the beginning of the experiment, growth of the exposed animals
r
was retarded somewhat at the beginning of the exposure and again at
about the 18th week of exposure.
i Of the original 12 rats admitted to the chamber at the beginning of
the exposure, eight survived until the experiment was terminated after 37
l	
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weeks of exposure. Two of the animals died during anesthesia for drawing
blood samples from the orbital sinus. Two others died from causes which
could not be determined from gross examination at autopsy. Autolysis
prevented a definitive histopathological examination for determination of
the cause of death. Of the twelve animals which entered the study as
controls, only.six survived, the others dying from respiratory infection.
The general health and well being of the animals is reflected in
"	 the hematology data shown in Figure 4. All the parameters examined were
•	 a
well within the normal range as determined in our laboratory, although
there was some evidence of hemo-concentration in the exposed rats during
the early stages of the experiment. This was indicated by slightly elevated
hematocrits and erythrocyte counts in the exposed animals during the 18-week
exposure period. However, after 37 weeks of exposure there were no differ-
ences between the exposed and the control groups. Total erythrocyte counts
were well within the normal ranges at all times and there was no evidence
that exposure to Freon 116 elicited a change in the osmotic fragility of
erythrocytes. At the termination of the experiment, no differences were
f-
observed in the concentrations within serum-of glucose, urea nitrogen,
sodium or potassium (Figure 5).	 -
With the exception of alkaline phosphatase activity, there were
essentially no differences between the exposed and the control groups in
the activities of those serum enzymes shown in Figure 6. In the exposed
•	 3
'the aver& a alkaline hos hatase activity was slightly higher thangroup, 
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that of the controls.	 This difference was statistically significant
W0.05).	 LDH activities in the sera of the rats are shown in Figure 7.
Significant increases were observed in the exposed rats after 18 weeks of
exposure, but this change was no longer present after 37 weeks of ex-
posure to Freon 116.
The biochemical studies of enzymes and levels of cytochrome
P-450 in liver (Figure 8) did not show any evidence of the induction common
following exposure to many chlorinated compounds.
Concentrations and total daily excretions of fluoride ion in the
urines of the rats are shown in Figure 96	 Regardless of the manner of ex-
pression, the absolute values are slightly lower in the exposed group al-
though there were no significant differences betweenexposed and control
groups of animals.	 Fluoride ion in the bone of the animals, expressed as
per cent of the bone ash, is also shown in Figure 9.
	 There was no significant
difference between exposed and control groups.
DISCUSSION
It has been pointed out that the low order oftoxicity of highly
fluorinated alkanes is a reflection of a low order of chemical reactivity
and a low order of biological activity. 	 The experiment described herein
confirmed a low order of toxicity of a perfluoroalkane and demonstrated
that in spite of the relatively high exposures over a long period of time
and under almost continuous conditions of exposure, there was remarkably
4
little response of any kind by the rats that could be attributed to the
fluorocarbon.' With the chamber containing 20% by volume of Freon 116, the
9.
animals were being exposed by the respiratory route to rather enormous
quantities of the chemical. 	 .Taking the vapor density of Freon 116 to be
5.7 g/Titer and the respiratory minute volume of the rats to be 0.073 liters/
! min.	 (Altman and Dittmer, 1964), a conservative estimate for rats weighing
200g or more, it can be calculated that the animals were exposed to about
115g of Freon 116 per day.
	
Certainly, not all was absorbed; in fact, we
have shown (Griffin'et'a1., 1972) that rabbits undergoing exposure to 20%
Freon 116 had a mean concentration of the Freon in their bloods of less
than 1.OUg/g.
The small fluctuations in the activities of serum enzymes, and
particularly the elevation of LDH activity during the initial phase of
exposure, may have been related to factors other than exposure to the
fluorocarbon.	 In our preliminary studies, in which groups of rats qZ^re
exposed to fluoroalkanes continuously in the closed dynamic chamber for
periods up to 30 days, and in control experiments, in which rats were con
fined to the chamber for 30 days but were not exposed to a fluoroa kane,
elevated LDH activities in serum were often observed. 	 In these experiments,
we also noted that slight retardation of growth accompanied confinement
of the rats to the chamber and thus did not-necessarily result from exposure
to a fluoroalkane. 	 It is difficult to conclude what right be the cause of
these apparent effects from confinement in the chamber. 	 Their presence
! within the chamber did expose the rats to an atmosphere different from that
i
of the control animals in more respects than just the presence of Freon 116.
As noted above, the temperature was slightly higher and we also observed that
!
!
the chamber air was often more humid than the air outside. 	 Many closed,
10.
environmentally-controlled chambers incorporate activated charcoal scrubbers
and catalytic burners to remove trace amounts of methane, ammonia, odors,
etc., from chamber atmospheres, but we could not use such systems because
of possible interactions with Freon 116. Hence, the slow purge of chamber
gasses was adopted to maintain low levels of such materials, but, even so,
minute quantities could still have been present. All of these factors taken
together may account for some of the slight differences between control and
exposed groups of rats.
Since Freon. 116 is a non-polar organic compound and soluble in
many organic substances, it is conceivable that the material might be trans-
ported to membrane systems and there interact with the lipid components of
such systems.	 It could be anticipated that incorporation of Freon 116 into
. membranes of cells or components of mixed function oxida'se,systems might
change the integrities of cell membranes or the activities of cellular en-
zyme systems.
	 If such an interaction occurred in the erythrocyte cell
membrane, it was not expressed by a change in the osmotic fragility of the
cells.
Decomposition of Freon 116 within the bodies of the rats was not
detected by measuring the excretion of the fluoride ion in the urine. 	 Ex-
cess fluoride ion accumultes in bone; our failure to find increased coneer.-'
trations of fluoride in the skeletons of the exposed rats is even stronger
evidence that breakage of the carbon-fluoride bond did not occur in these
animals.	 Urinary concentrations of fluoride were low in both the exposed
and the control groups and were lower in the exposed group, although by
only a small margin; the observed differences were not statistically
11.
significant. However, it is interesting that the trend was lower in the
exposed group; this may have been related to differences in dietary intakes
of fluoride ion. The growth was slightly retarded in the exposed animals,
which may have been due to a decreased consumption of food and a consequent
decreased intake of fluoride ion.
Many gaseous hydrocarbons are known to sensitize the myocardium
to the effect of catecholamines; although this phenomenon was not studied
l°	 specifically in our experiment, it is worthy of mention. Studies of this
effect of haloalkanes are under study in our laboratories, a preliminary
investigation having showed only a low order of catecholamine-induced
cardiac arrhythmia caused by Freon 116 (Wills et al., 1972). A comprehensive
study of cardiac arrhythmias induced by a variety of halogenated as well .as
non-halogenated hydrocarbons was reported by Reinhardt et al. (1971), but
Freon 116 was not included in this study. In a more recent communication
from the same laboratory (Trochimowicz, 1972), Freon 116 at 20% v/v in air
i
was reported not to induce cardiac arrhythmia in-dogs. We plan exposures 	 1
of rhex,,us inonkeys in a study to be conducted in a manner similar to the one
reported here for rats but to include also investigations of cardiac sensi-
tivi ty s
t
r
Table I. COMPOUNDS OF INTEREST
A• Substituted methaneo
Nalon 1301	 Bromotrifluoromethane 	 CBrF3
Nalon 1202	 Dibromodifluoromethane 	 %	 CBr2F2
Freon 11	 Trichlorofluoromethane	 CC13F
Freon 12	 Dichlorodifluoromethane	 CC12F2
A, Substituted ethaneQ
Freon 116	 Hexafluoroethane	 CF3-CF3
1	 Freon 115	 Chloropentafluoroethane	 CC1F2-CF2
Freon 114	 102-Dichlorotetrafluoroethane	 CC1F2-CC1F2
Halon 2402	 1,2-Dibromotetraflugroethane	 CBrF2-CBrF2
Freon 113	 101,2'-Trichloro-1,2,2-trifluoro-
ethane
	
CC12F-CC1F2
Halothane
	
Bromochlorotrifluoroethane	 CHBrC1-CfA
C. Other	 f ' !^•
Freon C-318	 Octafluorocyclobutane
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•Table 2. LEVELS OF IIALON 2402 IN RAT TISSUE FOLLOWING
EXPOSURE BY INHALATION.
Post-inhalstiol interval (hrs) ,.	 t
Tissue 0	 1-1/2	 3	 24
i Liver 258'	 "5	 2	 0.28
Lung .44	 18	 2	 0118
Brain 0.70	 2.1	 % r•	 0.78,	 0.36
• Kidney 82 {	 .	 ` .	 27	 , ,:	 23	 0.33
Heart 24 S '
	 2.1	 2	 1.1
.' Musr'le 73-	 19	 2.8	 1.0
Fat 365	 469	 410	 11
Blood 87	 7	 0.23	 0.22
--_
a All'valuee shown are in jig kalon2402/gtiesue.
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Figure 6..
SERUM ENZYMES 1
CONTROL EXPOSED
ALK. PHOS, K-A. units 14.4 -	 5.9 24.0	 7.2
ACID PHOS,	 K .:--A units 11.0	 2.0 11.1	 ± 2.7
GOT, S -F units 65.0 ± 12.0 67.0 ± 21.0
GPT, S- F units 28.0	 12.0 23.0 _ 6.0
_	 CPK, unit s 38.0 ± 24.0 32.0 ± 15.0	 ^-_-
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1.
Among the many applications of short-chain fluorinated hydrocarbons,
their current and potential u'se in combatting and controlling f ires in
confined spaces promises to be of great benef it in preventing injury and
damage. One projected application involves incorporation of a gaseous
fluorocarbon in the atmosphere of spacecraft, aircraft, submarines, etc.,
as an inerting component. perfluorinated compounds such as tetrafluoro
methane, hexafluoroethane and octafluorocyclobutane, have been shown to
suppress combustion by increasing the heat capacity of gaseous atmospheres
(Huggett, 1973). Before such use - of a perfluorocarbon can be initiated,
however, much more data on the safety of the compounds for man is required.
i.
Although beginnings have been made in studying the toxicology of fluorine--
containing hydrocarbons, most investigations have involved only simple
exposures of short duration. Little or no data is available relating to the
toxic effects W'"ich m -ight be 2ucount red during exposurc or. a
basis for a prolonged period. Men occupying spacecraft, aircraft or other
confined cabins containing inerting atomospheres would be exposed
continuously.
We investigated a variety of fluorocarbons (Griffin, et a . , 1972)
involving short teas single or multiple exposure of laboratory animals.
J
The observations we made were consistant-with the generally-accepted
principle relating the chemical constitution with the toxicity of many
of the fluoroalkanes, namely a lower toxicity is associated with an in-
creasing number of fluorine atoms in the molecule (Clayton, 1966). We
-determined that, among other compounds, the perfluorinated hydrocarbon
hexafluoroetha.ne was well tolerated by rats and rabbits. No immediate
p	 toxic effects were observed even when the concentration of hexafluoro-p
ethane was raised to 20% (v/v) for periods up to one hour. With this back-
i
p
2.
ground and with the goal of obtaining definative data during more prolonged
exposure, an experiment was devised in which rats would be exposed to hexa-
fluoroethane almost continuously for an extended period. We aimed at an
atmospheric concentration of 20% (v/v), a useful concentration of hexafluoro-
ethane as an inerting gas. A concentrated multidisciplinary approach was
taken since only a limited number of animals would be available.
s
Hematological and serum biochemical examinations were selected with a
two-fold purpose in mind. In the first place we wanted data on the general
health and clinical status of the animals and this was achieved through
abroad-based battery of tests performed at the termination of the ex-
posure. Secondly, some selected tests were incorporated with the hope of
showing specific sensitivity* to exposure to the halocarbon. Osmotic
fragility studies were employed to demonstrate whether the fluorocarbon
had any effects on the integrity of the erythrocyte membrane. It was hoped
that the studies of serum enzyme activities would disclose liver or other
tissue damage.
Preliminary studies employing acute exposures had not revealed lab-
ility of the carbon-fluorine bond as determined by measurements of urinary
fluoride concentrations. This approach to studying the metabolism of
hexaf luoro ethane was also employed in the present experiment but we also
i
felt that since excess fluoride accumulates in bone, a study of that tissue
G
	
	 was necessary and would provide a more sensitive indicator of metabolism.'
Fluoride levels in bone were studied at the termination of the experiment,.
Previous biochemical studies have shown that acute exposure to per
a
`	 fluorinated hydrocarbons has no effect on mitochondria (Griffin, et aZ.,
1972). Since then, the biochemical emphasis has been to determine if
i
3.
perfluorinated hydrocarbons have any effect on the endoplasmic reticulum
of the liver. The very stable carbon-fluorine bonds of perfluorinated hydro-
..
carbons do not appear to be attacked by the mixed function oxidase of the
liver endoplasmic reticulum (Ulbrich and Diehl, 1971). However, these
-authors have found that perfluorohexane binds to mixed function oxidase and
stimulates NADPH oxidation. Their findings suggest that exposure to a per-
fluorinated hydrocarbon might cause the peroxidation of the lipids of the
endoplasmic reticulum as a result of a contiuous activation of the mixed
function oxidase. To test this hypothesis, lipid peroxides and glucose-6-
phosphatase, an enzyme which is sensitive to lipid peroxidative damage,
were measured in isolated microsomes. Also, mixed function oxidase and
cytochrome b s were measured to see if the perfluorinated hydrocarbon
would induce the synthesis of microsomel processing enzymes.
r
r
,M
METHODS
Expodwce o6 An.unat.6. Fot exposure of the animals a portable animal
exposure chamber as described by Hinners, et aZ., (1968) was modified
to operate in a "closed dynamic" mode for control of the gaseous content.
This manner of operation was utilized since long term exposure studies
involving concentrations of hexafluoroethane on the order of 20% would
necessitate the use of large quantities of the fluorocarbon if a simple
flow through system of exposure were used. Such a system would not be
economically feasible because of relatively high cost of the fluoro-
carbon and therefore the recirculating system permitting the recovery
and reuse of hexafluoroethane was devised and was based on the system
described by Clayton, et at., (1960). In our variation of the closed
dynamic system, chamber gases were circulated through a bed of lithium
t:> .Jx...... aa...yurv:.o a+uvuwmeaaa.ai va.auc, Lvva.c L'aluCLtal vOI-iapally/ w
remove carbon dioxide. The lithium hydroxide was obtained in the an-
hydrous form, however, water was added at the rate of _750 ml per 10
pounds to improve the efficiency for absorption of carbon dioxide. The
concentration of carbon dioxide within the chamber was measured with a
Bendix Unico Model 400 gas detector. For each mole of carbon dioxide
removed it was necessary to add back an equivalent amount of oxygen.
This was accomplished by metering oxygen to the chamber at a rate re-
quired to maintain the concentration at about 20%. The concentration
of oxygen was monitored by use of a Chemtronics Model GP-10 gas phase
oxygen transducer with a Chemtronics Model BP-300A amplifier.
Hexaf luoro ethane (Freon 116, Du Pont) was metered to the chamber at
a rate required to maintain a 20% by volume concentration. The con
zentration of the fluorocarbon was monitored with a gas chromatograph
.,	 r
5.
(Perkin-Elmer Model 801) having a flame ionization detector and a 34"
x 6" stainless steel column packed with Pora Pak Q (Waters Associates
Incorporated). The column bath was maintained at a t. ,.)erature of
1;500C.	
i
The chamber was operated for 23 hours a day, 7 days a week. The
	 j
i
daily one hour down time was used for animal care and for cleaning.
In order to prevent the build-up of ammonia and other odorous materials
strict standards of cleanliness were observed. Animal cages and the
trays for collecting urine and feces were changed daily and the inside	
91
of the chamber was washed each day. Urine and any spillage from water
bottles was absorbed on Pel-E-Cel (Paxton Products). In addition,
boric acid crystals were sprinkled on the trays holding the aborbent-
to help prevent the formation of ammonia. Finally, the chamber was
purged at a slow rate throughout the exposure period to help prevent
.the build-up of foreign materials in the atmosphere.
With the chamber operating in this manner wedetermined that its
size limited the exposure capibility to no more than about 12 rats,
and therefore the experiment was started with that number of malei
Sprague Dawley rats in the chamber. Twelve male animals housed outside the
exposure chamber served as controls for the study. The exposure lasted for
37 weeks or nearly '9 _months.
CZ nicae ChemiztAy and HematoZog y. During some of our preliminary
studies of rats undergoing exposure to fluorocarbon chemicals for periods
up to one month, we oberved increases in levels of serum lactic dehydro-
i
	
	 genase (LDx) activity. This was investigated in the present study by
measurement of the enzyme activity at two intermediate periods and at-the
time of the terminal sacrifice. During these intermediate periods the
hematocrit, hemoglobin concentration, and red and white total cell counts
Ob .
t
ii
l
were also measured. More frequent sampling was avoided since t
essary anesthesia stressed the animals to an undesirable degree.
At the time of the terminal sacrifice more extensive serum studies
included, in addition to measurements of LDH activity, determinations
of acid and alkaline phosphatase activities, glutamic-oxaloacetate and
glutamic-pyruvate transaminase activities, creatine phosphokinase act-
ivity, glucose, urea nitrogen, sodium and potassium. Added to the
hematology studies were determinations of differential white cell counts
and erythrocyte osmotic fragility.
Me"a6uAement o
-5 Ftuox. de Zonis. Following. the 37 weeks of exposure to
hexafluoroethane, concentrations of fluoride were measured in urine
samples collected during a 24 hour period. A procedure described for the
determ`:n,:tion of fluoride ion content of human urine (Singer, et ak. , 1969)
was modified to permit suitable measurements in rat urine. Each volume of
urine was diluted with four volumes of a solution containing 8.5 g NaCl and
5 g of disodium ethylenediaminetetraacetic acid (IDTA) per liter. The
solution was adjusted to pH 6.5 with dilute potassium hydroxide before
dilution to final volume and additon to the rat urine.- Standard solutions
of fluoride ion were also prepared with the NaCl-IDTA diluent and a standard
curve prepared with the fluoride ion selective electrode. In order to
obtain another basis for the rate of urinary flurride excretion, creatinine
levels were measured in each of the urine samples.
At the time of sacrifice, a femur from each animal was disected free
of soft tissue, dried and defatted with ethyl ether. The bones were then
dry ashed at '500 0C and determination of fluoride in the bone was made
with the fluoride electrode using the procedure of Singer and Armstrong
(1963)
•
7.
Hepatic Iii,oehemi6tty. NADP, glucose-6-phosphatase and thiobarbituric
acid were purchased from Sigma Chemical Company, biphenyl, p-chloroaniline
and demethylaminobenzaldehyde were purchased from Eastman Kodak Company,
4-hydroxybiphenyl from Aldrich Chemical Company, and p -chloroaniline from
Calbiochem Company. Livers were homogenized in 5 volumes of 0.25 M
Tris-HC1 pH 7.4. Microsomes were prepared by differential centrifugation.
The 0 . 25-6. 10 6 g.min pellet was resuspended in 0.25 M sucrose-0.01 M
Tris-HC1 pH 7.4 for the enzyme assays and in 1.15 % KCL for the cytochrome
and lipid peroxidation assays. The cytochrome P-450 and b 5 assays were
performed on fresh microsomes, while the remaining assays were done on
microsomes which had been frozen one time.
Cytochrome P-450 and b 5 were assayed by the method of M.azel (La Du,
et ax., '.971), biphenyl hydroxylase by Creaven ' s method (Creaven ex ct^.,
1965), N-demethylase by Kupfer ' s met:&od (Kupfer and Bruggeman, 1966)9
lipid peroxidation by Wills' method using NADPH (Wills, 1969), and
glucose-6-phosphatase by Nordlei and Arions method (Nordlei and Arion,
1966) .
Protein was determined by a modified Gornall procedure (Gornall,
et at 1949) adapted to a Technican Autoanalyzer. One tenth ml of 5%
sodium dodecyl sulfate and one tenth ml of sample containing 0.5 -4
mg protein were mixed in a 0.5 ml micro sampling cuvette. The cuvettes,
including those containing buffer and 1,2 and 4 mg of bovine serum albumin
were sampled by the autoanalyzer.-About 0.06 ml of sample were
mixed with 20 volumes Biuret reagent containing 2% NaoH and disodium tart-
rate in place of sodium potassium taftrate. The mixture was passed through
a small mixing coil and then directly into a flow cell colorimeter where the
absorption at 550nm was measured. A linear standard curve was obtained
as well as highly reproducible determinations of protein in all subcellular
fractions, including mitochondria.
3
sRESULTS
GeneAaZ Reaponbe to Fxpobulte. The weekly average concentration of	
i
hexafluoroethane, oxygen and carbon dioxide are shown for each week of the
experiment in Table 1. The average temperature within the chamber during
each week is also shown in the table. The grand average of the weekly
hexafluornethane concentrations was 20.7% and the average of oxygen and
carboi-	 :gas 20.1% and 0.39% respectively. The system of exposure
utilized herein proved to be a suitable one for maintaining the gaseous
concentrations at the desired levels although there were some variations.
Carbon dioxide concentrations were maintained well below the upper limit
of 1% which would have been tolerated,. The temperature within the chamber
reflected the temperature outside the chamber-except that conditions were
2-3 0F higher inside.
The general response of the animals to the exposure conditions is re-
flected in the body weights also shown in Table 1. Although the weights
were equivalent at the beginning of the experiment, growth of theexposed
animals was retarded somewhat at the beginning of the exposure and again
r,
from about the 15th through the 23rd weeks of exposure.
Of the original 12 rats admitted to the chamber at the beginning of the
exposure, eight survived until the experiment was terminated after 37
weeks of exposure. Two of the animals died during anesthesia being admin-
istered to draw blood samples from the orbital sinus. Two others died from
causes which could not be determined from gross examination at autopsy.
E	
.
Autolysis prevented a def inative histopathological examination for deter-
mination of the cause of death. Of the twelve animals which began the
study as controls, only six survived, the remaining having died from an
intercurrent respiratory infection.
 0
e	 3 
9.
S¢htun Bi.oehem.cstAy. The result of biochemical studies of serum
obtained from the rats after 37 weeks of exposure to hexaf luoro ethane
are shown in Table 2.	 .
With the exception of the levels of alkaline phosphatase activity there
were essentially no differences between the exposed and control groups. In
the exposed group the average alkaline phosphatasEs activities was slightly
higher than the controls. This difference was statistically significant
(P < 0.05).
Levels of LDH activity in the serum of the rats are shown in Table 3.
Significant increases were observed in the exposed rats after 18 weeks of
exposure but this difference had disappeared by 34 weeks and was not observed
at the termination of the experiment after 37 weeks of exposure to hexa-
fluoroethane.
{{o_rn!rtoZogy,
	
Omotic fragility .,f the erythrocytes, measured aft-or 37
weeks of exposure, is shown in Table 4.	 It can be concluded from this data
that exposure of the animals to hexafluoroethane did not alter the
4
integrity of the erythrocyte membrane at least as could be determined by a
challenge from osmot3,c shock.
General health and well being of the animals is reflected in the
hematology data shown in Table 5. 	 All of the parameters examined were well
within the normal range as determined in our laboratory, although there
was some evidence of hemo-concentration in the exposed rats during the
early stages of the experiment. 	 This was indicated by slightly elevated
hematocrit and erythrocycte counts in the exposed animals during the 18
i
week exposure period.	 However, after 34 weeks of exposure there were no
E
differeuccs between the exposed and control groups nor were there any
E
differences when the study was termintated. 	 Total erythrocyte counts
were well within the normal ranges at all times.
v.
1
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10.
Ftuoh ide in Mine and Bone. Levels of fluoride ion excreted in the
urine by the rats as shown in' Table 6. Three method? are used in the
table to express the rate of fluoride ion excretion. In the first, it is
expressed as a simple concentration in the urine, in the second it is ex-
pressed as total excretion in the 24-hour period, and in the third it is
expressed as amount excreted per unit weight of creatinine excreted.
Regardless of the manner of expression the absolute values are slightly
lower in the exposed group although there were no significant differences
between exposed and control groups of animals. Level of fluoride ion in
the bone of the animals, expressed as a per cent of the bone ash, is also
shown in Table 6. There was no significant difference between exposed
and control groups.
Hepatic Si,ochem.c. tAy. The 37 week exposure to hexaf luoro ethane had
.^.. l ey2 C 1 -
--ant 	 ^	 the parameters meaasurEu (Ta'ula 7 j . iiiA edi 	 4.^1C _1{..Vt Vli any Of
function oxidase was not induced. No evidence of lipid peroxidation, in
tprma of inrrAaQPd mnlnnnlriclhvda nrnA»rtinn nr 4nh4h4t4nn of al»rnaa-6-
a
f
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•	 DISCUSSION
It has been pointed out 'that the low order of toxicity of highly
fluorinated alkanes is a reflection -of a low order of chemical re-
I' activity and a low order of biological activity (Clayton 1967). The
I"
i
experiment described herin confirmed a low order of toxicity and demon-
strated that In spite of the relatively high levels of exposure to
hexafluoroethane over a long period of time and under almost continuous
conditions of exposure, there was remarkably little response of any
kind by the rats. With the chamber containing 20% by volume of hexa-
fluoroethane, the animals were being exposed by the respiratory route
to rather enormous quantities of the chemical. Taking the vapor density
of hexafluoroethane to be 5.7 g/liter and the respiratory minute volume
of the rats to be 0.073 liter s/min. (Altman and Dittmer, 1964), a conser-
ative is ,%iwate for =rats "waighing 200 g or more, it zaa be calcuiatcu r=iot
the animals were exposed to about 115 g of hexafluoroethane per day.
j
	
	
3
Certainly not all was absorbed and in fact we have shown (Griffin, et are..,
1972) that in rabbits undergoing exposure to 20% hexafluoroethane, the
concentration in blood was less than 1.0 pg/g. 	 3
The small fluctuations in activity of serum enzymes, and particularly
the elevation of LDH activity during the initial phase of exposure, may
have been related to factors other than exposure to the fluorocarbon.
l
f
	
	 In our preliminary studies in which groups of rats were exposed to
fluoroalkaries continuously in the closed dynamic chamber for periods up to
30 days and in control experiments. in which rats were confined to the
chamber for 30 days but were not exposed to a fluoroalkane, elevated serum
LDH activities were often observed. In these experiments we also noted
that slight retardation of growth accompanied confinement of the rats to
12.
'r
•	 the chamber and thus did not necessarily result from exposure to a
fluoroalkane. It is difficult to conclude what might be the cause of these
apparent effects from confinement in the chamber. Confinement in the
chamber did expose the rats to an atmosphere different from that of the
control animals in more respects than just the presence of hexafluoroethane.
As noted above the temperature was slightly higher and we also observed
that the chamber air was often more humid than the air outside. Many
closed environmentally controlled chambers incorporate activated charcoal
scrubbers and catalytic burners to remove trace amounts of methane, ammonia,
L,	
odors, etc., from chamber atmospheres, but we could not use such systems
because of the possible interactions with hexafluoroethane. Hence, the slow
purge of chamber gasses was adopted to maintain low levels of such materials
but, even so, minute quantities could still have been present. All of these
aeLoru Laker LogeLher may account for some of the slight differences between
control and exposed groups of rats.
Since hexafluoroethane is a non-polar or-anic compound and soluable in
many organic substances, it is concievable that the material might be,trans-
ported to membrane systems and there interact with the lipid components of
P;
.such systems. It could be anticipated that incorporation of hexafluoroethane
into membranes of cells or components of mixed function oxidase systems
might change the integrity of the cell membrane or activities of the
enzyme systems. If such an interaction occurred in the erythrocyte cell
membrane it was not expressed by a change in the osmotic fragility of the
cells.
Although pert luorohexane was found by Ulbrich and Diehl(1971) to bind
to mixed function oxidase and activate NADPH oxidation, no stimulation of
lipid peroxidation or inhibition of glucose-6-phosphatase was found as 'a
result of a chronic exposure to hexafluoroethane. Our negative findings
J
3
i
.s
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may be due to the fact that reducing equivalents from NADPH go to 'd20 2 and
then to H2O as suggested by Ulbrich and Diehl instead of going to lipid
peroxides. Also hesafluoroethane may not activate P-450 in the same manner
as perfluorohexane. The thiobarbituric acid method for measuring lipid
peroxides is not very * sensitive aiid measures the tendency of the membranes
to perox::i.dize rather than determining the actual level of peroxides or
d ene conjugates in the membranes. Although the lipid peroxidation assay
is not very sensitive, glucose-6-phosphatase is quite sensitive to lipid
peroxidation (Ghoshal and Recknagel, 1965). The fact that this enzyme
was not lowered by chronic exposure to hexafluoroethane, indicates that
the mixed function oxidase was not activated to produce lipid peroxides.
Decomposition of hexafluoroethane within the bodies of the rats was
not detected by means of measurement of fluoride ion excretion in the
urine. MicCss iluarluz
 acc-aim 	 in bane and the lack of evi-erra of
increased levels in bone of the exposed rats is even stronger evidence
that breakage of the carbon-fluorine bond did not occur in these animals.
Urinary concentrations of fluoride were low in both exposed and control
groups and they were lower in the exposed group, although by only a small
margin; the observed differences were not statistically significant. 	 j
However, it is interesting that the trend was lower in the exposed group
and this may have been related to differences in dietary intake of
;l
fluoride ion. The growth was slightly retarded in the exposed animals
and this may have been due to a decreased consumption of food resulting.
also in a decreased intake of fluoride ion.
Many gaseous halogenated hydrocarbons are known to sensitize the
myocardium to the effect of catecholamines and although the phenomenon
was not studied specifically in this experiment it is worthy of mention.
Studies of this effect of haloalkanes are under study in our laboratories
t.
I14.
i
and a preliminary investigation showed only a low order of catecholamine-
induced cardiac arrhythmia caused by hexafluoroethane (Wills, et a.Z., 1972).
1
A comprehensive study of cardiac arrhythmias induced by a variety of halogenated
`	 as well as non-halogenated hydrocarbons was reported by Reinhardt, et at.,i
a
(1971) although hexafluoroethane was not investigated. In a more recent
9
communication from the same laboratory (Trochimowicz, 1972), hexafluoroethane
at 20% v/v in air was reported not to induce cardiac arrhythmia in dogs.
We plan exposures of rhesus monkeys in a study to be conducted in a manner
a
similar to the one reported here for the rats but also to include invest-
igations of cardiac sensitivity.
TBG*MC
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t7abte 1. Weefzty ehambetc eondit ms and body weights o6 tats
exposed to hexa6tuonoethane
Average
Chamber conditions Body weight, g
Week Freon, :a 0 2 , % CO 2 , % T,	 °F Exposed	 Control
1 20.3 19.8 0.09 ^77 194 192
2 18.3 18.1 0.23 77 197 237
3 20.7 19.2 0.51 77 257 2 90
s"
4 24.8 19.4 0.43 77 271 310
5 18.7 19.4 0.38 77 287 327 a
6 24.4 19.6 0.34 37 324 366	 l
7 18.4 19.9 0.42 76 326 372
8 .22.4 20.0 0.27 77 350 380
9 20.7 19.6 0.39 78 380 408
10 18.3 19.3 0.48 78 396` 422	 l
11 24.1 20.7 0.66 77 395 419
12 19.1 20.5 0.58 76 406 422
13 15.6 19.6 0.80 79 409 431
,r, i1u .v ^n niJ.J ^i^Irl ^n// ^^^-r .. ^. tooTVV
15 20.0 19.9 0.43 81 428 426
16 24.0 20.4 C.38 81 434 431
17 20.1 19.9 0.26 81 433• 436
18 22.2 19.9 10.29 75 433 447
19 20.2 18.8 0,.37 73 436 450
20 21.7 19.5 0.36 77 425 454
21 22.4 20.7 0.39 80 416 456
22 24.3 20.8 0.35 79 426 461
23. 21.9 20.5 0.35 77 428 466
24 20.9 20.1 0.42 77 432 470
25 17.8 19.3 0.43 77 435 475
26 18.5 20.3 0.32 77 429 464
27 22.8 20.6 0.41 77 442 470
28 19.6 24.4 0.31 75 439 465
29 20.6 20.7 0.34 76 442 466
30
.23.1 20.9 0.33• 76 449 462
31 21.3 20.4 0.43 76 455 477,
32 21.6 20.1 0.31 76 457 483
33 21.0 19.2 0.35 77 460 499
34 20.7 -	 21.2 0.52- 77 466 508
35 20.3 20.5 0.36 77 479 508
36 20.1 21.6 0.42 77 484 509	 -
: 37 19.7 20.7 0.36 76 489 516
fTab.ee 2.	 Senum ' biochemi4tky
.
pn06-cee6 o6 nat6 exposed to hexa6tu.onoethane
bon 37 weW
'
3
1
Parameter
i
ExposedControl
(N=6) (N=8)	 i
,Alkaline phosphatase,
-s 14.4 ±	 5.9* 24.0 ±	 7.2K-A units
Acid phosphatase,
K-A units Z 11.0 ±	 2.0 11.1 ±	 2.7
Glutamic-oxalacetic
65.0 ± 12.0 67.0 ± 21.0transaminase, S-F units
Glutam c-pyruvic
^^ 28.0 ± 12.0 23.0 ±	 6.0transaminase, S-F units
Creatine. phosphokinase, 38.0 ± 24.0 32.0 ± 15.0Sigma units
Sodium.
meq 143.0 +_	 2.0 i44.0 T	 1.0
Potassium
meq/1 5.1 ±	 0.2 -5.3 ±	 0.4
Glucose
MS/100 ml 131.0 ± 16.0 140.0 ± 18.0
Urea nitrogen
Mg/100 ml
	
-
- 18.0 ±	 2.0 16.0 +	 3.0
1Tabte 3. Lactic deh ydugeno a activity in b enum o6 %at6 exposed to
hexaStuono et1tane
Units* of Enzyme Activity
18 weeks	 34 weeks	 37 weeks
Control, (N=6)	 1470 ± 620	 1530 ± 40	 2220 ± 150
Exposed, (N=8)	 2990 ± 240	 1160 ± 270	 2050 ± 210
One unit will reduce 1.0 umole of pyruvate to lactate per minute at
pH 7.5 at 37 0
 C. Values shown are means ± S.D.
1Table 4. 0.6motic Sxag.t, Ltcy of exytivcocyted jxom xat6 exposed to
hexa6Zuoxoetkane. 	 Data a&e expxessed ass pet cent hemoZysi6.
% NaCl
0.65
	
0.55 0.50	 0.45 •0.40	 0.301
Control 0	 2.8 12.7	 56.2 95.1	 100
Exposed 0	 0 11.5	 53.9 94.1	 100
Tab.Ze 5. flematotogy pxo JiZu o f xats exposed to hexajZuoxoethan.e.
Hct Hb RBC WBC
% g% X106 X103
Control,	 (N=6)
18 wks 46.5 ± 1.5* 16.4 ± 1.2 8.2 ± 0.4 14.2 ± 2.6
34 wks 48.6 ± 2.1 18.5 ± 1.0 8.2 ± 0.8 8.2 ± 3.0
37 wks 45.9 ± 1.6 16.8 ±.1.2 7.0 ± 0.6 7.5 ± 2.1
Exposed, (N=8)
18 wks 49.9 ± 5.0 17.4 ± 1.1 9.1 ± 0.8 14.4 ± 6.8
34 wks 48.6 ± 1.9 18.6 ± 1.0 8.3 ± 0.8 8.5 ± 1.4
37 wks 44.7 ± 1.5 15.5 ± 0.7 6.8 ± 0.4 8.1 t 1.6
means + S.D.
^r
Tabte 6.	 FxcAe ti.on o 6 S.Zuo, i.de ion in urine o6 natA and conceattati.on
o6 ituoni.de in bone o6 natA expo6ed to hexa 6tuoAo ethane San
37 weekA
Control Exposed
(N=6) (N=8)
in urine 4.13	 * 1.34* 2.83	 t 0.61
leg/ml
F" excretion via urine 47.6	 * 15.0
J
36.6	 ± 7.3
r pg/24 hr
F- excretion via urine 2.65	 +	 0.67 2.19	 # 0.45
pg/mg creatinine
F- in bone.	 - 0.071 ±	 0.008_ 0.070 ± 0.009
% bone ash
TabQe 7.	 S iockem.i.cat patameteu o S Vie ►ni.cuz oma,Z mZxed Sunct, :on
'	 oxidasa in ti.veu o5 nat6 exposed 37 weeU to Freon 116
Biochemical Control Freon
parameter
(N=6) (N=8)	 j
cytochromr P-450,
O.D. 4 sonm X 10 3 /mg protein/ml 76	 25 * 69 ± 18
cytochrome bs"
O.D.42snm X 10 3 /mg protein /ml" 34 ± 14 35 ± 15
^--	 biphenyl hydroxylase,
nMoles 4-OH-biphenyl 43 + 4 36 ± 21
mg/protein/hr
^--	 N-demethylase,
nMoles p-chloroaniline 166	 30 146 ± 32
mg/protein/hr
lipid peroxidation,
n';nl es malonaldehvde 48 t 12 41 +_ 11
mg/Protein/hr
glucose-6 7;phosphatase,
uMoles Pi i	 n e 9 Q+, n
rSTUDIES OF SENSITIZATION OF CARDIAC MUSCLE TO EPINEPHRINE
BV SELECTED HALOCARBON COMPOUNDS
Methodb: Guinea pigs and mongrel dogs were anesthetized with sodiu
pentobarbital, the guinea pips being injected i.p. and the dogs i.v
Guinea pigs were exposed to the halocarbons by being placed within
plastic static chamber filled with air containing 4 or 57 (V/V) of
halocarbon. Dogs were exposed by breathing from a spirometer throu
tracheal cannula a gas mixture containing 4 or 5% (V/V) of halocarb
With both species, the same general protocol was used:
	
Time (min.)	 Pro-:educe
0	 Begin to record ECG.
	
1-2	 Infuse epinephrine i.v.
to record ECG.
3-6.7
	
	
Continue to record ECG until
arrhythmia stops.
	
7-22	 Animal breathes halocarbon.
23	 Begin to record ECG.
24-25 Infuse epinephrine i.v. while continuing
to record ECG and while animal continues
to breathe halocarbon.
	
26-29,30	 Continue to record ECG until arrhythmia
stops or animal dies (ventricular
fibrillation)„
The concentrations of halocarbons used with both the guinea pig and
the dog were: 2402-42; 116, 1301, and C318-5z. The gas mixtures were made
by volumetric measure but were not analyzed. They are nominal concentrations,
therefore, and are almost certainly higher than would be found by analysis
of the gas mixtures. Compound 2402 was found not to yield a stable vapor
or aerosol within the spirometer used, so that no actual exposures of dogs
Lo this compound were made.
1
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The effects of the halocarbon compounds on the experimental animals
were assessed by comparison of the response to infusion of epinephrine after
and during continued inhalation of the halocarbon with that to the similar
infusion before exposure to the halocarbon, each animal serving as its own
control. In a control experiment, in which two infusions of epinephrine
without an intervening exposure to a halocarbon were performed, arrhythmia
appeared within 30 and 31.6 seconds after the initiations of the infusions
and lasted for 180 and 208 seconds after the cessations of the two-minute
infusions.
The responses in the animals exposed to halocarbons Were graded on
an eight-point scale:
1. Arrhythmia appeared later and lasted for a shorter time
than after the control infusion into the same animal.
2. Arrhythmia appeared at about the same time (± 4 sec.) but
lasted for a shorter time.
3. Arrhythmia appeared earlier but lasted for a shorter time.
4. Arrhythmia appeared at about the same time (± 4 sec.) and
lasted for about the same time (+ 4 sec.).
S. Arrhythmia appeared later and lasted for about the same
time (± 4 sec.).
l	 6. Arrhythmia appeared later but lasted for a longer time.
7. Arrhythmia appeared at about the same time (+ 4 sec.) but
lasted longer.
8. Arrhythmia appeared earlier and lasted longer.
Re4uZt6 s The attached seven tables summarize the 41 experiments with guinea
pigs and the 12 with mongrel dogs that hava been performed. On the basis of
the scores assigned according to the scheme given above, 1301 was the least
objectionable compound in the guinea pig, followed in order by 2402, 116
and C318, In the dog, C318 was clearly the least objectionable compound,
followed by 116 and 1301.
E	 ,
^i
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When the scores in the two species are simply summed, 1301 seems to be
the least objectionable compound, with C318 following very closely. If-man's
heart is considered to be more similar to that of the dog than to that of
the guinea pig with respect to sensitization to epinephrine by halocarbons,
the order of preference of these two compounds would be reversed; in fact,
116 would be considered to be preferable to 1301, falling between C318 and
1301 in preferability.
Condlusdo" t 1. In the guinea pig, 1301 had the least sensitizing effect
on the myocardium, followed in order by 2402, 116 and C318.
2. In the dog, C318 had the least sensitizing effect on
the myocardium, followed in order by 116 and 1301.
3. On the basis of the effects of the four halocarbons
studied in sensitizing the hearts of the guinea pig and the dog to
epinephrine, either 1301 or C318 is Judged to be the safest compound
for man. The final choice depends upon whether the myocardium of man
responds to these halocarbons more as does that of the dog or that
of the guinea pig. Orth has stated that he considers the heart of
the dog to be the beat model of the human heart for such studies.
J
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Table 1. Cardiac sensitization in guinea piss to Freon 116.
time to start duration of
Animal arrhythmia arrhythmia
Number (seconds) (seconds) Grade
Before	 After Before
	 After
exposure	 exposure exposure	 exposure
1 41	 103 155	 93 1
2 67	 44 171	 189 8
3 63	 116 118	 185 6
4 40	 44 152	 194 6
5 34	 38 135
	 219 6
6 42	 40 203
	 144 2
7 34	 33 149	 21 2
8 47	 50 48	 46 4
9* 22	 >120 67	 0 5
10 222
	 55 58	 97 8
Mean',
1
5
* No arrhythmia was produced in this 116._animal after exposure to
^
F
1
ITable 2. Cardiac sensitization in dogs to Freon 116.
tima to start duration of
Animal arrhythmia arrhythmia
Number (seconds)
 (seconds) Grade
Before
	 After Before	 After
exposure	 eaosure exposure	 exposure
1 37	 30 213	 303 8
2 26	 19 206	 165 3
3* 29	 36 254	 272 6
4 28	 27 110	 18 2
Mean
5
* The spironeter may have been contaminated with 2402 during this
experiment; it had been flushed but not cleaned.
^,	 s
r	 1
'	 Tab_	 le 3. Cardiac sensitization in guinea pigs to Freon C318.
time to start duration of
Animal arrhythmia arrhythmia
Number (Seconds) (seconds) Crade
Before	 After Before	 After
exnorsura	 exposure exposure	 eX208ure
1 28	 47 162	 157 5
2 36	 39 156	 237 6
3 43	 53 64	 127 6
4 24	 52 86	 105 6
5 35	 42 115	 55 1
6 46	 48 43	 24 2
7 41	 52 76	 101 6
8* >120	 >120 0	 0 4
9 32	 78 18	 65 6
10 56	 37 73	 104 8
11 54	 52 50	 66 7
Mean
5
if
k.
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Table 4. 'Cardiac sensitization in dogs exposed to Freon C318.
time to start duration of
Animal arrhythmia arrhythmia
Number (seconds) (seconds)	 Grade
Bofors	 After Before	 After
expos ure	 exposure ex"og:!re	 ex2ocure
1 25	 28 207	 248	 6
2 26	 25 204	 76	 2
3 47	 33 144	 2	 3
4 14	 21 262	 105	 1
Mean 3
1
m
i
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Table 5.	 Cardiac sensitization in guinea pigs to Halon 1301.
time to start duration of
Animal arrhythmia arrhythmia
Number (seconds) seconds) Grade
Before	 After Before	 After
exposure	 exposure exposure	 exposure
1 36	 46 154	 182 6
2* 38-	 >120 134	 0 1
3 26	 19 73	 228 0
4 38	 147 16	 33 6
5 36	 38 195	 36 2
6 33	 40 34	 28 1
7 28	 34 58	 21 1
8 37	 44 74	 6 1
9 40	 42 77	 92 7
10 38	 36 71	 67 4
Mean 4
* No arrhythmia was produced in this animal after exposure to 1301.
l1
,i1
Table 6._ Cardiac sensitization in dogs to Halon 1301.
time to start duration of
Animal arrhythmia arrhythmia
Number
 (seconds) Keeconds) Grade
Before After Before	 After
exposure	 exposure exposure	 exposure
1 57	 78 161	 165 5
2 19	 34 400	 >480 6
3 38	 43 1195	 226 6
4 36	 22 176	 214 8
Mean 6
a'	 Tab` 1`7. Cardiac sensitization in guinea pigs to Halon 2402.
time to start duration of
Animal arrhythmia arrhythmia
Number (seconds) (seconds) Grade
Before	 After Before	 After
exposure	 exposure exposure	 exposure
1* >120	 36 0	 199 8
2 29	 35 92	 95 5
3 50	 37 162	 65 3
4 42	 54 45	 11 1
5 48	 37 58	 5 3
6 40	 38 124	 8 2
7 40	 38 37	 7 2
8 38	 51 141	 188 6
9 48	 63 76	 28 1
10 49	 41 65	 136 8
Mean	 4
t.y .
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PAPER NO. 16
SENSITIZATION OF THE HEART TO CATECHOLAMINE -
INDUCED ARRHYTHMIA
J. Henry Wills, Ph. D.
Albany Medical College
Albany, New York
This work was undertaken as a part of a cooperative effort between the
Institute of Experimental Pathology and Toxicology of Albany Medical College
and the Manned Space Flight Center of NASA, to find a fire-suppressant, or at
least a fire-retardant, that can be present within the atmosphere of a space
vehicle without significant hazard to the occupants. A group of fluorinated halo-
carbon compounds was selected for further study on the basis of the existing in-
formation on their antipyral and toxic activities.
The specific task of my group was to determine the effects of candidate
chemicals on the cardiovascular system. In view of previous work showing
that such halogenated compounds as chloroform (Levy and Lewis, 1911; Brow
et al., 1930 Morris et al., 1953; Raventos, 1956), halothane (Raventos, 1956;
Hall and Norris, 1958; Katz et al., 162; Flacke and Alper, 1962), methoxy-
flurane (Bamforth et al. , 1961), and other fluorinated halocarbons (Taylor and
Harris, 1970; Reinhardt et al. , 1971) are capable of sensitizing the heart to
catecholamines, study of the effects of the candidate compounds on the re-
sponse of the heart to infused catecholamines seemed particularly pertinent.
Methods
Two sorts of studies with guinea pigs, cats, and dogs anesthetised with
Na pentobarbital were performed. In both, the animals have been made to
breathe a mixture of a halocarbon compound and air, made up in a calibrated
spirometer, through an intake-output valve system attached to a cannula inserted
into the trachea just below the larynx. In one type of experiment, represented
schematically in figure 1, epinephrine was infused into the femoral vein of one
hind leg at a rate of about 3.5 {tg/kg/min during periods of two minutes before
and after exposure to a halocarbon compound during 15 minutes, inhalation of
the halocarbon continuing during the second infusion. The second type of experi-
ment was similar except that the infusions of epinephrine were replaced by intra-
venous injections into the femoral vein of one hind limb of 5, 10, or 15 µg/kg of
epinephrine before and at various times after inception of exposure to a halocarbon.
ir
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Figure 1. SCHEMATIC REPRE-
SENTATION OF THE SCHEDULE.
FOR A TYPICAL EXPERIMENT,
WITH TWO INFUSIONS OF
EPINEPHRINE, INDICATING THE
TIMES AT WHICH RECORDINGS
OF THE ECG (IN SOME CASES 8.
OF BLOOD PRESSURE ALSO),
INFUSIONS OF EPINEPHRINE
AND INHALATION OF VAPORS
OF A HALOCARBON COMPOUND,
DILUTED IN AIR WERE 	 awlPERFORMED.
The halocarbon compounds studied were: I = Freon ®
 11 = trichloro
fluoromethane, II = HalonO 1301 = trifluorobromoethane, III = Halone 2402 =
1, 2-dibromotetrafluoroethane, IV = Freon® 116 = 1, 2-hexafluoroethane, and
V = Freon ® C-318 = cyclic octafluorobutane. Some studies have been made also
with Freon® 12 = difluorodichloromethane. Halocarbon-air mixtures have been
-	 analyzed by gas-liquid chromatography.
Calcium and potassium have been estimated by flame photometry. Nor-
epinephrine has been estimated by the method of Lund (1950), using extraction
with perchloric acid, adsorption on alumina, and oxidation with potassium fer-
ricyanide instead of manganese dioxide.
Magnesium chloride, calcium chloride, and MK-486 [L-2-hydrazino-2
methyl-3-(3, 4-dihydroxyphenyl) propionic acid] have been injected or infused.
intravenously. The MK-486 was provided kindly by Alexander Scriabine, M. D.,
of Merck Sharp and Dohme.
I	 .
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Results
Figure 2 shows the responses of a dog to duplicate infusions of epinephrine
before and after a 145-minute period of inhalation of a 0.877 (v/v) concentration
of Freon (D 11 in air, the times indicated beneath the various sections of record
being the times elapped since the start of the infusion. The upper record repre-
sents limb lead I in each pane and the lower record limb lead II, The only effect
of the infusion in the unexposed animal (left) was some slowing of the heart's rate,
whereas in the same animal after exposure to the FreonO compound the duplicate
infusion of epinephrine produced initially a more marked slowing of the rate and
then the appearance of ectopically generated ventricular contractions and fairly
marked arrhythmia. The exposure to the halocarbon compound of itself had lit-
tle effect on the ECG recordings.
^i-ta,' i~ ♦  -F
	 4-^ t + ♦
..	 f	 ...	 1.
CONTROL - 15 .27 SECONDS	 FREON - 12-24 SECONDS .
i---	 'T	 .-Y'^.i.. ^t	 .-nl} /	 ; 'fr. 44	 •i ^^	 i-.-	 kr. •..;	 {	 T	 j	 ii1}	 i	 ..
"^-"	 ^.	 r _',	 _'} ALT :	 l-a
	 I+ ^ ? 7
WN I KOL - 39.51 SECONDS
	
MWN - 35.48 SECONDS
*1t
	 :	 ^+ j" _. r ,:i t	 ,fix +,	 f
CONTROL 75.87 SECONDS
	
FREON - 72.84 SECONDS
Figure 2. ECG RECORDS MADE AT VARIOUS TIMES AFTER THE BEGIN-
NINGS OF INFUSIONS OF EPINEPHRINE BEFORE (LEFT) AND
AFTER (RIGHT) EXPOSURE OF THE ANIMAL TO A VAPORIZED
HALOCARBON COMPOUND BY ILNHALATION.
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When the various halocarbon compounds were compared in the type of
experiment illustrated above, the results set forth in table I were obtained.
The experiments with II and IV in the guinea pig show that although the sensitiz-
ing effect of exposure to a halocarbon compound is dose related, the relationship
is far from a proportional one; quadrupling the concentration of halocarbon pro-
duced only a little more than an eleven percent increase in the number of animals
showing sensittzntloa to the infusion of epinephrine, on the average between com-
pounds II and IV. In the case of compound IV, this change in the concentration of
the halocarbon compound produced less than a 35 percent increase in the number
of animals showing sensitization. This table shows also that the dog and the
guinea pig are not entirely identical in their responses to the various halocarbon
compounds. Freon® 11 (I) is clearly the most potent of the five chemicals within
this table. It is probably followed in order of decreasing effectiveness as a sen-
sitizer to catecholamines by V, II and IV, and 111, although the choice among the
last four compounds on this basis is not clear.
Table I
Effect of Inhalation of Halocarbon Compounds on Arrhythmia
Induced by Infusion of Epinephrine
Concentration
	
Arrhythmia Increased
Compound	 in Air (v/v)	 Guinea Pig
I '	 0 87	 6 6.	 J
IL 2.2 4/10 3/4
8.7 2/6
1	 III 1.8 3/10 1/4
IV 2.2 5/10 2/4
8,.7 2/3
33.8	 _ 2/2
V
i
2.2 7/11 1/4 a
^a
1
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In one cat, exposure to Freon® 11 in a concentration of 1 > 79 70 produced
arrhythmia without infusion of epinephrine. In a similar experiment in which
8.870 Freon 0 12 was administered, spontaneous arrhythmia appec red also.
Two cats responded to this concentration of Freon® 12 in this way. These
three experiments are the only ones in which arrhythmia has appeared without
infusion of epinephrine, although much higher concentrations of some halocarbon
compounds have been used [for example, 4497 (v/v) of Freon® 116 (IV)]. A com-
parison of Freons ® 12 and 116 (IV) and Halon( 1301 (II) in concentrations of
2.67 (v/v) in the inspired air disclosed that Freon ® 12 sensitized more than II
to the hypertensive and pulse-pressure elevating effects of infused epinephrine,
but less to its chronotropic action. Freon® 12 sensitized less than IV to the
hypertensive, pulse-pressure elevating, and chronotropic actions of the infusion
of epinephrine. Freon (R) 12 under these conditions induced arrhythmia during
infusion of epinephrine in 1/6 cats whereas the other two halocarbon compounds
produced arrhythmia in 0/6 animals.
In experiments in which discrete doses of epinephrine were injected intra-
venously at various times after beginning exposure to 0.87 (v/v) I, the maximum
arrhythmia was found to occur at around 10 minutes of exposure to this most
potent of the halocarbon compounds studied; thereafter, despite continuedexpo-
sure to I, the response decreased. When the exposure to I was terminated, the
enhanced responsiveness to epinephrine disappeared rapidly (table II, +5 min.
5 minutes after termination of the exposure at 15 minutes after its start).
Table II
RESPONSES TO I.V. DOSES OF EPINEPHRINE AT VARIOUS TIMES (MINUTES)
G AFTER BEGINNING EXPOSURE TO 0.87% (V/V) I
DOSE OF EPINEPHRINE RESPONSE*
(j,ig/kg)	 0 MIN.	 MIN. 10 MIN. 14 MIN. +	 MIN.5 4	 29
31	 21	 4
10 30	 42 88	 28	 21
15 73	 111 153	 123	 33
* NUMBER OF ARRHYTHMIC HEART BEATS AFTER EPINEPHRINE.
k
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Because of the well-known interaction of anoxia and epinephrine in the
genesis of arrhythmia (see, for example McNamara et al., 1952), a series
of animals was given a standard concentration of 1 (0.870 made up in air
enriched by either nitrogen or oxygen. Sensitization to injected epinephrine
was enhanced by low oxygen and decreased, but not abolished, by high oxygen.
Section of the vagi, vagal activity being known to enhance the effect of anoxia
(McNamara et al., 1952), also reduced, but did not remove entirely, the sen-
sitizing action of ^ on the chronotropic effect of epinephrine (table III).
Table III
EFFECT OF VAGOTODIY ON THE NUMBER OF ARRHYTI'MIC HEART BEATS INDUCED BY
I.V. EPINEPHRINE AT VARIOUS TIDIES DURING EXPOSURE TO 0.87% (V/V) I
DOSE OF	 CONTROL	 VAGOTO?WISED
EPINEPHRINE 0 MIN. 5 MIN. 1O MIN. 14 MIN. 0 MIN. 5 MIN. 10 MIN. 14 MIN.
5 pg/kg	 2	 11	 8	 0	 8	 11	 7	 2
10	 60	 28	 72	 0	 60	 17	 6	 5
15	 116	 116	 144	 104	 116	 21	 9	 7
In attempting to identify the change in the heart elicited by exposure to a
halocarbon compound, we have used Freon® 11 (I) as the most potent represent-
ative of its general chemical type. Whether it is a typical representative remains
to be seen, although we have some indication that it is not too different from the
others in its qualitative actions.
One obvious factor in sensitization of the heart to extraneous catecholamines
is the intrinsic concentration of norepinephrine. To study the effect of exposure to
halocarbon compounds on this possible variable, we exposed anesthetised guinea
pigs to I and IV by inhalation through a tracheal cannula during a period of 15 min-
utes. At the end of that time, the animals were killed quickly by intravenous injec-
tion of an overdose of Na pentobarbital; the hearts were excised rapidly and put
immediately into previously cooled beakers held in an ice bucket. The hearts were
homogenized in an all-glass homogenizer and analyzed for norepinephrine. Control
animals were treated similarly except that they inhaled normal room air. The
results are given in table IV, where each mean represents-a group of 6 guinea pigs.
Although the concentrations of the two halocarbon compounds used were both known
from previous work to be capable of sensitizing the heart of the guinea pig to in-
fused epinephrine, the hearts from the animals exposed to the halocarbon materials
did not differ significantly in catecholamine concentration from those from the con'-
_a
trol animals.	 j
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Table IV
Effect of Inhalation of Freon in Air on the
Concentration (pg/gm) of Norepinephrine within
the Heart of the Guinea Pig
Freon	 Concentration	 Control	 Experimental
	
116	 5.0%
	
2.29 + 1.04	 2.19 + 0.81
	
11	 0.4%	 1.60-+ 0.36	 1.89 + 0.60
To study the possibility that dopamine contributes to the sensitization of
the myocardium by halocarbon compounds, cats were given i. v. doses of 25 mg/
kg of MK-486 five minutes before the beginning of exposure to I. This treatment
did not modify the response of the heart to infusion of epinephrine at the end of
the 15-minute exposure. This result is in sharp contradistinction to those ob-
tained with MK-486 in arrhythmia induced by the administration of DOPA (Mars
and Krall, 1971),
Another possible factor in the sensitizing action of the halocarbon compounds
is alteration of the relation of the heart to potassium. We have determined that
our standard 15-minute exposure to I (in a v/v concentration in air of 0.457) does
not alter significantly the concentration of potassium within blood plasma (table V).
We are in the process of determining the effect of this treatment on the concentra-
tion of potassium within the heart muscle, but do not have final figures yet.
Table V
Effect of Inhalation of Freon ® 11 in Air on the
1'	 fConcentration (meq/ iter} o Potassium m
Plasma of the Cat
Control After Freon
P	
.
4.1 4.1
6.4 4.8i	 6.2 4.6
4.2 4.3	 li	 3.7 3.8
6.6 5.2	 I4.6 4.0
Mean	 5.1:6 1.2 4.4 f 0.5
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We have examined also the effect of i. v. injection of MgSO 4 (6 ml/kg of
3.3 j) on sensitization of the heart to epinephrine by I, with the result that this
dose of MgSO4 did not alter the sensitization. This finding suggests that the
halocarbons, unlike digitalis glycosides (Langer and Serena, 1970; Seller, 1971),
do not facilitate arrhythmogenic activity through shifting intracellular potassium
into the plasma. If the analyses of heart muscle for potassium corroborate this
tentative conclusion, we think that we will have good evidence that alteration of
the permeability of the myocardial membrane to potassium is not a factor in
sensitization of the heart to catecholamines by halocarbon compounds.
We have just begun to study the possibility that the relationship of the
myocardial membrane to calcium may be modified by exposure to a halocarbon
compound. About all that I am in a position to say with fair certainty at present
is that by infusing CaCl2 into cats at a rate of 5 mg/kg/min we have been able to
obtain about as great sensitization of the heart to infused epinephrine as we can
obtain by the standard exposure to I. A different sort of experiment will be under-
taken soon to attempt to determine more directly whether calcium is involved in
sensitization by halocarbon compounds, possibly by enhancing release of catechol-
amines from secretory granules (Greenberg and Kolen, 1966).
In another connection, we have been interested in a compound that has both
alpha- and beta-adrenergic blocking abilities, the beta-blocking activity being
somewhat the greater, as well as an anticholesterolemic action.  This compound
has been found to prevent the induction of arrythmia by infusion of epinephrine
after exposure to halocarbon compounds. Both phenoxybenzamine and propranolol
also have this ability. It is apparent, therefore, that both alpha- and beta-receptors
may be involved in the sensitization of the heart by halocarbon compounds to the
arrhythmogenic action of extraneous epinephrine.
Moe et al. (1948) showed clearly the involvement of the peripheral alpha-
receptors of the cardiovascular system in the induction of idioventricular rhythms
by epinephrine administered during cyclopropane anesthesia. Kunkel et al. (1951)
found that veratramine, which did not alter the pressor actions of epinephrine but
did reduce its cardioaccelerator effect, was capable of preventing ventricular
fibrillation induced by epinephrine in cats that had been exposed to vapors of benzene.
It is possible, therefore, that effects on both inotropic and chronotropic properties
of the myocradium may be involved in such phenomena as the sensitization by halo-
carbon compounds that we are studying. Depression of myocardial contractility
without significant beta-adrenergic blocking action actually is capable of mitigat-
ing the arrhythmogenic action of daunomycin (Burka et al., 1970).
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i
THE EFFECTS OF FREON ® 11 AND CERTAIN DRUGS ON
ISOLATED AURICLES
j. H. Wills
D. Silber
Albany Medical College
Albany, New York
Last year, I reported that 6 fluorinated halocarbon compounds that
we had studied, Freons® 11, 12, 116, and C-318 and lialons® 1301 and
2402, had been found to sensitize the myocardium to the arrhythmogenic
action of epinephrine. As an extension of that work, we undertook a study
of the effect of Freon®
 11, one of the most potent sensitizing compounds,
on isolated atrial tissue.
We used the auricles of the heart of the rat, which were suspended
between the bendable member of a bonded strain-gauge transducer and a
fixed point and immersed in a bAth of Locke's solution. This bath was
aerated through a fritted glass disk with a gas mixture containing 95% O,
and 5% CO,, pumped by a diaphragm pump. The same pump was arranged
to transfer the same mixture of gases containing a small amount of vaporized
Freon® 11 from a spirometer through the organ bath. The set-up is rep-
resented in Figure 1.
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Last year, I reported that 6 fluorinated halocarbon compounds that
we had studied, Freons® 11, 12, 116, and C-318 and Halons® 1301 and
2402, had been found to sensitize the myocardium to the arrhythmogenic
action of epinephrine. As an extension of that work, we undertook a study
of the effect of Freon® 11, one of the most potent sensitizing compounds,
on isolated atrial tissue.
We used the auricles of the heart of the rat, which were suspended
between the bendable member of a bonded strain-gauge transducer and a
fixed point and immersed in a bAth of Locke's solution. This bath was
aerated through a fritted glass disk with a gas mixture containing 9570 O,
and 5% CO, pumped by a diaphragm pump. The same pump was arranged
to transfer the same mixture of gases containing a small amount of vaporized
Freon® 11 from a spirometer through the organ bath. The set-up is rep-
resented in Figure 1.
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Figure 2 shows t
the beginning of an ex-
posure of a pair of au-
ricles to the gas mix-
ture containing 170
	 /v)Oof vaporized Freon R 11.
It is obvious that there 17,1^f
,!	 1=^, 111
^..	 ,I11'l,l^lllll,illt
„",1^'j
was no immediate effect
After aeriod of expo-
he
t^
s^:yre of	 auricles to ^ti^uh!^i	 ^ tlht{i!'ii i^
1	 4^,-r y e g as mixture con-R (raining Freon@ 11,
there was a marked de-
crease in their rate of
>	 repetitive contraction Figure 2.	 Beginning Exposure of Auricles(Figure 3).	 This was to Aerating Gas Containing Freon @ 11.	 !followed fairly promptly
by complete cessation
of contraction (Figure 4).
3
Upon replace-
ment of the gas mixture
containing Freon @) 11
by the uncontaminated
gas, rhythmic contrac-
tion by the auricles was !	 ,!
resumed rapidly u'	 +	 !!	 ^,rr
(Figure 5) and contin-
ued for long periods of
time thereafter.	 This
!	 recovery of normal
rhythmic contraction
indicates to us that the
exposure to vaporized
Freon® 11, even though
it was pressed to the
point of stopping the
spontaneous contrac- e ^ 
tions of the auricles, C3	 u
.
did not injure the au-
ricular muscles. Figur.^ . ,	 Decrease in Rate of Beating of
Auricles Exposed to Vaporized Freon@ 11.
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Last year, we presented evidence that the sensitization of the heart to
extrinsic catecholamines by inhalation of vapors of Freon ® 1.1 was not re-
lated to an increased concentration of norepinephrine within the myocardium,
to enhanced formation of either DOPA or 1 OPamine, or to altered perme-
ability of the myocardial cells to K. Because of the well-known ability of
'	 calcium to link the excitatory and contractile: processes in the myocardial
muscle (Langer, 1968; Bailey and Dresel, 1968; Little: and Sleator, 1969;
Sanborn and Langer, 1970; Saari and Johnson, 1971; Shine, Serena, and
Langer, 1971), we decided to use the isolated auricles to study the effect of
a low external concentration of calcium on the response of the heart to
catecholamines as well as on spontaneous activity by the auricles. We found
that lowering the concentration of calcium in the Locke's solution to 1/] 0 its
usual value decreased the force of contraction of the auricles with only a
slight, immediate effect to decrease their rate of beating, but eventually did
stop the contractions; the auricles did not respond to addition of epinephrine
to the fluid within the bath either while they continued to beat or after they
'	 became quiescent (Figure 6). Addition of CaCl 2 to the fluid within the tissue
bath restored both the force of contraction of the auricles (Figure 7) and
their responsiveness to added catecholamines (Figure 8). The threshold
concentration of calcium in the Locke's solution to render the auricles re-
sponsive to epinephrine was found to be about 0.225 of the usual concentra-
tion (or about 2.7 mgT instead of the standard 12 mg%o).
1
Figure 6. Decrease in	 10 j
force of contraction and
eventual cessation of 	 a	 b	 C	 d
beating of auricles sus-
pended in Locke's solu-
tion containing only
1/10 the usual concen-
tration of Ca; lack of
responsiveness of these
3auricles to epinephrine, 	 j
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Figure 7. Restora-
tion of contractile
force by addition of
CaCl, to the bath.
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Figure 8. Restoration of
responsiveness to epine-
phrine after addition of
CaCla to the bath.
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Because we were interested in providing to NASA, if possible, guid-
ance on ways for preventing the sensitization of the heart by the fluorinated
halocarbon compounds, we thought that Verapamil (or Iproveratril or Isoptin)
might be of use. When we applied this drug, which is held by some to act by
preventing the migration of calcium through the excited membrane of 01C
muscle fiber to the contractile elements, minimizing thereby the activatwr)
of ca-dependent ATPase (Fleckenstein et al., 1967; V luckQmstu hi, l 970), wu
found that its addition to the bath in a concentration of 0. 48 mg /100 ml had
effects quite different from those of lowered external concentration of ca lciui
Instead of decreasing the force of contraction, as dial a low external coilcu")-
tration of calcium, Verapamil increased the force of contraction, but did
slow the rate of beating somewhat (Figure 9. ) In this figure, the rate had
been decreased by only about 7%. With longer exposure to the drug, the ram
fell further (to about 33% of its original value), but the force of contraction
increased even more (Figure 10).
r
Figure 9. Decrease in
rate of beating and in-
crease in force of con-
traction of auricles by
addition of Verapamil
to the bath.
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Another drug that we have studied with our isolation auricle prepara-
N	 b	 1' d	 h d be f d	 h d	 bLion is a capo enatc. T us rug a	 en oun to prevent t e m ucLion y
epinephrine of arrhythmias in anesthetized dogs, cats and guinea pigs that
were breathing vapors of halocarbon compounds. This com pound, added to
the bath after periods of exptx3ure to Freon® and of recovery thereafter,
induced an apparent increase in the strength of contraction of the auricular
m!iscle (Figure 11).
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Figure 11. Increase in strength of contraction of
auricles by Na capobenate added to the bath after
periods of exposure to Freon ® 11 and of recovery
therefrom.
From this work, we derive the following conclusions: 	 i
1	 Vaporized Freon® 11 apparently has enough solubility
in water to be able to affect the contractile properties
of auricular muscle, =decreasing the rate of beating
after an initial heightening of tension development.
2.	 Exposure to vaporized Freon ® 11, although it may
stop spontaneous beating of the auricles, seems not
to damage the tissue, so that spontaneous beating
will reappear when the Freon ® has been washed
out of the tissue.
a
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3. A lowered external concentration of calcium and
addition of Verapamil to the Locke's solution in
which the *auricles were suspended had quite dif-
ferent effects on the beating of the auricles, so
that we tend to be somewhat skeptical, about the
theory that Verapamil operates entirely through
preventing the ingress of calcium to the cardiac
muscle cell.
4. A compound that has A -adrenergic blocking activity
and also some a-adrenergic blocking activity, Na
capobenate, seems to be able to improve tension
development by auricular muscle after a period
of exposure to vaporized Freon 11.
i
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DISCUSSION
DR. STOKINGER (National Institute of Occupational Safety and
Health): What's the chemical nature of those drugs? Are they amines or
what?
DR. WILLS (Albany Medical College): Sodium capobenate is a fairly
long chain fatty acid ester. Verapamil has an amine structure, but I can't
give you its constitution in detail now. I have it in my briefcase.
DR. BACK (Aerospace Medical Research Laboratory): I looked it up.
It's a dimethoxy compound that would look like a steroid if it were bent
around. It has 2 benzene rings on it with 2 methoxy groups on each ring.
,.^	 If you could bend it around, it would look like a veratrum alkaloid but it isn't.
It's in the Merck Index. I never heard of the compound before, frankly. I
think it's a German drug, but I don't know whether it's ever been marketed.
I'm really not familiar with it.
MR. VERNOT (University of California, Irvine): Dr. Wills, was it
your intention to use this preparation as an in vitro model of the heart to try
to obtain some insight into the arrythmic potential of these freons in the in-
tact animal?
DR. WILLS: That's right. Unfortunately, however, we've not been
able to demonstrate sensitization with this preparation.
MR. VERNOT: You didn't show that epinephrine, itself, had any
1. action on the system, did you?
DR. WILLS: Yes, it does but we haven't been able to show that
freon increases its action.
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Last year, I reported that 6 fluorinated halocarbon compounds that
we had studied, Freons® 11, 12, 116, and C-318 and Halons ®
 1301 and
2402, had been found to sensitize the myocardium to the arrhythmogenic
action of epinephrine. As an extension of that work, we undertook a study
of the effect of Freon®
 11, one of the most potent sensitizing compounds,
on isolated atrial tissue.
We used the auricles of the heart of the rat, which were suspended
between the bendable member of a bonded strain-gauge transducer and a
fixed point and immersed in a bAth of Locke's solution. This bath was
aerated through a fritted glass disk with a gas mixture containing 957, O,
and 57 CO,, pumped by a diaphragm pump. The same pump was arranged
to transfer the same mixture of gases containing a small amount of vaporized
Freon®
 11 from a spirometer through the organ bath. The set-up is rep-}}
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Figure 2 shows
the beginning of an ex-
posure of a pair of au-
ricles to the gas mix-
ture containing ITT (v/v)
of vaporized Freon® 11.
It is obvious that there
was no immediate effect
After a period of expo-
s!r-e of the auricles to
he gas mixture con-
taining Freon® 11,
there was a marked de-
crease in their rate of
repetitive contraction
(Figure 3). This was
followed fairly promptly
by complete cessation
of contraction (Figure 4).
Upon replace-
ment of the gas mixture
containing Freon ® 11
by the uncontaminated
gas, rhythmic contrac-
tion by the auricles was
resumed rapidly
(Figure 5) and contin-
ued for long periods of
time thereafter. This
recovery of normal
rhythmic contraction
indicates to us that the
exposure to vaporized
Freon® 11, even though
it was pressed to the
point of stopping the
spontaneous contrac-
tions of the auricles,
did not injure the au-
ricular muscles.
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Figure 4. Cessationof
Contraction of Auricles
Exposed to Vaporized
Freon® 11.
5
L
Figure 5. Resumption of
Beating by Auricles after 	 , ^•^	 +•^, "'^
Aeration witl: Gas Contain-
ing no Freon® 11.
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Last year, we presented evidence that the sensitization of the heart to
extrinsic catecholamines by inhalation of vapors of FreonO 11 was not re-
lated to an increased concentration of norepinephrine within the myocardium,
to enhanced formation of either l»l'A or DOPamine, or to altered perme-
ability of the myocardial cells to K. Because of the well-known ability of
calcium to link the excitatory and contractile processes in the myocardial
muscle (Langer, 1968; Bailey and Dresel, 1968; Little and Sleator, 1969;
Sanborn and Langer, 1970; Saari and Johnson, 1971; Shine, Serena, and
Langer, 1971), we decided to use the isolated auricles to study the effect of
a low external concentration of calcium on the response of the heart to
catecholamines as well as on spontaneous activity by the auricles. We found
that lowering the concentration of calcium in the I.ocke's solution to 1/10 its
usual value decreased the force of contraction of the auricles with only a
slight, immediate effect to decrease their rate of beating, but eventually did
stop the contractions; the auricles did not respond to addition of epinephrine
to the fluid within the bath either while they continued to beat or after they
became quiescent (Figure 6). Addition of CaCl 2 to the fluid within the tissuebath restored both the force of contraction of the auricles (Figure 7) and
their responsiveness to added catecholamines (Figure 8). The threshold
concentration of calcium in the Locke's solution to render the auricles re-
sponsive to epinephrine was found to be about 0.225 of the usual concentra-
tion (or about 2.7 mgJo instead of the standard 12 mgTO ).
10Figure 6. Decrease in
force of contraction and
eventual cessation of
beating of auricles sus-
pended in Locke's solu-
tion containing only
1/10 the usual concen-
tration of Ca; lack of
responsiveness of these
auricles to epinephrine.
a	 b	 c d
a = normal
b = after 0. 2 normal Cam
c = after epinephrine
d = later, second addi-
tion of epinephrine
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Figure 7. Restora-
tion of contractile
force by addition of
CaC1 2 to the bath.
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Figure 8. Restoration of
responsiveness to epine-
phrine after addition of
CaC12 to the bath.
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Because we were interested in providing to NASA, if possible, guid-
ance on ways for preventing the sensitisation of the heart by the fluorinated
halocarbon compounds, we thought that Verapamil (or Iproveratril or Isuptin)
might be of use. Whenwe applied this drug, which is held by some to act by
preventing the migration of calcium through the excited membrane of Lhe
muscle fiber to the contractile elements, minimising thereby theactivation
of ca-dependent An ase (Fleckenstein et al. , 1967; Fleckenstein, 1970), we
found that its addition to the bath in a concentration of 0. 48 mg/100 inl had
effects quite different from those of lowered external concentration of calcium.
Instead of decreasing the force of contraction, as did a low external cuei4.:tn-
tration of calcium, Verapamil increased the force of contraction, but did
slow the rate of beating somewhat (Figure 9. ) In this figure, the rate had
been decreased by only about 7%. With longer exposure to the drug, the rare
fell further (to about 33 0 of its original value), but the force of contraction
increased even more (Figure 10).
Figure 10. Further
slowing and increase
in force of contraction
of auricles by longer
contact with
Verapamil.	
1
5 min. A4tr V er b p 'CM.`41
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Another drug that we have studied with our isolation auricle prepara-
tion is Na capobenatc. This drug had been found to prevent the induction by
epinephrine of arrhythmias in anesthetized dogs, cats and guinea pigs that
were breathing vapors of haiocarbon compounds. This com pound, added to
the bath after periods of exposure to Freon @ and of recovery thereafter,
induced an apparent increase in the strength of contraction of the auricular
ml iscle (Figure 11).
^arm-) ECa"l
Figure 11. Increase in strength of contraction of
auricles by Na capobenate added to the bath after
periods of exposure to Freon® 11 and of recovery
therefrom.
From this work, we derive the following conclusions:
1. Vaporized Freon ® 11 apparently has enough solubility
in water to be able to affect the contractile properties
of auricular muscle, decreasing the rate of beating
after an initial heightening of tension development.
2. Exposure to vaporized Freon ® 11, although it may
stop spontaneous beating of the auricles, seems not
to damage the tissue, so that spontaneous beating
will reappear when the Freon ® has been washed
out of the tissue.
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3. A lowered external concentration of calcium and
addition of Verapamil to the Locke's solution in
which the auricles were suspended had quite dif-
ferent effects on the beating of the auricles, so
that we tend to be somewhat skeptical about the
theory that Verapamil operates entirely through
preventing the ingress of calcium to the cardiac
muscle cell.
4. A compound that has 0 -adrenergic blocking activity
and also some a-adrenergic blocking activity, Na
capobenate, seems to be able to improve tension
development by auricular muscle after a period
of exposure to vaporized Freon 11.
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DISCUSSION
DR. STOKINGER (National Institute of Occupational Safety and
Health): What's the chemical nature of those drugs? Are they amines or
what?
DR. WILLS (Albany Medical College): Sodium capobenate is a fairly
long chain fatty acid ester. Verapamil has an amine structure, but I can't
give you its constitution in detail now. I have it in my briefcase.
DR. BACK (Aerospace Medical Research Laboratory): I looked it up.
It's a dimethoxy compound that would look like a steroid if it were bent
around. It has 2 benzene rings on it with 2 methoxy groups on each ring.
If you could bend it around, it would look like a veratrum alkaloid but it isn't.
It's in the Merck Index. I never heard of the compound before, frankly. I
think it's a German drug, but I don't know whether it's ever been marketed.
I'm really not familiar with it.
MR. VERNOT (University of California, Irvine): Dr. Wills, was it
your intenticn to use this preparation as an in vitro model of the heart to try
to obtain some insight into the arrythmic potential of these freons in the in-
tact animal?
DR. WILLS: That's right. Unfortunately, however, we've not been
able to demonstrate sensitization with this preparation.
MR. VERNOT: You didn't show that epinephrine, itself, had any
action on the system, did you?
-'	 DR. WILLS: Yes, it does but we haven't been able to show that
freon increases its action.
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